<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication" DOI="10.1002/14651858.CD000937.pub2" GROUP_ID="PREG" ID="706399081020093629" MERGED_FROM="" MODIFIED="2014-04-01 09:42:18 +0100" MODIFIED_BY="Leanne Jones" REVIEW_NO="0181" REVMAN_SUB_VERSION="5.2.8 " REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="11.0">
<COVER_SHEET MODIFIED="2014-04-01 09:42:18 +0100" MODIFIED_BY="Leanne Jones">
<TITLE>Magnesium supplementation in pregnancy</TITLE>
<CONTACT MODIFIED="2014-04-01 09:42:18 +0100" MODIFIED_BY="Leanne Jones"><PERSON ID="4805" ROLE="AUTHOR"><PREFIX>Prof</PREFIX><FIRST_NAME>Maria</FIRST_NAME><LAST_NAME>Makrides</LAST_NAME><POSITION>Theme Leader</POSITION><EMAIL_1>maria.makrides@health.sa.gov.au</EMAIL_1><ADDRESS><DEPARTMENT>Healthy Mothers, Babies and Children</DEPARTMENT><ORGANISATION>South Australian Health and Medical Research Institute</ORGANISATION><ADDRESS_1>C/- WCHRI</ADDRESS_1><ADDRESS_2>72 King William Road</ADDRESS_2><CITY>North Adelaide</CITY><ZIP>5006</ZIP><REGION>SA</REGION><COUNTRY CODE="AU">Australia</COUNTRY><PHONE_1>0881617443</PHONE_1><PHONE_2>0881616179</PHONE_2><FAX_1>0882390267</FAX_1></ADDRESS></PERSON></CONTACT>
<CREATORS MODIFIED="2014-04-01 09:42:18 +0100" MODIFIED_BY="Leanne Jones"><PERSON ID="4805" ROLE="AUTHOR"><PREFIX>Prof</PREFIX><FIRST_NAME>Maria</FIRST_NAME><LAST_NAME>Makrides</LAST_NAME><POSITION>Theme Leader</POSITION><EMAIL_1>maria.makrides@health.sa.gov.au</EMAIL_1><ADDRESS><DEPARTMENT>Healthy Mothers, Babies and Children</DEPARTMENT><ORGANISATION>South Australian Health and Medical Research Institute</ORGANISATION><ADDRESS_1>C/- WCHRI</ADDRESS_1><ADDRESS_2>72 King William Road</ADDRESS_2><CITY>North Adelaide</CITY><ZIP>5006</ZIP><REGION>SA</REGION><COUNTRY CODE="AU">Australia</COUNTRY><PHONE_1>0881617443</PHONE_1><PHONE_2>0881616179</PHONE_2><FAX_1>0882390267</FAX_1></ADDRESS></PERSON><PERSON ID="5B46BAC782E26AA201D66C39740F85A3" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Danielle</FIRST_NAME><MIDDLE_INITIALS>D</MIDDLE_INITIALS><LAST_NAME>Crosby</LAST_NAME><POSITION>Research Assistant</POSITION><EMAIL_1>ddcrosby86@gmail.com</EMAIL_1><ADDRESS><DEPARTMENT>ARCH: Australian Research Centre for Health of Women and Babies, The Robinson Institute, Discipline of Obstetrics and Gynaecology</DEPARTMENT><ORGANISATION>The University of Adelaide</ORGANISATION><ADDRESS_1>Women's and Children's Hospital</ADDRESS_1><ADDRESS_2>72 King William Road</ADDRESS_2><CITY>Adelaide</CITY><ZIP>SA 5006</ZIP><COUNTRY CODE="AU">Australia</COUNTRY><FAX_1>+61 8 81617652</FAX_1></ADDRESS></PERSON><PERSON ID="80185962598070725765110310093139" ROLE="AUTHOR"><PREFIX>Ms</PREFIX><FIRST_NAME>Emily</FIRST_NAME><LAST_NAME>Bain</LAST_NAME><EMAIL_1>emily.bain@adelaide.edu.au</EMAIL_1><ADDRESS><DEPARTMENT>ARCH: Australian Research Centre for Health of Women and Babies, The Robinson Institute, Discipline of Obstetrics and Gynaecology</DEPARTMENT><ORGANISATION>The University of Adelaide</ORGANISATION><CITY>Adelaide</CITY><ZIP>5006</ZIP><REGION>South Australia</REGION><COUNTRY CODE="AU">Australia</COUNTRY><PHONE_1>+61 8 81617647</PHONE_1><FAX_1>+61 8 81617652</FAX_1></ADDRESS></PERSON><PERSON ID="15869" ROLE="AUTHOR"><PREFIX>Prof</PREFIX><FIRST_NAME>Caroline</FIRST_NAME><MIDDLE_INITIALS>A</MIDDLE_INITIALS><LAST_NAME>Crowther</LAST_NAME><POSITION>Professor</POSITION><EMAIL_1>caroline.crowther@adelaide.edu.au</EMAIL_1><ADDRESS><DEPARTMENT>Liggins Institute</DEPARTMENT><ORGANISATION>The University of Auckland</ORGANISATION><ADDRESS_1>Private Bag 92019</ADDRESS_1><ADDRESS_2>85 Park Road</ADDRESS_2><CITY>Auckland</CITY><COUNTRY CODE="NZ">New Zealand</COUNTRY></ADDRESS></PERSON></CREATORS>
<DATES MODIFIED="2014-03-28 13:52:04 +0000" MODIFIED_BY="Leanne V Jones">
<UP_TO_DATE>
<DATE DAY="31" MONTH="3" YEAR="2013"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="31" MONTH="3" YEAR="2013"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="22" MONTH="7" YEAR="2015"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="1" YEAR="1998"/>
<REVIEW_PUBLISHED ISSUE="2" YEAR="1998"/>
<LAST_CITATION_ISSUE ISSUE="4" YEAR="2014"/>
</DATES>
<WHATS_NEW MODIFIED="2014-03-19 13:09:34 +0000" MODIFIED_BY="Heather Maxwell">
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_NEW_CONCLUSIONS" MODIFIED="2014-03-19 13:09:34 +0000" MODIFIED_BY="Heather Maxwell">
<DATE DAY="3" MONTH="9" YEAR="2013"/>
<DESCRIPTION>
<P>New evidence incorporated. In this update there is now some evidence of an effect for magnesium on the secondary outcomes of neonatal death prior to discharge, Apgar score less than seven at five minutes, meconium-stained liquor, fetal heart rate deceleration and mild hypoxic ischaemic encephalopathy. There is now no evidence of an effect for magnesium supplementation on the primary outcome small-for-gestational age and secondary outcomes of preterm birth at less than 37 weeks, low birthweight and antepartum haemorrhage.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2013-09-04 02:24:54 +0100" MODIFIED_BY="[Empty name]">
<DATE DAY="3" MONTH="9" YEAR="2013"/>
<DESCRIPTION>
<P>We have included three new trials (<LINK REF="STD-Hungary-1979" TYPE="STUDY">Hungary 1979</LINK>; <LINK REF="STD-Italy-1994" TYPE="STUDY">Italy 1994</LINK>; <LINK REF="STD-South-Africa-2007" TYPE="STUDY">South Africa 2007</LINK>), and have excluded nine studies (<LINK REF="STD-Denmark-1990" TYPE="STUDY">Denmark 1990</LINK>; <LINK REF="STD-Denmark-1991" TYPE="STUDY">Denmark 1991</LINK>; <LINK REF="STD-Detroit-1999" TYPE="STUDY">Detroit 1999</LINK>; <LINK REF="STD-India-2012" TYPE="STUDY">India 2012</LINK>; <LINK REF="STD-ISRCTN03989660" TYPE="STUDY">ISRCTN03989660</LINK>; <LINK REF="STD-NCT01709968" TYPE="STUDY">NCT01709968</LINK>; <LINK REF="STD-Norway-2008" TYPE="STUDY">Norway 2008</LINK>; <LINK REF="STD-Sweden-1987" TYPE="STUDY">Sweden 1987</LINK>; <LINK REF="STD-Sweden-1995" TYPE="STUDY">Sweden 1995</LINK>). Two trials have been classified as ongoing (<LINK REF="STD-ISRCTN98365455" TYPE="STUDY">ISRCTN98365455</LINK>; <LINK REF="STD-NCT01510665" TYPE="STUDY">NCT01510665</LINK>).</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</WHATS_NEW>
<HISTORY MODIFIED="2013-07-22 05:28:16 +0100" MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2013-07-22 05:28:14 +0100" MODIFIED_BY="[Empty name]">
<DATE DAY="11" MONTH="9" YEAR="2012"/>
<DESCRIPTION>
<P>Contact details updated.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2013-05-03 04:27:53 +0100" MODIFIED_BY="[Empty name]">
<DATE DAY="1" MONTH="10" YEAR="2009"/>
<DESCRIPTION>
<P>Search updated. Fifteen reports added to <A HREF="http://archie.cochrane.org/sections/documents/view?version=02826074589734674810120911115459&amp;format=REVMAN#AWAITING_STUDIES">Studies awaiting classification</A>.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2013-05-03 04:27:53 +0100" MODIFIED_BY="[Empty name]">
<DATE DAY="17" MONTH="9" YEAR="2008"/>
<DESCRIPTION>
<P>Converted to new review format.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_NEW_CONCLUSIONS" MODIFIED="2013-07-17 04:09:40 +0100" MODIFIED_BY="[Empty name]">
<DATE DAY="24" MONTH="7" YEAR="2001"/>
<DESCRIPTION>
<P>Substantive amendment.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2013-07-22 05:28:16 +0100" MODIFIED_BY="[Empty name]">
<DATE DAY="17" MONTH="7" YEAR="2001"/>
<DESCRIPTION>
<P>Addition of primary paper of Austrian trial (<A HREF="http://archie.cochrane.org/sections/documents/view?version=02826074589734674810120911115459&amp;format=REVMAN#STD-Austria-1997">Austria 1997</A>), addition of Chinese trial (<A HREF="http://archie.cochrane.org/sections/documents/view?version=02826074589734674810120911115459&amp;format=REVMAN#STD-China-1997">China 1997</A>), additional meta-analysis with the exclusion of Hungarian trial (<A HREF="http://archie.cochrane.org/sections/documents/view?version=02826074589734674810120911115459&amp;format=REVMAN#STD-Hungary-1988">Hungary 1988</A>) based on comment/criticism.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</HISTORY>
<SOURCES_OF_SUPPORT MODIFIED="2012-11-02 04:43:12 +0000" MODIFIED_BY="[Empty name]">
<INTERNAL_SOURCES MODIFIED="2012-11-02 04:43:12 +0000" MODIFIED_BY="[Empty name]">
<SOURCE MODIFIED="2012-11-02 04:43:07 +0000" MODIFIED_BY="[Empty name]">
<NAME>ARCH, Robinson Institute, The University of Adelaide</NAME>
<COUNTRY CODE="AU">Australia</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE MODIFIED="2012-11-02 04:43:12 +0000" MODIFIED_BY="[Empty name]">
<NAME>Women's &amp; Children's Health Research Institute, Adelaide</NAME>
<COUNTRY CODE="AU">Australia</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</INTERNAL_SOURCES>
<EXTERNAL_SOURCES MODIFIED="2010-07-15 05:48:21 +0100" MODIFIED_BY="[Empty name]">
<SOURCE>
<NAME>National Health and Medical Research Council</NAME>
<COUNTRY CODE="AU">Australia</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE MODIFIED="2010-07-15 05:48:21 +0100" MODIFIED_BY="[Empty name]">
<NAME>Commonwealth Department of Health and Ageing</NAME>
<COUNTRY CODE="AU">Australia</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</EXTERNAL_SOURCES>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2014-04-01 09:39:01 +0100" MODIFIED_BY="Leanne V Jones">
<SUMMARY MODIFIED="2014-01-21 04:34:57 +0000" MODIFIED_BY="[Empty name]">
<TITLE>There is not enough high quality evidence to show that dietary magnesium supplementation during pregnancy is beneficial</TITLE>
<SUMMARY_BODY MODIFIED="2014-01-21 04:34:57 +0000" MODIFIED_BY="[Empty name]">
<P>Many women, especially those from disadvantaged backgrounds, have intakes of magnesium below recommended levels. Magnesium supplementation during pregnancy may be able to reduce growth restriction of the fetus and pre-eclampsia (high blood pressure and protein in the urine during pregnancy), and increase birthweight. This review aimed to assess the effects of magnesium supplementation during pregnancy on maternal, neonatal and paediatric outcomes.</P>
<P>We included 10 randomised trials involving 9090 women and their babies in this review. These trials were of a low to moderate quality overall. No difference in the risk of perinatal mortality (stillbirth and death of babies prior to hospital discharge) was found when we compared the group of babies born to mothers who received magnesium during their pregnancy and the group of babies born to mothers who did not receive magnesium. Magnesium supplementation did not reduce the risk of babies being born small for their gestational age, and did not reduce the risk of pre-eclampsia for the mothers.</P>
<P>We found no convincing evidence that magnesium supplementation during pregnancy is beneficial.</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT MODIFIED="2014-03-31 12:24:53 +0100" MODIFIED_BY="Leanne V Jones">
<ABS_BACKGROUND MODIFIED="2013-02-04 23:20:21 +0000" MODIFIED_BY="[Empty name]">
<P>Magnesium is an essential mineral required for regulation of body temperature, nucleic acid and protein synthesis and in maintaining nerve and muscle cell electrical potentials. Many women, especially those from disadvantaged backgrounds, have low intakes of magnesium. Magnesium supplementation during pregnancy may be able to reduce fetal growth restriction and pre-eclampsia, and increase birthweight.</P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES MODIFIED="2013-08-22 07:15:11 +0100" MODIFIED_BY="[Empty name]">
<P>To assess the effects of magnesium supplementation during pregnancy on maternal, neonatal/infant and paediatric outcomes.</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY MODIFIED="2013-09-06 09:15:14 +0100" MODIFIED_BY="[Empty name]">
<P>We searched the Cochrane Pregnancy and Childbirth Group's Trials Register (31 March 2013).</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA MODIFIED="2014-01-21 03:55:58 +0000" MODIFIED_BY="[Empty name]">
<P>Randomised and quasi-randomised trials assessing the effects of dietary magnesium supplementation during pregnancy were included. The primary outcomes were perinatal mortality (including stillbirth and neonatal death prior to hospital discharge), small-for-gestational age, maternal mortality and pre-eclampsia.</P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION MODIFIED="2013-02-04 23:20:33 +0000" MODIFIED_BY="[Empty name]">
<P>Two review authors independently assessed study eligibility, extracted data and assessed the risk of bias of included studies.</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS MODIFIED="2014-03-31 12:24:53 +0100" MODIFIED_BY="Leanne V Jones">
<P>Ten trials involving 9090 women and their babies were included; one trial had a cluster design (with randomisation by study centre). All 10 trials randomly allocated women to either an oral magnesium supplement or a control group; in eight trials a placebo was used, and in two trials no treatment was given to the control group. In the 10 included trials, the compositions of the magnesium supplements, gestational ages at commencement, and doses administered varied, including: magnesium oxide, 1000 mg daily from &#8804; four months post-conception (one trial); magnesium citrate, 365 mg daily from &#8804; 18 weeks until hospitalisation after 38 weeks (one trial), and 340 mg daily from nine to 27 weeks' gestation (one trial); magnesium gluconate, 2 to 3 g from 28 weeks' gestation until birth (one trial), and 4 g daily from 23 weeks' gestation (one trial); magnesium aspartate, 15 mmol daily (three trials, commencing from either six to 21 weeks' gestation until birth, &#8804; 16 weeks' gestation until birth, or &lt; 12 weeks until birth), or 365 mg daily from 13 to 24 weeks until birth (one trial); and magnesium stearate, 128 mg elemental magnesium from 10 to 35 weeks until birth (one trial). </P>
<P>In the analysis of all trials, oral magnesium supplementation compared to no magnesium was associated with no significant difference in perinatal mortality (stillbirth and neonatal death prior to discharge) (risk ratio (RR) 1.10; 95% confidence interval (CI) 0.72 to 1.67; five trials, 5903 infants), small-for-gestational age (RR 0.76; 95% CI 0.54 to 1.07; three trials, 1291 infants), or pre-eclampsia (RR 0.87; 95% CI 0.58 to 1.32; three trials, 1042 women). None of the included trials reported on maternal mortality.</P>
<P>Considering secondary outcomes, while no increased risk of stillbirth was observed, a possible increased risk of neonatal death prior to hospital discharge was shown for infants born to mothers who had received magnesium (RR 2.21; 95% CI 1.02 to 4.75; four trials, 5373 infants). One trial contributed over 70% of the participants to the analysis for this outcome; the trial authors suggested that the large number of severe congenital anomalies in the supplemented group (unlikely attributable to magnesium) and the deaths of two sets of twins (with birthweights &lt; 750 g) in the supplemented group likely accounted for the increased risk of death observed, and thus this result should be interpreted with caution. Furthermore, when the deaths due to severe congenital abnormalities in this trial were excluded from the meta-analysis, no increased risk of neonatal death was seen for the magnesium supplemented group. Magnesium supplementation was associated with significantly fewer babies with an Apgar score less than seven at five minutes (RR 0.34; 95% CI 0.15 to 0.80; four trials, 1083 infants), with meconium-stained liquor (RR 0.79; 95% CI 0.63 to 0.99; one trial, 4082 infants), late fetal heart decelerations (RR 0.68; 95% CI 0.53 to 0.88; one trial, 4082 infants), and mild hypoxic-ischaemic encephalopathy (RR 0.38; 95% CI 0.15 to 0.98; one trial, 4082 infants). Women receiving magnesium were significantly less likely to require hospitalisation during pregnancy (RR 0.65, 95% CI 0.48 to 0.86; three trials, 1158 women).</P>
<P>Of the 10 trials included in the review, only two were judged to be of high quality overall. When an analysis was restricted to these two trials none of the review's primary outcomes (perinatal mortality, small-for-gestational age, pre-eclampsia) were significantly different between the magnesium supplemented and control groups.</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS MODIFIED="2013-09-04 01:36:33 +0100" MODIFIED_BY="[Empty name]">
<P>There is not enough high-quality evidence to show that dietary magnesium supplementation during pregnancy is beneficial.</P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2014-04-01 09:39:01 +0100" MODIFIED_BY="Leanne V Jones">
<BACKGROUND MODIFIED="2014-03-20 09:44:04 +0000" MODIFIED_BY="Heather Maxwell">
<P>Magnesium is one of the essential minerals needed by humans in relatively large amounts. Magnesium works with many enzymes to regulate body temperature, synthesise nucleic acids and proteins as well as maintaining electrical potentials in nerves and muscle membranes. Magnesium also has an important role in modulating vasomotor tone and cardiac excitability. Magnesium occurs widely in many foods; dairy products, breads and cereals, legumes, vegetables and meats are all good sources. It is therefore not surprising that frank magnesium deficiency has never been reported to occur in healthy individuals who eat varied diets. However, processing of the above foods can lead to marked depletion of magnesium. Common causes of magnesium deficiency include inadequate dietary intake or gastrointestinal absorption, increased losses through the gastrointestinal or renal systems and increased requirement for magnesium, such as in pregnancy.</P>
<P>A study measuring serum magnesium during low-risk pregnancies reported that both ionised and total serum magnesium were significantly reduced after the 18th week of gestation compared to measurements prior to this time (<LINK REF="REF-Arikan-1999" TYPE="REFERENCE">Arikan 1999</LINK>). Dietary intake studies during pregnancy consistently demonstrate that many women, especially those from disadvantaged backgrounds, have intakes of magnesium below recommended levels (<LINK REF="REF-Inst-Med-1990" TYPE="REFERENCE">Inst Med 1990</LINK>). In a retrospective study of medical records, <LINK REF="REF-Conradt-1984" TYPE="REFERENCE">Conradt 1984</LINK> reported that magnesium supplementation during pregnancy was associated with a reduced risk of fetal growth retardation and pre-eclampsia. A later cross-sectional study of dietary intake towards the end of the first trimester of pregnancy reported that higher magnesium intake was associated with increased birthweight (<LINK REF="REF-Doyle-1989" TYPE="REFERENCE">Doyle 1989</LINK>). Stimulated by these encouraging preliminary reports, several randomised clinical trials have been undertaken to evaluate the potential benefits of magnesium supplementation during pregnancy on maternal and infant outcomes.</P>
<IMPORTANCE MODIFIED="2013-10-04 09:34:44 +0100" MODIFIED_BY="[Empty name]">
<P>This review updates a previously published Cochrane review on magnesium supplementation during pregnancy (<LINK REF="REF-Makrides-2001" TYPE="REFERENCE">Makrides 2001</LINK>). In this previous version of the review, magnesium supplementation was shown to be associated with a lower frequency of preterm birth, low birthweight and small-for-gestational age when compared with placebo. However, of the seven trials included in this previous version, only one was judged to be of high quality. Thus the review authors concluded that there was not enough high-quality evidence to show that dietary magnesium supplementation during pregnancy is beneficial.</P>
<P>It is important to assess whether magnesium supplementation during pregnancy has benefits for mothers and their infants without causing harm. We believe this review could provide information about the potential for magnesium supplementation to improve neonatal/infant outcomes such as weight and growth and improve maternal outcomes such as pre-eclampsia, without causing adverse effects for women and their babies.</P>
</IMPORTANCE>
</BACKGROUND>
<OBJECTIVES MODIFIED="2013-07-23 01:20:14 +0100" MODIFIED_BY="[Empty name]">
<P>To assess the effects of magnesium supplementation during pregnancy on maternal, neonatal/infant and paediatric outcomes, using the best available evidence.</P>
</OBJECTIVES>
<METHODS MODIFIED="2014-04-01 09:39:01 +0100" MODIFIED_BY="Leanne V Jones">
<SELECTION_CRITERIA MODIFIED="2014-04-01 09:37:37 +0100" MODIFIED_BY="Leanne V Jones">
<CRIT_STUDIES MODIFIED="2014-01-17 03:08:06 +0000" MODIFIED_BY="[Empty name]">
<P>All published, unpublished and ongoing randomised, quasi-randomised trials or cluster-randomised trials of dietary magnesium supplementation during pregnancy. For the purpose of this review, a dietary supplement was defined as a product taken by mouth that contains a <I>"dietary ingredient"</I> intended to supplement the diet (<LINK REF="REF-US-FDA-2009" TYPE="REFERENCE">US FDA 2009</LINK>).</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS>
<P>Women with normal or high-risk pregnancies.</P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS MODIFIED="2013-08-22 07:25:39 +0100" MODIFIED_BY="[Empty name]">
<P>We included studies where magnesium was administered orally at any time during the antenatal period, regardless of dose. We excluded where magnesium was administered intravenously/intramuscularly.</P>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES MODIFIED="2014-04-01 09:37:37 +0100" MODIFIED_BY="Leanne V Jones">
<CRIT_OUTCOMES_PRIMARY MODIFIED="2014-01-21 03:57:20 +0000" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="5">Infant</HEADING>
<UL>
<LI>Perinatal mortality (including stillbirth and neonatal death prior to hospital discharge)</LI>
<LI>Small-for-gestational age</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Maternal</HEADING>
<UL>
<LI>Maternal mortality</LI>
<LI>Pre-eclampsia</LI>
</UL>
</SUBSECTION>
</CRIT_OUTCOMES_PRIMARY>
<CRIT_OUTCOMES_SECONDARY MODIFIED="2014-04-01 09:37:37 +0100" MODIFIED_BY="Leanne V Jones">
<SUBSECTION>
<HEADING LEVEL="5">Infant</HEADING>
<UL>
<LI>Stillbirth</LI>
<LI>Neonatal death prior to hospital discharge</LI>
<LI>Miscarriage</LI>
<LI>Gestational age at birth</LI>
<LI>Preterm birth at less than 37 weeks</LI>
<LI>Birthweight and low birthweight</LI>
<LI>Admission to a neonatal intensive care unit</LI>
<LI>Long-term infant outcomes (disability at paediatric follow-up)</LI>
</UL>
<SUBSECTION>
<HEADING LEVEL="6">Infant outcomes not pre-specified in the original protocol</HEADING>
<UL>
<LI>Low Apgar score at one or five minutes</LI>
<LI>Late fetal heart decelerations</LI>
<LI>Meconium-stained liquor and meconium aspiration</LI>
<LI>Breech presentation</LI>
<LI>Placental abruption</LI>
<LI>Placental weight</LI>
<LI>Hypoxic ischaemic encephalopathy (HIE) and neonatal encephalopathy</LI>
<LI>Congenital abnormalities</LI>
</UL>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Maternal</HEADING>
<UL>
<LI>Maternal acceptance of treatment</LI>
<LI>Side effects of therapy (grouped as gastrointestinal and non-gastrointestinal)</LI>
<LI>Systolic and diastolic blood pressure</LI>
<LI>Pregnancy-induced hypertension</LI>
<LI>Eclampsia</LI>
<LI>Need for maternal hospitalisation</LI>
<LI>Antepartum and postpartum haemorrhage</LI>
<LI>Length of labour</LI>
</UL>
<P/>
<P>The methods section of this review is based on a standard template used by the Cochrane Pregnancy and Childbirht Group. </P>
</SUBSECTION>
</CRIT_OUTCOMES_SECONDARY>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2014-03-20 09:44:34 +0000" MODIFIED_BY="Heather Maxwell">
<ELECTRONIC_SEARCHES MODIFIED="2014-03-20 09:44:34 +0000" MODIFIED_BY="Heather Maxwell">
<P>For the search strategy used to identify trials included in the previous version of this review (<LINK TAG="OTHER_VERSIONS_REFERENCES" TYPE="SECTION">Other published versions of this review</LINK>), see <LINK REF="APP-01" TYPE="APPENDIX">Appendix 1</LINK>.</P>
<P>For this update, we contacted the Trials Search Co-ordinator to search the Cochrane Pregnancy and Childbirth Group&#8217;s Trials Register (31 March 2013). </P>
<P>The Cochrane Pregnancy and Childbirth Group&#8217;s Trials Register is maintained by the Trials Search Co-ordinator and contains trials identified from:</P>
<OL>
<LI>monthly searches of the Cochrane Central Register of Controlled Trials (CENTRAL);</LI>
<LI>weekly searches of MEDLINE;</LI>
<LI>weekly searches of Embase;</LI>
<LI>handsearches of 30 journals and the proceedings of major conferences;</LI>
<LI>weekly current awareness alerts for a further 44 journals plus monthly BioMed Central email alerts.</LI>
</OL>
<P>Details of the search strategies for CENTRAL, MEDLINE and Embase, the list of handsearched journals and conference proceedings, and the list of journals reviewed via the current awareness service can be found in the &#8216;Specialized Register&#8217; section within the editorial information about the <A HREF="http://www.mrw.interscience.wiley.com/cochrane/clabout/articles/PREG/frame.html">Cochrane Pregnancy and Childbirth Group</A>.</P>
<P>Trials identified through the searching activities described above are each assigned to a review topic (or topics). The Trials Search Co-ordinator searches the register for each review using the topic list rather than keywords. </P>
<P>We did not apply any language restrictions.</P>
</ELECTRONIC_SEARCHES>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2014-04-01 09:39:01 +0100" MODIFIED_BY="Leanne V Jones">
<P>For the methods used when assessing the trials identified in a previous version of this review (<LINK TAG="OTHER_VERSIONS_REFERENCES" TYPE="SECTION">Other published versions of this review</LINK>), see <LINK REF="APP-01" TYPE="APPENDIX">Appendix 1</LINK>.</P>
<P>For the most recent update we used the following methods when assessing the trials identified by the search.</P>
<STUDY_SELECTION MODIFIED="2013-05-03 01:35:06 +0100" MODIFIED_BY="[Empty name]">
<P>Two review authors independently assessed for inclusion all the potential studies we identified as a result of the search strategy. We resolved any disagreement through discussion or, if required, we consulted a third person.</P>
</STUDY_SELECTION>
<DATA_EXTRACTION MODIFIED="2014-03-28 13:54:51 +0000" MODIFIED_BY="Leanne V Jones">
<P>We designed a form to extract data. For eligible studies, at least two review authors extracted the data using the agreed form. We resolved discrepancies through discussion or, if required, we consulted a third person. We entered data into Review Manager software (<LINK REF="REF-RevMan-2012" TYPE="REFERENCE">RevMan 2012</LINK>) and checked for accuracy.</P>
<P>When information regarding any of the above was unclear, we attempted to contact authors of the original reports to provide further details. When articles were not written in English, every attempt was made to obtain translations to ensure accurate data extraction and analysis.</P>
</DATA_EXTRACTION>
<QUALITY_ASSESSMENT MODIFIED="2014-03-20 09:45:30 +0000" MODIFIED_BY="Heather Maxwell">
<P>Two review authors independently assessed risk of bias for each study using the criteria outlined in the <I>Cochrane Handbook for Systematic Reviews of Interventions</I> (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>). We resolved any disagreement by discussion or by involving a third author.</P>
<SUBSECTION>
<HEADING LEVEL="4">(1) Random sequence generation (checking for possible selection bias)</HEADING>
<P>We described for each included study the methods used to generate the allocation sequence in sufficient detail to allow an assessment of whether it should produce comparable groups.</P>
<P>We assessed the methods as:</P>
<UL>
<LI>low risk of bias (any truly random process, e.g. random number table; computer random number generator);</LI>
<LI>high risk of bias (any non-random process, e.g. odd or even date of birth; hospital or clinic record number);</LI>
<LI>unclear risk of bias.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">(2) Allocation concealment (checking for possible selection bias)</HEADING>
<P>We described for each included study the method used to conceal the allocation sequence and determined whether intervention allocation could have been foreseen in advance of, or during recruitment, or changed after assignment.</P>
<P>We assessed the methods as:</P>
<UL>
<LI>low risk of bias (e.g. telephone or central randomisation; consecutively numbered sealed opaque envelopes);</LI>
<LI>high risk of bias (open random allocation; unsealed or non-opaque envelopes, alternation; date of birth);</LI>
<LI>unclear risk of bias.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">(3.1) Blinding of participants and personnel (checking for possible performance bias)</HEADING>
<P>We described for each included study, the methods, if any, used to blind study participants and personnel from knowledge of which intervention a participant received. We considered studies to be at a low risk of bias if they were blinded, or if we judged that the lack of blinding would be unlikely to affect results. We assessed blinding separately for different outcomes or classes of outcomes.</P>
<P>We assessed the methods as:</P>
<UL>
<LI>low, high or unclear risk of bias for participants;</LI>
<LI>low, high or unclear risk of bias for personnel.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">(3.2) Blinding of outcome assessment (checking for possible detection bias)</HEADING>
<P>We described for each included study the methods used, if any, to blind outcome assessors from knowledge of which intervention a participant received. We assessed blinding separately for different outcomes or classes of outcomes.</P>
<P>We assessed methods used to blind outcome assessment as:</P>
<UL>
<LI>low, high or unclear risk of bias.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">(4) Incomplete outcome data (checking for possible attrition bias due to the amount, nature and handling of incomplete outcome data)</HEADING>
<P>We described for each included study and for each outcome or class of outcomes, the completeness of data including attrition and exclusions from the analysis. We stated whether attrition and exclusions were reported, the numbers included in the analysis at each stage (compared with the total randomised participants), reasons for attrition or exclusion where reported, and whether missing data were balanced across groups or were related to outcomes. Where sufficient information was reported or was supplied by the trial authors, we included the missing data in the analyses which we undertook.</P>
<P> We assessed the methods as:</P>
<UL>
<LI>low risk of bias (e.g. where there was no missing data or where reasons for missing data were balanced across groups);</LI>
<LI>high risk of bias (e.g. numbers or reasons for missing data imbalanced across groups; 'as treated' analysis done with substantial departure of intervention received from that assigned at randomisation);</LI>
<LI>unclear risk of bias.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">(5) Selective reporting bias (checking for reporting bias)</HEADING>
<P>We described for each included study how the possibility of selective outcome reporting bias was examined by us and what we found.</P>
<P>We assessed the methods as:</P>
<UL>
<LI>low risk of bias (where it was clear that all of the study&#8217;s pre-specified outcomes and all expected outcomes of interest to the review had been reported);</LI>
<LI>high risk of bias (where not all the study&#8217;s pre-specified outcomes had been reported; one or more reported primary outcomes were not pre-specified; outcomes of interest were reported incompletely and so could not be used; study failed to include results of a key outcome that would have been expected to have been reported);</LI>
<LI>unclear risk of bias.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">(6) Other sources of bias (checking for bias due to problems not covered by (1) to (5) above)</HEADING>
<P>We described for each included study any important concerns we had about other possible sources of bias. We assessed whether each study was free of other problems that could put it at risk of bias:</P>
<UL>
<LI>low risk of other bias;</LI>
<LI>high risk of other bias;</LI>
<LI>unclear whether there is risk of other bias.</LI>
</UL>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">(7) Overall risk of bias</HEADING>
<P>We made explicit judgements about whether studies were at high risk of bias, according to the criteria given in the <I>Cochrane Handbook for Systematic Reviews of Interventions</I> (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>). With reference to (1) to (6) above, we assessed the likely magnitude and direction of the bias and whether we considered it is likely to impact on the findings. We explored the impact of the level of bias through undertaking sensitivity analyses - <I>see </I>
<LINK TAG="SENSITIVITY_ANALYSIS" TYPE="SECTION">Sensitivity analysis</LINK>.</P>
</SUBSECTION>
</QUALITY_ASSESSMENT>
<EFFECT_MEASURES MODIFIED="2013-08-27 12:19:41 +0100" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="4">Dichotomous data</HEADING>
<P>For dichotomous data, we presented results as summary risk ratio with 95% confidence intervals</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Continuous data</HEADING>
<P>For continuous data, we used the mean difference when outcomes were measured in the same way between trials. We planned to use the standardised mean difference to combine trials that measured the same outcome, but used different methods.</P>
</SUBSECTION>
</EFFECT_MEASURES>
<UNIT_OF_ANALYSIS MODIFIED="2014-03-20 09:45:56 +0000" MODIFIED_BY="Heather Maxwell">
<SUBSECTION>
<HEADING LEVEL="4">Cluster-randomised trials</HEADING>
<P>We have included one cluster-randomised trial (<LINK REF="STD-Hungary-1988" TYPE="STUDY">Hungary 1988</LINK>) in the analyses along with individually-randomised trials. We have adjusted its sample size and event rates using the methods described in the <I>Cochrane Handbook</I> and a conservative estimate of the intracluster correlation co-efficient (ICC) (0.02) in the primary analysis (<A HREF="http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD009021.pub2/full#CD009021-bbs2-0053">Higgins 2011</A>) (<LINK REF="TBL-01" TYPE="TABLE">Table 1</LINK>). As estimates of ICCs for mortality outcomes have been shown to be lower than for other perinatal outcomes, we also carried out a sensitivity analysis to investigate the effect of varying the ICC (using a range of ICCs from 0.0002 to 0.02) for the outcomes perinatal mortality, stillbirth, and neonatal death prior to discharge.</P>
<P>We acknowledged heterogeneity in the randomisation unit and performed a subgroup analysis to investigate the effects of the randomisation unit.</P>
</SUBSECTION>
</UNIT_OF_ANALYSIS>
<MISSING_DATA MODIFIED="2013-08-22 07:26:47 +0100" MODIFIED_BY="[Empty name]">
<P>For included studies, we noted levels of attrition. We planned to explore the impact of including studies with high levels of missing data in the overall assessment of treatment effect by using sensitivity analyses.</P>
<P>For all outcomes, we carried out analyses, as far as possible, on an intention-to-treat basis, i.e. we attempted to include all participants randomised to each group in the analyses, and all participants were analysed in the group to which they were allocated, regardless of whether or not they received the allocated intervention. The denominator for each outcome in each trial was the number randomised minus any participants whose outcomes were known to be missing.</P>
</MISSING_DATA>
<HETEROGENEITY_ASSESSMENT MODIFIED="2014-03-28 13:54:06 +0000" MODIFIED_BY="Leanne V Jones">
<P>We assessed statistical heterogeneity in each meta-analysis using the Tau², I² and Chi² statistics. We regarded heterogeneity as substantial if an I² was greater than 30% and either the Tau² was greater than zero, or there was a low P value (less than 0.10) in the Chi² test for heterogeneity. </P>
</HETEROGENEITY_ASSESSMENT>
<BIAS_ASSESSMENT MODIFIED="2014-03-20 09:34:51 +0000" MODIFIED_BY="Heather Maxwell">
<P>In future updates of this review, if there are 10 or more studies in the meta-analysis, we plan to investigate reporting biases (such as publication bias) using funnel plots. We will assess funnel plot asymmetry visually. If asymmetry is suggested by a visual assessment, we will perform exploratory analyses to investigate it.</P>
</BIAS_ASSESSMENT>
<DATA_SYNTHESIS MODIFIED="2014-04-01 09:39:01 +0100" MODIFIED_BY="Leanne V Jones">
<P>We carried out statistical analysis using the Review Manager software (<LINK REF="REF-RevMan-2012" TYPE="REFERENCE">RevMan 2012</LINK>). We used fixed-effect meta-analysis for combining data where it was reasonable to assume that studies were estimating the same underlying treatment effect: i.e. where trials were examining the same intervention, and the trials&#8217; populations and methods were judged sufficiently similar. If there was clinical heterogeneity sufficient to expect that the underlying treatment effects differed between trials, or where substantial statistical heterogeneity was detected, we used random-effects meta-analysis to produce an overall summary, if an average treatment effect across trials was considered clinically meaningful. The random-effects summary was treated as the average range of possible treatment effects and we have discussed the clinical implications of treatment effects differing between trials. If the average treatment effect was not clinically meaningful, we would not have combined trials.</P>
<P>Where we have used random-effects analyses, we have presented the results as the average treatment effect with its 95% confidence interval, and the estimates of  Tau² and I².</P>
</DATA_SYNTHESIS>
<SUBGROUP_ANALYSIS MODIFIED="2014-03-20 09:36:53 +0000" MODIFIED_BY="Heather Maxwell">
<P>If we had identified substantial heterogeneity, we planned to investigate it using subgroup analyses and sensitivity analyses. We planned to consider whether an overall summary was meaningful, and if it was, used random-effects analysis to produce it.</P>
<P>Maternal characteristics and characteristics of the intervention may affect health outcomes.</P>
<P>We planned to carry out the following subgroup analyses.</P>
<UL>
<LI>Composition of magnesium supplement (i.e. magnesium citrate versus magnesium aspartate versus other)</LI>
<LI>Dose of magnesium (i.e. high versus low)</LI>
<LI>Gestational age at commencement of supplementation (i.e. commencement at &lt; 28 weeks versus &#8805; 28 weeks)</LI>
<LI>Normal versus high-risk women</LI>
</UL>
<P>However, we were not able to conduct subgroup analyses based on the gestational age at commencement of supplementation or on the inclusion of normal versus high-risk women, as only one trial administered magnesium after 28 weeks' gestation and included high-risk women (<LINK REF="STD-China-1997" TYPE="STUDY">China 1997</LINK>), and this trial did not report on any of the review's primary outcomes. We were not able to conduct a subgroup analysis based on dose in this update.</P>
<P>We restricted subgroup analyses to primary outcomes.</P>
<P>We assessed subgroup differences by interaction tests available within RevMan (<LINK REF="REF-RevMan-2012" TYPE="REFERENCE">RevMan 2012</LINK>). We have reported the results of subgroup analyses quoting the Chi² statistic and P value, and the interaction test I² value.</P>
</SUBGROUP_ANALYSIS>
<SENSITIVITY_ANALYSIS MODIFIED="2013-08-22 07:28:45 +0100" MODIFIED_BY="[Empty name]">
<P>We carried out a sensitivity analysis to explore the effects of trial quality assessed by allocation concealment and sequence generation, by omitting studies rated as 'high risk of bias' and 'unclear' for these components. We restricted this to the primary outcomes.</P>
</SENSITIVITY_ANALYSIS>
</DATA_COLLECTION>
</METHODS>
<RESULTS MODIFIED="2014-03-28 13:57:30 +0000" MODIFIED_BY="Leanne V Jones">
<STUDY_DESCRIPTION MODIFIED="2014-03-20 09:47:51 +0000" MODIFIED_BY="Heather Maxwell">
<P>
<I>See</I> <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>; <LINK TAG="CHARACTERISTICS_OF_EXCLUDED_STUDIES" TYPE="SECTION">Characteristics of excluded studies</LINK> and <LINK TAG="CHARACTERISTICS_OF_ONGOING_STUDIES" TYPE="SECTION">Characteristics of ongoing studies</LINK>.</P>
<SEARCH_RESULTS MODIFIED="2013-08-27 12:21:56 +0100" MODIFIED_BY="[Empty name]">
<P>The updated search of the Cochrane Pregnancy and Childbirth Group&#8217;s Trials Register identified 22 new reports relating to 14 studies.</P>
<P>We have included three new trials (<LINK REF="STD-Hungary-1979" TYPE="STUDY">Hungary 1979</LINK>; <LINK REF="STD-Italy-1994" TYPE="STUDY">Italy 1994</LINK>; <LINK REF="STD-South-Africa-2007" TYPE="STUDY">South Africa 2007</LINK>), and have excluded nine studies (<LINK REF="STD-Denmark-1990" TYPE="STUDY">Denmark 1990</LINK>; <LINK REF="STD-Denmark-1991" TYPE="STUDY">Denmark 1991</LINK>; <LINK REF="STD-Detroit-1999" TYPE="STUDY">Detroit 1999</LINK>; <LINK REF="STD-India-2012" TYPE="STUDY">India 2012</LINK>; <LINK REF="STD-ISRCTN03989660" TYPE="STUDY">ISRCTN03989660</LINK>; <LINK REF="STD-NCT01709968" TYPE="STUDY">NCT01709968</LINK>; <LINK REF="STD-Norway-2008" TYPE="STUDY">Norway 2008</LINK>; <LINK REF="STD-Sweden-1987" TYPE="STUDY">Sweden 1987</LINK>; <LINK REF="STD-Sweden-1995" TYPE="STUDY">Sweden 1995</LINK>).</P>
<P>Two trials are currently ongoing, assessing magnesium supplementation in the second trimester of pregnancy for overweight individuals (<LINK REF="STD-NCT01510665" TYPE="STUDY">NCT01510665</LINK>) and magnesium citrate for the prevention of increased blood pressure during the final weeks of pregnancy (<LINK REF="STD-ISRCTN98365455" TYPE="STUDY">ISRCTN98365455</LINK>) (<I>see</I> <LINK TAG="CHARACTERISTICS_OF_ONGOING_STUDIES" TYPE="SECTION">Characteristics of ongoing studies</LINK> for further details).</P>
<P>We previously included seven trials in this review (<LINK REF="STD-Angola-1992" TYPE="STUDY">Angola 1992</LINK>; <LINK REF="STD-Austria-1997" TYPE="STUDY">Austria 1997</LINK>; <LINK REF="STD-China-1997" TYPE="STUDY">China 1997</LINK>; <LINK REF="STD-Hungary-1988" TYPE="STUDY">Hungary 1988</LINK>; <LINK REF="STD-Memphis-1989" TYPE="STUDY">Memphis 1989</LINK>; <LINK REF="STD-Mississippi-1992" TYPE="STUDY">Mississippi 1992</LINK>; <LINK REF="STD-Zurich-1988" TYPE="STUDY">Zurich 1988</LINK>). We have therefore included a total of 10 trials (<LINK REF="STD-Angola-1992" TYPE="STUDY">Angola 1992</LINK>; <LINK REF="STD-Austria-1997" TYPE="STUDY">Austria 1997</LINK>; <LINK REF="STD-China-1997" TYPE="STUDY">China 1997</LINK>; <LINK REF="STD-Hungary-1979" TYPE="STUDY">Hungary 1979</LINK>; <LINK REF="STD-Hungary-1988" TYPE="STUDY">Hungary 1988</LINK>; <LINK REF="STD-Italy-1994" TYPE="STUDY">Italy 1994</LINK>; <LINK REF="STD-Memphis-1989" TYPE="STUDY">Memphis 1989</LINK>; <LINK REF="STD-Mississippi-1992" TYPE="STUDY">Mississippi 1992</LINK>; <LINK REF="STD-South-Africa-2007" TYPE="STUDY">South Africa 2007</LINK>; <LINK REF="STD-Zurich-1988" TYPE="STUDY">Zurich 1988</LINK>), and excluded a total of nine studies from this review.</P>
</SEARCH_RESULTS>
<INCLUDED_STUDIES_DESCR MODIFIED="2014-03-20 09:47:42 +0000" MODIFIED_BY="Heather Maxwell">
<P>For full details <I>see </I>
<LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK>.</P>
<P>Five studies were conducted in Europe (<LINK REF="STD-Austria-1997" TYPE="STUDY">Austria 1997</LINK>; <LINK REF="STD-Hungary-1979" TYPE="STUDY">Hungary 1979</LINK>; <LINK REF="STD-Hungary-1988" TYPE="STUDY">Hungary 1988</LINK>; <LINK REF="STD-Italy-1994" TYPE="STUDY">Italy 1994</LINK>; <LINK REF="STD-Zurich-1988" TYPE="STUDY">Zurich 1988</LINK>), two in America (<LINK REF="STD-Memphis-1989" TYPE="STUDY">Memphis 1989</LINK>; <LINK REF="STD-Mississippi-1992" TYPE="STUDY">Mississippi 1992</LINK>), two in Africa (<LINK REF="STD-Angola-1992" TYPE="STUDY">Angola 1992</LINK>; <LINK REF="STD-South-Africa-2007" TYPE="STUDY">South Africa 2007</LINK>), and one in Asia (<LINK REF="STD-China-1997" TYPE="STUDY">China 1997</LINK>).</P>
<SUBSECTION>
<HEADING LEVEL="4">Participants</HEADING>
<P>A total of 9090 women and their babies were included in the 10 trials; four trials had sample sizes of less than 150 women (<LINK REF="STD-Angola-1992" TYPE="STUDY">Angola 1992</LINK>; <LINK REF="STD-China-1997" TYPE="STUDY">China 1997</LINK>; <LINK REF="STD-Italy-1994" TYPE="STUDY">Italy 1994</LINK>; <LINK REF="STD-Mississippi-1992" TYPE="STUDY">Mississippi 1992</LINK>), and the <LINK REF="STD-South-Africa-2007" TYPE="STUDY">South Africa 2007</LINK> trial randomised 4476 women.</P>
<P>In six trials both primiparous and multiparous women were included (<LINK REF="STD-Angola-1992" TYPE="STUDY">Angola 1992</LINK>; <LINK REF="STD-Austria-1997" TYPE="STUDY">Austria 1997</LINK>; <LINK REF="STD-Hungary-1988" TYPE="STUDY">Hungary 1988</LINK>; <LINK REF="STD-Mississippi-1992" TYPE="STUDY">Mississippi 1992</LINK>; <LINK REF="STD-South-Africa-2007" TYPE="STUDY">South Africa 2007</LINK>; <LINK REF="STD-Zurich-1988" TYPE="STUDY">Zurich 1988</LINK>) while in three trials, only primiparous women were included (<LINK REF="STD-China-1997" TYPE="STUDY">China 1997</LINK>; <LINK REF="STD-Italy-1994" TYPE="STUDY">Italy 1994</LINK>; <LINK REF="STD-Memphis-1989" TYPE="STUDY">Memphis 1989</LINK>); this was not clearly specified in <LINK REF="STD-Hungary-1979" TYPE="STUDY">Hungary 1979</LINK>.</P>
<P>Women were recruited at various stages in their pregnancies into the included trials. In the <LINK REF="STD-Angola-1992" TYPE="STUDY">Angola 1992</LINK> trial, designed for the prevention of pre-eclampsia, women were recruited at any stage during their first four months of pregnancy, whereas in <LINK REF="STD-China-1997" TYPE="STUDY">China 1997</LINK>, also designed for the prevention of pregnancy-induced hypertension, normal and high-risk women were recruited from 22 weeks' gestation. Women with low-risk pregnancies were recruited into the <LINK REF="STD-Austria-1997" TYPE="STUDY">Austria 1997</LINK> trial before their 18th week of pregnancy, for the prevention of preterm labour; in the <LINK REF="STD-Mississippi-1992" TYPE="STUDY">Mississippi 1992</LINK> trial however, women with risk factors for preterm birth were recruited at a mean gestational age at entry between 23 and 24 weeks. In <LINK REF="STD-Hungary-1988" TYPE="STUDY">Hungary 1988</LINK> and <LINK REF="STD-South-Africa-2007" TYPE="STUDY">South Africa 2007</LINK>, women were recruited at their first antenatal clinic/appointment (in <LINK REF="STD-South-Africa-2007" TYPE="STUDY">South Africa 2007</LINK> the gestational age of women varied from 10 to 35 weeks, with a mean of 21 weeks). In <LINK REF="STD-Memphis-1989" TYPE="STUDY">Memphis 1989</LINK> women were recruited from between 13 and 24 weeks' gestation, whereas in <LINK REF="STD-Italy-1994" TYPE="STUDY">Italy 1994</LINK> and <LINK REF="STD-Zurich-1988" TYPE="STUDY">Zurich 1988</LINK>, women were included at no later than 12 and 16 weeks respectively.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Interventions and comparisons</HEADING>
<P>In the 10 included trials, the composition of the magnesium supplements, gestational ages at commencement of supplementation, and doses administered varied. In eight of the trials a placebo supplement (<LINK REF="STD-Angola-1992" TYPE="STUDY">Angola 1992</LINK>; <LINK REF="STD-China-1997" TYPE="STUDY">China 1997</LINK>; <LINK REF="STD-Hungary-1988" TYPE="STUDY">Hungary 1988</LINK>; <LINK REF="STD-Italy-1994" TYPE="STUDY">Italy 1994</LINK>; <LINK REF="STD-Mississippi-1992" TYPE="STUDY">Mississippi 1992</LINK>; <LINK REF="STD-South-Africa-2007" TYPE="STUDY">South Africa 2007</LINK>) or active control (aspartic acid) (<LINK REF="STD-Memphis-1989" TYPE="STUDY">Memphis 1989</LINK>; <LINK REF="STD-Zurich-1988" TYPE="STUDY">Zurich 1988</LINK>) was used; in two trials, no treatment was given to the control group (<LINK REF="STD-Austria-1997" TYPE="STUDY">Austria 1997</LINK>; <LINK REF="STD-Hungary-1979" TYPE="STUDY">Hungary 1979</LINK>).</P>
<P>
<I>Magnesium oxide:</I>
<B> </B>in one trial (<LINK REF="STD-Angola-1992" TYPE="STUDY">Angola 1992</LINK>) women were given two tablets daily of magnesium oxide 500 mg (1000 mg total daily) beginning from no later than four months post-conception.</P>
<P>
<I>Magnesium citrate:</I>
<B> </B>in two trials, women received magnesium citrate tablets (<LINK REF="STD-Austria-1997" TYPE="STUDY">Austria 1997</LINK>; <LINK REF="STD-Hungary-1979" TYPE="STUDY">Hungary 1979</LINK>). Women in <LINK REF="STD-Austria-1997" TYPE="STUDY">Austria 1997</LINK> were given 365 mg of magnesium citrate daily from no later than 18 weeks' gestation until hospitalisation after 38 weeks, whereas women in <LINK REF="STD-Hungary-1979" TYPE="STUDY">Hungary 1979</LINK> received 340 mg of magnesium citrate daily, either before nine weeks' gestation, or from nine to 27 weeks' gestation.</P>
<P>
<I>Magnesium gluconate:</I>
<B> </B>women in two trials received magnesium gluconate (<LINK REF="STD-China-1997" TYPE="STUDY">China 1997</LINK>; <LINK REF="STD-Mississippi-1992" TYPE="STUDY">Mississippi 1992</LINK>).<B> </B>In <LINK REF="STD-China-1997" TYPE="STUDY">China 1997</LINK> women received 2 g of magnesium gluconate daily from 28 weeks' gestation to 30 weeks; they then received 3 g daily from 30 weeks until delivery. In <LINK REF="STD-Mississippi-1992" TYPE="STUDY">Mississippi 1992</LINK> women received two 500 mg tablets of magnesium gluconate four times daily (4 g daily total, 215 mg elemental magnesium) from 23 weeks' gestation.</P>
<P>
<I>Magnesium aspartate:</I>
<B> </B>in four trials, women received magnesium aspartate. In <LINK REF="STD-Hungary-1988" TYPE="STUDY">Hungary 1988</LINK>, <LINK REF="STD-Italy-1994" TYPE="STUDY">Italy 1994</LINK> and <LINK REF="STD-Zurich-1988" TYPE="STUDY">Zurich 1988</LINK> women received 15 mmol of magnesium aspartate daily. In <LINK REF="STD-Hungary-1988" TYPE="STUDY">Hungary 1988</LINK> women received a tablet of 5 mmol three times per day from six to 21 weeks' gestation until birth, whereas in <LINK REF="STD-Zurich-1988" TYPE="STUDY">Zurich 1988</LINK> women received six tablets daily from no later than 16 weeks' gestation until birth. In <LINK REF="STD-Italy-1994" TYPE="STUDY">Italy 1994</LINK> supplementation commenced before 12 weeks' gestation. In <LINK REF="STD-Memphis-1989" TYPE="STUDY">Memphis 1989</LINK> women received six tablets of magnesium aspartate hydrochloride per day (each containing 60.8 mg elemental magnesium: 365 mg daily) from between 13 to 24 weeks until birth.</P>
<P>
<I>Magnesium stearate:</I> in <LINK REF="STD-South-Africa-2007" TYPE="STUDY">South Africa 2007</LINK> women received two 'slow-release' magnesium tablets daily (64 mg elemental magnesium per tablet) from the time of enrolment (10 to 35 weeks; mean: 21 weeks) until birth.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Outcomes</HEADING>
<P>All of the 10 included trials focused on perinatal outcomes for women and/or their babies (<LINK REF="STD-Angola-1992" TYPE="STUDY">Angola 1992</LINK>; <LINK REF="STD-Austria-1997" TYPE="STUDY">Austria 1997</LINK>; <LINK REF="STD-China-1997" TYPE="STUDY">China 1997</LINK>; <LINK REF="STD-Hungary-1979" TYPE="STUDY">Hungary 1979</LINK>; <LINK REF="STD-Hungary-1988" TYPE="STUDY">Hungary 1988</LINK>; <LINK REF="STD-Italy-1994" TYPE="STUDY">Italy 1994</LINK>; <LINK REF="STD-Memphis-1989" TYPE="STUDY">Memphis 1989</LINK>; <LINK REF="STD-Mississippi-1992" TYPE="STUDY">Mississippi 1992</LINK>; <LINK REF="STD-South-Africa-2007" TYPE="STUDY">South Africa 2007</LINK>; <LINK REF="STD-Zurich-1988" TYPE="STUDY">Zurich 1988</LINK>). None of the included studies reported on any longer-term outcomes for the infants.</P>
</SUBSECTION>
</INCLUDED_STUDIES_DESCR>
<EXCLUDED_STUDIES_DESCR MODIFIED="2014-03-20 09:47:51 +0000" MODIFIED_BY="Heather Maxwell">
<P>Four studies were excluded as intravenous magnesium sulphate was administered as part of the intervention (<LINK REF="STD-Denmark-1990" TYPE="STUDY">Denmark 1990</LINK>; <LINK REF="STD-Denmark-1991" TYPE="STUDY">Denmark 1991</LINK>; <LINK REF="STD-Detroit-1999" TYPE="STUDY">Detroit 1999</LINK>; <LINK REF="STD-India-2012" TYPE="STUDY">India 2012</LINK>). Four further trials were excluded (<LINK REF="STD-ISRCTN03989660" TYPE="STUDY">ISRCTN03989660</LINK>; <LINK REF="STD-NCT01709968" TYPE="STUDY">NCT01709968</LINK>; <LINK REF="STD-Norway-2008" TYPE="STUDY">Norway 2008</LINK>; <LINK REF="STD-Sweden-1995" TYPE="STUDY">Sweden 1995</LINK>), as they assessed the effects of oral magnesium supplementation on pregnancy-related leg cramps and therefore have been (or are likely to be) considered for inclusion in the relevant Cochrane review (<LINK REF="REF-Garrison-2012" TYPE="REFERENCE">Garrison 2012</LINK>). One further trial (<LINK REF="STD-Sweden-1987" TYPE="STUDY">Sweden 1987</LINK>) did not assess magnesium, rather assessed calcium and vitamin C for pregnant women with leg cramps.</P>
<P>
<I>See</I> <LINK TAG="CHARACTERISTICS_OF_EXCLUDED_STUDIES" TYPE="SECTION">Characteristics of excluded studies</LINK> for further details.</P>
</EXCLUDED_STUDIES_DESCR>
</STUDY_DESCRIPTION>
<STUDY_QUALITY MODIFIED="2014-03-20 09:53:51 +0000" MODIFIED_BY="Heather Maxwell">
<P>We judged the trials to have a moderate risk of bias overall. See <LINK REF="FIG-01" TYPE="FIGURE">Figure 1</LINK> and <LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK>.</P>
<ALLOCATION MODIFIED="2014-03-20 09:48:02 +0000" MODIFIED_BY="Heather Maxwell">
<P>Four of the 10 trials used adequate methods to generate a random sequence (<LINK REF="STD-Angola-1992" TYPE="STUDY">Angola 1992</LINK>; <LINK REF="STD-Austria-1997" TYPE="STUDY">Austria 1997</LINK>; <LINK REF="STD-Memphis-1989" TYPE="STUDY">Memphis 1989</LINK>; <LINK REF="STD-South-Africa-2007" TYPE="STUDY">South Africa 2007</LINK>). <LINK REF="STD-Angola-1992" TYPE="STUDY">Angola 1992</LINK> used a table of random numbers; in <LINK REF="STD-Austria-1997" TYPE="STUDY">Austria 1997</LINK>, <LINK REF="STD-Memphis-1989" TYPE="STUDY">Memphis 1989</LINK> and <LINK REF="STD-South-Africa-2007" TYPE="STUDY">South Africa 2007</LINK> a computer-generated randomisation list was used. For five trials, the methods used for random sequence generation were unclear (<LINK REF="STD-China-1997" TYPE="STUDY">China 1997</LINK>; <LINK REF="STD-Hungary-1979" TYPE="STUDY">Hungary 1979</LINK>; <LINK REF="STD-Hungary-1988" TYPE="STUDY">Hungary 1988</LINK>; <LINK REF="STD-Italy-1994" TYPE="STUDY">Italy 1994</LINK>; <LINK REF="STD-Mississippi-1992" TYPE="STUDY">Mississippi 1992</LINK>), and in one trial, allocation was based on the participants' date of birth (<LINK REF="STD-Zurich-1988" TYPE="STUDY">Zurich 1988</LINK>).</P>
<P>Only two trials were judged to have adequate methods to conceal allocation (<LINK REF="STD-Memphis-1989" TYPE="STUDY">Memphis 1989</LINK>; <LINK REF="STD-South-Africa-2007" TYPE="STUDY">South Africa 2007</LINK>). In <LINK REF="STD-Memphis-1989" TYPE="STUDY">Memphis 1989</LINK> allocation was performed through the hospital pharmacy; in <LINK REF="STD-South-Africa-2007" TYPE="STUDY">South Africa 2007</LINK> research assistants not involved in the care of the women issued consecutive numbers to each participant. For the remaining seven trials, the risk of selection bias due to inadequate allocation concealment was judged as unclear (<LINK REF="STD-Angola-1992" TYPE="STUDY">Angola 1992</LINK>; <LINK REF="STD-Austria-1997" TYPE="STUDY">Austria 1997</LINK>; <LINK REF="STD-China-1997" TYPE="STUDY">China 1997</LINK>; <LINK REF="STD-Hungary-1979" TYPE="STUDY">Hungary 1979</LINK>; <LINK REF="STD-Hungary-1988" TYPE="STUDY">Hungary 1988</LINK>; <LINK REF="STD-Italy-1994" TYPE="STUDY">Italy 1994</LINK>; <LINK REF="STD-Mississippi-1992" TYPE="STUDY">Mississippi 1992</LINK>).</P>
</ALLOCATION>
<BLINDING MODIFIED="2014-03-20 09:48:11 +0000" MODIFIED_BY="Heather Maxwell">
<P>A placebo was used in six of the 10 trials (<LINK REF="STD-Angola-1992" TYPE="STUDY">Angola 1992</LINK>; <LINK REF="STD-China-1997" TYPE="STUDY">China 1997</LINK>; <LINK REF="STD-Hungary-1988" TYPE="STUDY">Hungary 1988</LINK>; <LINK REF="STD-Italy-1994" TYPE="STUDY">Italy 1994</LINK>; <LINK REF="STD-Mississippi-1992" TYPE="STUDY">Mississippi 1992</LINK>; <LINK REF="STD-South-Africa-2007" TYPE="STUDY">South Africa 2007</LINK>); in <LINK REF="STD-Memphis-1989" TYPE="STUDY">Memphis 1989</LINK> and <LINK REF="STD-Zurich-1988" TYPE="STUDY">Zurich 1988</LINK> women in the control group received tablets containing aspartic acid. Blinding of participants, personnel and outcome assessors was judged to be adequate in five of these eight trials (<LINK REF="STD-China-1997" TYPE="STUDY">China 1997</LINK>; <LINK REF="STD-Italy-1994" TYPE="STUDY">Italy 1994</LINK>; <LINK REF="STD-Memphis-1989" TYPE="STUDY">Memphis 1989</LINK>; <LINK REF="STD-Mississippi-1992" TYPE="STUDY">Mississippi 1992</LINK>; <LINK REF="STD-South-Africa-2007" TYPE="STUDY">South Africa 2007</LINK>). In <LINK REF="STD-Angola-1992" TYPE="STUDY">Angola 1992</LINK> whilst a placebo was used, the placebo and magnesium oxide tablets were distributed in different quantities to the women, and it was unclear if the tablets were identical in appearance; thus the risk of performance and detection bias were judged as unclear. In <LINK REF="STD-Hungary-1988" TYPE="STUDY">Hungary 1988</LINK> the success of blinding of participants and personnel was also judged as unclear, as while a placebo was used, it was unclear whether this was identical in appearance to the magnesium aspartate tablets, and the leader of the study was able to identify of the composition of the tablets by identification marks.</P>
<P>In <LINK REF="STD-Zurich-1988" TYPE="STUDY">Zurich 1988</LINK>, while the study was described as <I>"double-blind" </I>and a placebo was used, allocation was based on the participants' date of birth, and thus it was unclear as to whether blinding would have been successfully achieved for personnel, participants and outcome assessors.</P>
<P>
<LINK REF="STD-Austria-1997" TYPE="STUDY">Austria 1997</LINK> was judged to be at a high risk of performance and detection bias with no blinding of participants, personnel or outcome assessors. In <LINK REF="STD-Hungary-1979" TYPE="STUDY">Hungary 1979</LINK>, while no placebo was used, the translation of the manuscript detailed blind outcome assessment.</P>
</BLINDING>
<EXCLUSIONS MODIFIED="2014-03-20 09:53:51 +0000" MODIFIED_BY="Heather Maxwell">
<P>Three of the nine trials were judged to be at a low risk of attrition bias, with no or minimal post-randomisation exclusions or attrition (<LINK REF="STD-China-1997" TYPE="STUDY">China 1997</LINK>; <LINK REF="STD-Hungary-1979" TYPE="STUDY">Hungary 1979</LINK>; <LINK REF="STD-Italy-1994" TYPE="STUDY">Italy 1994</LINK>). The remaining seven trials were judged to be at an unclear risk of attrition bias (<LINK REF="STD-Angola-1992" TYPE="STUDY">Angola 1992</LINK>; <LINK REF="STD-Austria-1997" TYPE="STUDY">Austria 1997</LINK>; <LINK REF="STD-Hungary-1988" TYPE="STUDY">Hungary 1988</LINK>; <LINK REF="STD-Memphis-1989" TYPE="STUDY">Memphis 1989</LINK>; <LINK REF="STD-Mississippi-1992" TYPE="STUDY">Mississippi 1992</LINK>; <LINK REF="STD-South-Africa-2007" TYPE="STUDY">South Africa 2007</LINK>; <LINK REF="STD-Zurich-1988" TYPE="STUDY">Zurich 1988</LINK>).</P>
<P>In <LINK REF="STD-Angola-1992" TYPE="STUDY">Angola 1992</LINK> post-randomisation exclusions were not reported. In <LINK REF="STD-Austria-1997" TYPE="STUDY">Austria 1997</LINK>, 7.5% of women (25 from the treatment group (9.7%) and 15 (5.7%) from the control group) were excluded for a variety of reasons including lack of compliance and gastro-intestinal problems with supplementation. In <LINK REF="STD-Hungary-1988" TYPE="STUDY">Hungary 1988</LINK>, while only 7/507 and 5/490 women were excluded from the placebo and magnesium groups initially (1.2% total), a further 104/500 (20.8%) were excluded from the placebo group and 85/485 (17.5%) from the magnesium group for a number of reasons including loss to follow-up. In the <LINK REF="STD-Memphis-1989" TYPE="STUDY">Memphis 1989</LINK> trial, 11/200 (5.5%) women from the placebo group and 15/200 (7.5%) from the treatment group were excluded as they never started medication. In <LINK REF="STD-South-Africa-2007" TYPE="STUDY">South Africa 2007</LINK>, 190 women were excluded post-randomisation, and a further 204 were lost to follow-up (394/4476) and it was not possible to determine to which groups these women were randomised. Similarly in <LINK REF="STD-Mississippi-1992" TYPE="STUDY">Mississippi 1992</LINK>, it was not possible to ascertain from which group(s) the seven (13%) excluded women were originally assigned. Finally in <LINK REF="STD-Zurich-1988" TYPE="STUDY">Zurich 1988</LINK>, the total number of women in each group were not reported in results tables, and it was thus difficult to determine exclusions or attrition; the manuscript detailed that <I>"For various reasons such as refusal to take further tablets, delivery in other hospitals or abortion, some data were not available for analysis".</I>
</P>
</EXCLUSIONS>
<SELECTIVE_REPORTING MODIFIED="2013-07-22 06:48:17 +0100" MODIFIED_BY="[Empty name]">
<P>Only one trial was judged to be at a low risk of selective reporting, with data reported for all pre-specified and/or expected outcomes (<LINK REF="STD-Memphis-1989" TYPE="STUDY">Memphis 1989</LINK>). For the remaining nine trials, the risk of reporting bias was judged to be unclear (<LINK REF="STD-Angola-1992" TYPE="STUDY">Angola 1992</LINK>; <LINK REF="STD-Austria-1997" TYPE="STUDY">Austria 1997</LINK>; <LINK REF="STD-China-1997" TYPE="STUDY">China 1997</LINK>; <LINK REF="STD-Hungary-1979" TYPE="STUDY">Hungary 1979</LINK>; <LINK REF="STD-Hungary-1988" TYPE="STUDY">Hungary 1988</LINK>; <LINK REF="STD-Italy-1994" TYPE="STUDY">Italy 1994</LINK>; <LINK REF="STD-Mississippi-1992" TYPE="STUDY">Mississippi 1992</LINK>; <LINK REF="STD-South-Africa-2007" TYPE="STUDY">South Africa 2007</LINK>; <LINK REF="STD-Zurich-1988" TYPE="STUDY">Zurich 1988</LINK>), with for example, no pre-specification of outcomes, important or expected outcomes not reported, or outcome data reported in such a way that it could not be included in a meta-analysis.</P>
</SELECTIVE_REPORTING>
<OTHER_BIAS_SOURCES MODIFIED="2013-08-27 12:39:07 +0100" MODIFIED_BY="[Empty name]">
<P>Five of the trials were judged to be at a low risk of other potential of bias, with no obvious sources of bias identified (<LINK REF="STD-Austria-1997" TYPE="STUDY">Austria 1997</LINK>; <LINK REF="STD-China-1997" TYPE="STUDY">China 1997</LINK>; <LINK REF="STD-Hungary-1979" TYPE="STUDY">Hungary 1979</LINK>; <LINK REF="STD-Italy-1994" TYPE="STUDY">Italy 1994</LINK>; <LINK REF="STD-Mississippi-1992" TYPE="STUDY">Mississippi 1992</LINK>). For the other trials, this was unclear, for example, with high non-compliance (<LINK REF="STD-Hungary-1988" TYPE="STUDY">Hungary 1988</LINK>; <LINK REF="STD-South-Africa-2007" TYPE="STUDY">South Africa 2007</LINK>).</P>
</OTHER_BIAS_SOURCES>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2014-03-28 13:57:30 +0000" MODIFIED_BY="Leanne V Jones">
<SUBSECTION>
<HEADING LEVEL="3">Magnesium supplementation versus no magnesium</HEADING>
<SUBSECTION>
<HEADING LEVEL="4">Primary outcomes</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">Infant outcomes</HEADING>
<P>Magnesium supplementation compared with no magnesium supplementation was associated with no significant difference in the risk of perinatal mortality (risk ratio (RR) 1.10; 95% confidence interval (CI) 0.72 to 1.67; five trials, 5903 infants) (<LINK REF="CMP-001.01" TYPE="ANALYSIS">Analysis 1.1</LINK>), or small-for-gestational age (RR 0.76; 95% CI 0.54 to 1.07; three trials; 1291 infants; I² = 7%) (<LINK REF="CMP-001.02" TYPE="ANALYSIS">Analysis 1.2</LINK>). For the outcome perinatal mortality, data from the <LINK REF="STD-Austria-1997" TYPE="STUDY">Austria 1997</LINK> and <LINK REF="STD-Memphis-1989" TYPE="STUDY">Memphis 1989</LINK> trials have been included in the meta-analysis; it should be noted, however, that <LINK REF="STD-Austria-1997" TYPE="STUDY">Austria 1997</LINK> only reported on stillbirths (and did not report on neonatal deaths), and <LINK REF="STD-Memphis-1989" TYPE="STUDY">Memphis 1989</LINK> only reported on neonatal deaths (and did not report on stillbirths). Considering the outcome small-for-gestational age, the definition provided in <LINK REF="STD-Hungary-1988" TYPE="STUDY">Hungary 1988</LINK> and <LINK REF="STD-Zurich-1988" TYPE="STUDY">Zurich 1988</LINK> was birthweight below the 10th percentile for gestational age; in <LINK REF="STD-Memphis-1989" TYPE="STUDY">Memphis 1989</LINK>, no definition was provided.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Maternal outcomes</HEADING>
<P>The effect of magnesium supplementation on maternal death was not reported by any of the included studies. No significant difference in pre-eclampsia was observed between the magnesium supplemented and control groups (RR 0.87; 95% CI 0.58 to 1.32; three trials, 1042 women) (<LINK REF="CMP-001.03" TYPE="ANALYSIS">Analysis 1.3</LINK>). The definitions for the three trials reporting on pre-eclampsia varied: in <LINK REF="STD-Memphis-1989" TYPE="STUDY">Memphis 1989</LINK> pre-eclampsia was defined as <I>"a systolic blood pressure reading of &#8805; 140 mm Hg, diastolic blood pressure of &#8805; 90 mm Hg on two occasions at least 6 hours apart with or without proteinuria, or both"; </I>however in <LINK REF="STD-Angola-1992" TYPE="STUDY">Angola 1992</LINK>, the definition was <I>"the simultaneous occurrence of the clinical triad of hypertension, edema, and proteinuria at any time during the course of pregnancy"</I>; with hypertension defined as <I>"A rise in systolic BP greater than 30 mm Hg and/or a rise in diastolic BP greater than 15 mm Hg"</I>; proteinuria defined as <I>"Protein greater than one determine by test tape"</I> and oedema defined as <I>"Visible fluid accumulation in the ankles and feet; indentation produced by pressure applied by the thumb over the anterior surface of the tibia."</I> In <LINK REF="STD-Zurich-1988" TYPE="STUDY">Zurich 1988</LINK>, the definition was not clear.</P>
<P>No statistical heterogeneity was observed in the meta-analyses for the primary outcomes (I² = 0%), excluding small-for-gestational age, where the I² has been reported above.</P>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="4">Secondary outcomes</HEADING>
<SUBSECTION>
<HEADING LEVEL="5">Infant outcomes</HEADING>
<P>Magnesium supplementation compared with no magnesium supplementation was associated with no significant difference in the risk of stillbirth (risk ratio (RR) 0.73; 95% confidence interval (CI) 0.43 to 1.25; four trials, 5526 infants) (<LINK REF="CMP-001.04" TYPE="ANALYSIS">Analysis 1.4</LINK>), however, a possible increased risk of neonatal death prior to discharge was seen for the group of infants whose mothers had received magnesium supplementation (RR 2.21; 95% CI 1.02 to 4.75; four trials, 5373 infants) (P = 0.04) (<LINK REF="CMP-001.05" TYPE="ANALYSIS">Analysis 1.5</LINK>). The <LINK REF="STD-South-Africa-2007" TYPE="STUDY">South Africa 2007</LINK> trial contributed the majority of participants (more than 70%) to this outcome, with 17 infant deaths occurring in the magnesium supplemented group and seven in the control group. The authors of the <LINK REF="STD-South-Africa-2007" TYPE="STUDY">South Africa 2007</LINK> trial suggested that the large number of severe congenital anomalies in the supplemented group (accounting for seven of the 17 deaths) and the deaths of two sets of twins (with birthweights of less than 750 g) in the supplemented group likely accounted for the increased risk of death observed with magnesium supplementation, and thus this result should be interpreted with caution. When we excluded the seven deaths due to <I>"congential abnormalities incompatible with life"</I> from the meta-analysis for this outcome, reassuringly, no increased risk of neonatal death was seen for the magnesium supplemented group (RR 1.45; 95% CI 0.63 to 3.32; four trials, 5373 infants) (<LINK REF="CMP-001.05" TYPE="ANALYSIS">Analysis 1.5</LINK>).</P>
<P>There was no significant difference between the magnesium supplemented group and the control group for the outcome miscarriage (average RR 0.85; 95% CI 0.49 to 1.49; six trials, 3704 women) (<LINK REF="CMP-001.06" TYPE="ANALYSIS">Analysis 1.6</LINK>). As we identified moderate statistical heterogeneity for this outcome (Tau² = 0.19; I² = 44%) a random-effects model was used. It is possible that the differing types of magnesium supplement (and the differing regimens for administration used) across the six included trials (<LINK REF="STD-Austria-1997" TYPE="STUDY">Austria 1997</LINK>; <LINK REF="STD-Hungary-1979" TYPE="STUDY">Hungary 1979</LINK>; <LINK REF="STD-Hungary-1988" TYPE="STUDY">Hungary 1988</LINK>; <LINK REF="STD-Italy-1994" TYPE="STUDY">Italy 1994</LINK>; <LINK REF="STD-Memphis-1989" TYPE="STUDY">Memphis 1989</LINK>; <LINK REF="STD-Zurich-1988" TYPE="STUDY">Zurich 1988</LINK>) contributed to this moderate level of heterogeneity. Similarly, no significant differences between the magnesium supplemented group and the control group were observed for the outcomes gestational age at birth (mean difference (MD) 0.06 weeks; 95% CI -0.07 to 0.20; five trials; 5564 women) (<LINK REF="CMP-001.07" TYPE="ANALYSIS">Analysis 1.7</LINK>) and preterm birth (average RR 0.89; 95% CI 0.69 to 1.14; seven trials; 5981 women; Tau² = 0.04; I² = 37%) (<LINK REF="CMP-001.08" TYPE="ANALYSIS">Analysis 1.8</LINK>).</P>
<P>Five trials reported on low birthweight infants of less than 2500 g and revealed no significant difference in the incidence of low birthweight with magnesium supplementation (RR 0.95; 95% CI 0.83 to 1.09; 5577 infants) (<LINK REF="CMP-001.09" TYPE="ANALYSIS">Analysis 1.9</LINK>). One trial (<LINK REF="STD-Zurich-1988" TYPE="STUDY">Zurich 1988</LINK>) reported data relating to very low birthweight infants (less than 1500 g), with no observed effect of maternal magnesium supplementation (RR 0.52; 95% CI 0.13 to 2.07). No difference in mean birthweight between the two groups was observed (MD 22.21 g; 95% CI -27.23 to 71.65; five trials, 5564 infants) (<LINK REF="CMP-001.10" TYPE="ANALYSIS">Analysis 1.10</LINK>). As we identified moderate statistical heterogeneity for this outcome (Tau² = 1138.34; I² = 38%) a random-effects model was used.</P>
<P>Magnesium supplementation was not shown to be associated with a difference in admission to the neonatal intensive care unit (RR 0.74; 95% CI 0.50 to 1.11; three trials, 1435 infants) (<LINK REF="CMP-001.11" TYPE="ANALYSIS">Analysis 1.11</LINK>).</P>
<P>Disability at paediatric follow-up was not reported by any of the included trials.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Non pre-specified infant outcomes</HEADING>
<P>We have reported data on a number of outcomes relating to neonatal morbidity that were not pre-specified in the original review protocol, but that we considered to be clinically relevant and important to include in this update.</P>
<P>Magnesium supplementation was not shown to be associated with any differences considering the outcomes of a one-minute Apgar score less than five (RR 0.83; 95% CI 0.41 to 1.67; one trial, 377 infants) (<LINK REF="CMP-001.12" TYPE="ANALYSIS">Analysis 1.12</LINK>), meconium aspiration (RR 0.63; 95% CI 0.32 to 1.26; one trial, 4082 infants) (<LINK REF="CMP-001.15" TYPE="ANALYSIS">Analysis 1.15</LINK>), breech presentation (RR 1.25; 95% CI 0.81 to 1.92; one trial, 4082 infants) (<LINK REF="CMP-001.16" TYPE="ANALYSIS">Analysis 1.16</LINK>), placental abruption (RR 0.96; 95% CI 0.48 to 1.94; one trial, 4082 infants) (<LINK REF="CMP-001.17" TYPE="ANALYSIS">Analysis 1.17</LINK>), placental weight (MD -0.01 g; 95% CI -22.16 to 22.14; two trials, 4459 infants; Tau² = 113.95; I² = 36%) (<LINK REF="CMP-001.18" TYPE="ANALYSIS">Analysis 1.18</LINK>), any hypoxic ischaemic encephalopathy (HIE) (RR 0.70; 95% CI 0.36 to 1.34; one trial, 4082 infants), moderate HIE (RR 1.02; 05% CI 0.26 to 4.09; one trial, 4082 infants), severe HIE (RR 2.56; 95% CI 0.50 to 13.19; one trial, 4082 infants) (<LINK REF="CMP-001.19" TYPE="ANALYSIS">Analysis 1.19</LINK>), or significant congenital abnormalities (RR 2.05; 95% CI 0.77 to 5.45; one trial, 4082 infants) (<LINK REF="CMP-001.20" TYPE="ANALYSIS">Analysis 1.20</LINK>).</P>
<P>Magnesium supplementation was, however, shown to reduce the risk of a five-minute Apgar score less than seven (RR 0.34; 05% CI 0.15 to 0.80; four trials, 1083 infants) (<LINK REF="CMP-001.12" TYPE="ANALYSIS">Analysis 1.12</LINK>). Significant reductions in late fetal heart rate decelerations (RR 0.68; 95% CI 0.53 to 0.88) (<LINK REF="CMP-001.13" TYPE="ANALYSIS">Analysis 1.13</LINK>), meconium-stained liquor (RR 0.79; 95% CI 0.63 to 0.99) (<LINK REF="CMP-001.14" TYPE="ANALYSIS">Analysis 1.14</LINK>), and mild HIE (RR 0.38; 95% CI 0.15 to 0.98) (<LINK REF="CMP-001.19" TYPE="ANALYSIS">Analysis 1.19</LINK>) were also observed with magnesium supplementation in one trial of 4082 infants (<LINK REF="STD-South-Africa-2007" TYPE="STUDY">South Africa 2007</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="5">Maternal outcomes</HEADING>
<P>There were no data available from any of the trials relating to maternal acceptance of treatment. Of the five trials reporting maternal side effects of treatment (<LINK REF="STD-Hungary-1988" TYPE="STUDY">Hungary 1988</LINK>; <LINK REF="STD-Italy-1994" TYPE="STUDY">Italy 1994</LINK>; <LINK REF="STD-Memphis-1989" TYPE="STUDY">Memphis 1989</LINK>; <LINK REF="STD-Mississippi-1992" TYPE="STUDY">Mississippi 1992</LINK>; <LINK REF="STD-Zurich-1988" TYPE="STUDY">Zurich 1988</LINK>), four reported on gastro-intestinal symptoms and found no significant difference between the magnesium supplemented group and control group (RR 0.88; 95% CI 0.69 to 1.12; 1388 women) (<LINK REF="CMP-001.21" TYPE="ANALYSIS">Analysis 1.21</LINK>). The <LINK REF="STD-Mississippi-1992" TYPE="STUDY">Mississippi 1992</LINK> trial reported that no women in either group had any side effects.</P>
<P>Magnesium supplementation was associated with a significantly higher systolic blood pressure near birth (MD 1.00 mm Hg; 95% CI 0.03 to 1.97; three trials, 1432 women) (<LINK REF="CMP-001.22" TYPE="ANALYSIS">Analysis 1.22</LINK>), however no significant differences in diastolic blood pressure (MD 0.23 mm Hg; 95% CI -0.67 to 1.13; three trials, 1432 women) (<LINK REF="CMP-001.23" TYPE="ANALYSIS">Analysis 1.23</LINK>), or pregnancy-induced hypertension (average RR 0.39; 95% CI 0.11 to 1.41; three trials, 4284 women) (<LINK REF="CMP-001.24" TYPE="ANALYSIS">Analysis 1.24</LINK>) were observed between groups. Substantial statistical heterogeneity was observed for the outcome pregnancy-induced hypertension (Tau² = 0.98; I² = 77%), and thus a random-effects model was used. It is possible that the differing types of magnesium supplement (and the differing regimens for administration used) across the three included trials, or variation between trials in the definitions used for this outcome contributed to this level of heterogeneity (with only the <LINK REF="STD-Angola-1992" TYPE="STUDY">Angola 1992</LINK> trial providing a clear definition: a rise in systolic blood pressure &gt; 30 mm Hg and/or a rise in diastolic blood pressure &gt; 15 mm Hg during the course of the pregnancy). Furthermore, the <LINK REF="STD-Angola-1992" TYPE="STUDY">Angola 1992</LINK> and <LINK REF="STD-China-1997" TYPE="STUDY">China 1997</LINK> trials, which showed benefit for the outcome pregnancy-induced hypertension with magnesium supplementation, were of comparatively small sample sizes (150 and 102 women respectively), and judged to be of a lower quality than the <LINK REF="STD-South-Africa-2007" TYPE="STUDY">South Africa 2007</LINK> trial, of 4476 women, which did not show a difference between groups.</P>
<P>Three trials assessed the need for maternal hospitalisation and demonstrated a reduced need with magnesium supplementation compared with no treatment (RR 0.65; 95% CI 0.48 to 0.86; 1158 women) (<LINK REF="CMP-001.26" TYPE="ANALYSIS">Analysis 1.26</LINK>). No difference between magnesium supplementation and no treatment was shown for the outcomes eclampsia (RR 0.14; 95% CI 0.01 to 2.70; one trial, 100 women) (<LINK REF="CMP-001.25" TYPE="ANALYSIS">Analysis 1.25</LINK>), length of labour (MD -0.00 hours; 95% CI -0.50 to 0.50; two trials, 4650 women) (<LINK REF="CMP-001.28" TYPE="ANALYSIS">Analysis 1.28</LINK>) or antepartum haemorrhage (average RR 0.53; 95% CI 0.09 to 3.15; two trials. 942 women) (<LINK REF="CMP-001.27" TYPE="ANALYSIS">Analysis 1.27</LINK>). It is possible that the <LINK REF="STD-Zurich-1988" TYPE="STUDY">Zurich 1988</LINK> trial's low quality (being quasi-randomised, with unclear blinding) contributed to the substantial statistical heterogeneity observed for the outcome antepartum haemorrhage (Tau² = 1.12; I² = 67%).</P>
<P>The incidence of postpartum haemorrhage was not reported by the included studies.</P>
</SUBSECTION>
</SUBSECTION>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Subgroup analysis based on type of magnesium supplement</HEADING>
<P>Subgroup analysis based on the type of magnesium supplement used, revealed no subgroup differences for the outcome perinatal mortality (Chi² = 0.33; P = 0.85; I² = 0%) (<LINK REF="CMP-001.01" TYPE="ANALYSIS">Analysis 1.1</LINK>). We were not able to perform a subgroup analysis for small-for-gestational age, as all the trials that reported on this outcome used magnesium aspartate (<LINK REF="CMP-001.02" TYPE="ANALYSIS">Analysis 1.2</LINK>).</P>
<P>Similarly, subgroup analysis based on the type of magnesium supplement used revealed no subgroup differences for pre-eclampsia (Chi² = 1.03; P = 0.31; I² = 3.1%) (<LINK REF="CMP-001.03" TYPE="ANALYSIS">Analysis 1.3</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Subgroup analysis based on study design</HEADING>
<P>Subgroup analysis based on the study designed used (cluster-randomised versus individually-randomised), revealed no subgroup differences for the primary outcomes, perinatal mortality (Chi² = 0.12; P = 0.73; I² = 0%) (<LINK REF="CMP-002.01" TYPE="ANALYSIS">Analysis 2.1</LINK>), and small-for-gestational age (Chi² = 1.93; P = 0.16; I² = 48.3%) (<LINK REF="CMP-002.02" TYPE="ANALYSIS">Analysis 2.2</LINK>). We were not able to perform a subgroup analysis for pre-eclampsia, as the three trials that reported on this outcome were all individually-randomised.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Sensitivity analysis - varying the ICC for the cluster-randomised trial</HEADING>
<P>We conducted a sensitivity analysis using less conservative estimates of the ICC for mortality outcomes (0.0002, 0.002) (less conservative when considering the ICC of 0.02 used throughout the main analysis). Although selecting less conservative ICC values (assuming less clustering and thereby increasing the weight of the one included cluster-randomised trial (<LINK REF="STD-Hungary-1988" TYPE="STUDY">Hungary 1988</LINK>)) narrowed the confidence intervals slightly, overall this did not have a serious impact on the findings (<LINK REF="CMP-003.01" TYPE="ANALYSIS">Analysis 3.1</LINK>; <LINK REF="CMP-003.02" TYPE="ANALYSIS">Analysis 3.2</LINK>; <LINK REF="CMP-003.03" TYPE="ANALYSIS">Analysis 3.3</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Sensitivity analysis by quality rating</HEADING>
<P>Only two trials had an allocation concealment and sequence generation rating of 'low risk of bias' (<LINK REF="STD-Memphis-1989" TYPE="STUDY">Memphis 1989</LINK>; <LINK REF="STD-South-Africa-2007" TYPE="STUDY">South Africa 2007</LINK>). The sensitivity analysis excluded trials with an allocation concealment and/or sequence generation rating of 'unclear' or 'high risk of bias.' Among the 'high quality studies' there were no significant differences between the magnesium supplemented group and control group for the outcomes perinatal mortality (RR 1.05; 95% CI 0.67 to 1.65; two trials, 4459 infants) (<LINK REF="CMP-004.01" TYPE="ANALYSIS">Analysis 4.1</LINK>) small-for-gestational age (RR 0.76; 95% CI 0.33 to 1.77; one trial, 377 infants) (<LINK REF="CMP-004.02" TYPE="ANALYSIS">Analysis 4.2</LINK>) or pre-eclampsia (RR 0.93; 95% CI 0.60 to 1.44; one trial, 374 women) (<LINK REF="CMP-004.03" TYPE="ANALYSIS">Analysis 4.3</LINK>), as in the main analysis.</P>
</SUBSECTION>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION MODIFIED="2014-03-21 08:45:11 +0000" MODIFIED_BY="[Empty name]">
<SUMMARY_OF_RESULTS MODIFIED="2014-03-21 08:45:11 +0000" MODIFIED_BY="[Empty name]">
<P>The meta-analysis of trials included in this review indicated no statistically significant effects of magnesium supplementation on the frequency of perinatal mortality or small-for-gestational age infants when compared with placebo or no treatment. Similarly, the results of this review indicated that magnesium supplementation during pregnancy had no significant effect on pre-eclampsia; maternal deaths were not reported by the included trials.</P>
<P>For secondary outcomes, many of the included studies did not provide data, and where they did, mostly we did not detect differences between the magnesium supplemented and control groups. It is important to note that for some outcomes, the definitions used by individual trials were unclear and/or varied, such as for the outcomes pre-eclampsia, small-for-gestational age and pregnancy-induced hypertension. Some results did appear to show differences between the groups.</P>
<P>Magnesium supplementation was shown to result in fewer maternal hospitalisations during pregnancy; and while higher maternal systolic blood pressure near birth was shown for the magnesium supplemented group of women, this observed mean difference in blood pressure of 1 mm Hg is considered unlikely to be clinically significant. For both outcomes the <LINK REF="STD-Zurich-1988" TYPE="STUDY">Zurich 1988</LINK> trial significantly influenced the meta-analysis; and as this trial was of low quality, being quasi-randomised with women allocated according to their date of birth, and thus these findings should be interpreted with caution. While no significant difference between groups was shown for the outcome stillbirth, on meta-analysis, a possible increased risk of neonatal death prior to discharge was observed for infants born to mothers who had received magnesium supplementation. It is important to highlight that only four of the 10 trials included in this review reported data to include in the meta-analysis for this outcome. Furthermore, in the <LINK REF="STD-South-Africa-2007" TYPE="STUDY">South Africa 2007</LINK> trial (which contributed over 70% of the participants to the analysis for this outcome), the trial authors documented a high number of severe congenital anomalies in the supplemented group (unlikely attributable to magnesium, as none of these seven infants had been exposed to magnesium prior to the 19th week of gestation) and the deaths of two sets of twins (with birthweights of less than 750 g) in the supplemented group. When the deaths due to <I>"congenital abnormalities incompatible with life"</I> (including thanatophoric dwarf, anencephaly, hypoplastic left heart, hypoplastic lungs, and multiple abnormalities) were excluded from the meta-analysis for this outcome, reassuringly, no increased risk of neonatal death was seen for the magnesium supplemented group.</P>
<P>When only high-quality trials were included in the analysis, there was no effect of magnesium supplementation on the frequency of perinatal mortality, small-for-gestational age, or pre-eclampsia (<LINK REF="STD-Memphis-1989" TYPE="STUDY">Memphis 1989</LINK>; <LINK REF="STD-South-Africa-2007" TYPE="STUDY">South Africa 2007</LINK>). One of the highest quality trials, <LINK REF="STD-Memphis-1989" TYPE="STUDY">Memphis 1989</LINK>, of 400 women, demonstrated no effect of maternal magnesium supplementation on blood pressure, pre-eclampsia or other pregnancy outcomes. The results of this trial may have however been influenced by the fact that all women (both magnesium supplemented and placebo groups) received a multivitamin and mineral preparation containing 100 mg of magnesium. For the outcomes small-for-gestational age and pre-eclampsia, only the <LINK REF="STD-Memphis-1989" TYPE="STUDY">Memphis 1989</LINK> trial reported data for inclusion in the sensitivity analysis, and this study was underpowered to detect differences between groups for both of these outcomes, with considerable uncertainly about the treatment effects observed; unfortunately the <LINK REF="STD-South-Africa-2007" TYPE="STUDY">South Africa 2007</LINK>, of over 4000 women, did not report on small-for-gestational age or pre-eclampsia.</P>
<P>The <LINK REF="STD-South-Africa-2007" TYPE="STUDY">South Africa 2007</LINK> trial found no difference in meconium aspiration, breech presentation, placental abruption, congenital abnormalities, moderate or severe hypoxic ischaemic encephalopathy (HIE) and neonatal encephalopathy between the magnesium supplemented and placebo groups however it found that magnesium supplementation reduced the risk of late fetal heart decelerations, meconium-stained liquor and mild HIE (<LINK REF="STD-South-Africa-2007" TYPE="STUDY">South Africa 2007</LINK>). These outcomes relating to infant morbidity were not pre-specified in the original protocol for the review, and while the review authors believed their reporting in this update to be important, they acknowledge the potential for bias associated with the reporting of non pre-specified review outcomes.</P>
</SUMMARY_OF_RESULTS>
<QUALITY_OF_EVIDENCE MODIFIED="2013-08-27 12:35:06 +0100" MODIFIED_BY="[Empty name]">
<P>There is a lack of high-quality evidence assessing the use of magnesium supplementation during pregnancy. Only two trials were judged to be at a low risk of selection bias, with adequate methods to conceal allocation and to generate a random sequence (<LINK REF="STD-Memphis-1989" TYPE="STUDY">Memphis 1989</LINK>; <LINK REF="STD-South-Africa-2007" TYPE="STUDY">South Africa 2007</LINK>); the remaining trials were largely judged to be at an unclear risk of selection bias. Only four of the 10 trials were judged at a low risk of both performance and detection bias (<LINK REF="STD-Italy-1994" TYPE="STUDY">Italy 1994</LINK>; <LINK REF="STD-Memphis-1989" TYPE="STUDY">Memphis 1989</LINK>; <LINK REF="STD-Mississippi-1992" TYPE="STUDY">Mississippi 1992</LINK>; <LINK REF="STD-South-Africa-2007" TYPE="STUDY">South Africa 2007</LINK>), and for the <LINK REF="STD-Austria-1997" TYPE="STUDY">Austria 1997</LINK> trial, the risk of performance and detection bias was judged as high, with no control/placebo treatment used. The majority of trials were judged at an unclear risk of attrition bias and reporting bias.</P>
</QUALITY_OF_EVIDENCE>
<POTENTIAL_BIASES MODIFIED="2014-03-20 09:52:52 +0000" MODIFIED_BY="Heather Maxwell">
<P>The evidence for this review is derived from trials identified through a detailed search process. It is possible (but unlikely) that additional trials assessing magnesium supplementation during pregnancy, have been published but not identified. It is also possible that other studies have been conducted but not published. Should such studies be identified, we will include them in future updates of this review.</P>
</POTENTIAL_BIASES>
</DISCUSSION>
<CONCLUSIONS MODIFIED="2013-09-04 02:43:09 +0100" MODIFIED_BY="[Empty name]">
<IMPLICATIONS_PRACTICE MODIFIED="2013-09-04 01:56:23 +0100" MODIFIED_BY="[Empty name]">
<P>There is currently no evidence to support magnesium supplementation during pregnancy for improving maternal and neonatal/infant health outcomes. Until additional evidence from large, well-designed randomised trials becomes available, current evidence is insufficient to make recommendations for routine clinical practice on the use of magnesium supplementation during pregnancy.</P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH MODIFIED="2013-09-04 02:43:09 +0100" MODIFIED_BY="[Empty name]">
<P>In light of the limited current evidence, further randomised controlled trials may be warranted to determine whether supplementation with magnesium during pregnancy can improve maternal and neonatal/infant health outcomes. Such trials must be sufficiently powered, and well-designed to allow important differences to be detected. Future research must consider relevant maternal and neonatal/infant outcomes (including reporting on maternal and perinatal mortality), as well as longer-term paediatric outcomes (including disabilities). In addition to assessing effectiveness and safety, such trials may address specific considerations including timing of commencement of supplementation and dosage.</P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS MODIFIED="2014-03-10 09:26:45 +0000" MODIFIED_BY="[Empty name]">
<P>We thank Cordula Blank for translation of German papers, Emily Lemon and Esther Vitalis for the translations of a Hungarian papers, Wengxiong Chen and Sarah Dodd for translations of the Chinese paper and Louise Flanagan for the translation of the Austrian paper.</P>
<P>Marc JNC Keirse compiled an earlier version of this review published in the Oxford Database of Perinatal Trials.</P>
<P>We thank Lynn Hampson who performed the literature searches and Philippa Middleton who commented on all drafts.</P>
<P>As part of the pre-publication editorial process, this review has been commented on by three peers (an editor and two referees who are external to the editorial team) and the Group's Statistical Adviser.</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST>
<P>None known.<BR/> </P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS MODIFIED="2013-07-21 23:53:38 +0100" MODIFIED_BY="[Empty name]">
<P>For this update DC and EB assessed the new studies for inclusion, performed data extraction and assessed the risk of bias for included trials. EB and DC drafted the changes to the text and prepared subsequent drafts. MM and CAC contributed to the subsequent drafts and the final version.</P>
<P>MM and CAC developed the original protocol, extracted data and wrote the previous versions of this review.</P>
</CONTRIBUTIONS>
<PRO_REV_DIFF MODIFIED="2014-01-21 04:57:28 +0000" MODIFIED_BY="[Empty name]">
<P>We have updated the methods for this review update.</P>
<P>We have specified that the intervention could be commenced at any time during pregnancy (rather than prior to the 25th week of pregnancy as previously specified), and we planned to assess variation according to gestation of commencement by a pre-specified subgroup analysis, as detailed in the methods.</P>
<P>We have specified that cluster-randomised trials are eligible for inclusion.</P>
<P>We have separated the review's outcomes into primary and secondary outcomes, and have detailed in this update a number of non pre-specified infant outcomes for which we have reported data, as they were considered to be clinically relevant and important for inclusion in this review.</P>
</PRO_REV_DIFF>
<PUBLIC_NOTES/>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2014-03-19 13:39:13 +0000" MODIFIED_BY="Heather Maxwell">
<STUDIES MODIFIED="2014-03-19 13:39:13 +0000" MODIFIED_BY="Heather Maxwell">
<INCLUDED_STUDIES MODIFIED="2014-03-19 13:28:40 +0000" MODIFIED_BY="Heather Maxwell">
<STUDY DATA_SOURCE="PUB" ID="STD-Angola-1992" NAME="Angola 1992" YEAR="1992">
<REFERENCE NOTES="&lt;p&gt;[7783]&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>D'Almeida A, Carter JP, Antol A, Prost C</AU>
<TI>Effects of a combination of evening primrose oil (gamma linolenic acid) and fish oil (eicosapentaenoic + docosahexaenoic acid) versus magnesium, and placebo in preventing pre-eclampsia</TI>
<SO>Women and Health</SO>
<YR>1992</YR>
<VL>19</VL>
<PG>117-31</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Austria-1997" MODIFIED="2012-11-05 00:43:37 +0000" MODIFIED_BY="[Empty name]" NAME="Austria 1997" YEAR="1997">
<REFERENCE MODIFIED="2012-11-05 00:43:37 +0000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Arikan G, Gucer F, Scholl W, Weiss PAM</AU>
<TI>Preterm labour during oral magnesium supplementation in uncomplicated pregnancies</TI>
<TO>Fruhgeburtlichkeit unter oraler magnesium substitution bei unkomplizierten schwangerschaften: eine randomisiert kontrolliert klinische studie</TO>
<SO>Geburtshilfe und Frauenheilkunde</SO>
<YR>1997</YR>
<VL>57</VL>
<PG>491-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE NOTES="&lt;p&gt;[9504]&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Arikan G, Panzitt T, Gaucer F, Boritsch J, Trojovski A, Haeusler MCH</AU>
<TI>Oral magnesium supplementation and the prevention of preterm labor</TI>
<SO>American Journal of Obstetrics and Gynaecology</SO>
<YR>1997</YR>
<VL>176</VL>
<PG>(1Pt2):S45</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-China-1997" NAME="China 1997" YEAR="1997">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Li S, Tian H</AU>
<TI>Oral low-dose magnesium gluconate preventing pregnancy induced hypertension (translation)</TI>
<SO>Chunh-Hua-Fu-Chan-Ko-Tsa-Chih [Chinese Journal of Obstetrics and Gynaecology]</SO>
<YR>1997</YR>
<VL>32</VL>
<PG>613-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hungary-1979" MODIFIED="2014-03-19 13:24:18 +0000" MODIFIED_BY="Heather Maxwell" NAME="Hungary 1979" YEAR="1979">
<REFERENCE MODIFIED="2014-03-19 13:23:33 +0000" MODIFIED_BY="Heather Maxwell" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Balazs M, Kuti V, Morvay F, Varenka Zs, Szekely A, Szucs M</AU>
<TI>New data on the relationship between magnesium intake and the quality of pregnancy</TI>
<TO>Données nouvelles sur les relations entre l'apport alimentaire en magnésium et la qualité de la grossesse</TO>
<SO>Revue Française d'Endocrinologie Clinique, Nutrition, et Métabolisme</SO>
<YR>1980</YR>
<VL>21</VL>
<NO>6</NO>
<PG>525-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2014-03-19 13:24:18 +0000" MODIFIED_BY="Heather Maxwell" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Balazs M, Morvai F, Szekely Z, Miklos Szucs, Varenka Z, Kuti V</AU>
<TI>Miscarriage and magnesium intake</TI>
<TO>Avortment spontané et apport en magnésium de la ration alimentaire</TO>
<SO>Revue Française d'Endocrinologie Clinique, Nutrition, et Métabolisme</SO>
<YR>1979</YR>
<VL>20</VL>
<NO>6</NO>
<PG>525-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hungary-1988" MODIFIED="2013-05-03 01:44:21 +0100" MODIFIED_BY="[Empty name]" NAME="Hungary 1988" YEAR="1988">
<REFERENCE MODIFIED="2013-05-03 01:44:21 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kovacs L, Molnar BG, Huhn E, Bodis L</AU>
<TI>Magnesium substitution in pregnancy. A prospective, randomized double-blind study</TI>
<TO>Magnesium substitution in der Schwangerschaft: eine prospektive, randomisierte doppelblindstudie</TO>
<SO>Geburtshilfe und Frauenheilkunde</SO>
<YR>1988</YR>
<VL>48</VL>
<PG>595-600</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2010-05-18 05:21:55 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Kovacs L, Molnar GB, Huhn E, Bodis L. Magnesium substitution during pregnancy. A prospective randomised, double blind, clinical trial. Magyar Noorvosok Lapja 1988;51:9-14&lt;/p&gt;" NOTES_MODIFIED="2010-05-18 05:21:55 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kovacs L, Molnar GB, Huhn E, Bodis L</AU>
<TI>Magnesium substitution during pregnancy. A prospective randomised, double blind, clinical trial</TI>
<SO>Magyar Noorvosok Lapja</SO>
<YR>1988</YR>
<VL>51</VL>
<PG>9-14</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Italy-1994" MODIFIED="2010-05-19 23:59:40 +0100" MODIFIED_BY="[Empty name]" NAME="Italy 1994" YEAR="1994">
<REFERENCE MODIFIED="2010-05-19 23:59:40 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zarcone R, Cardone G, Bellini P</AU>
<TI>Role of magnesium in pregnancy</TI>
<SO>Panminerva Medica</SO>
<YR>1994</YR>
<VL>36</VL>
<PG>168-70</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Memphis-1989" MODIFIED="2014-01-14 22:29:33 +0000" MODIFIED_BY="[Empty name]" NAME="Memphis 1989" YEAR="1989">
<REFERENCE MODIFIED="2014-01-14 22:29:33 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;[5013]&lt;/p&gt;" NOTES_MODIFIED="2014-01-14 22:29:33 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sibai BM, Villar MA, Bary E</AU>
<TI>Magnesium supplementation during pregnancy: a double-blind randomized controlled clinical trial</TI>
<SO>American Journal of Obstetrics and Gynaecology</SO>
<YR>1989</YR>
<VL>161</VL>
<PG>115-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mississippi-1992" MODIFIED="2014-03-19 13:26:13 +0000" MODIFIED_BY="Heather Maxwell" NAME="Mississippi 1992" YEAR="1992">
<REFERENCE MODIFIED="2014-03-19 13:25:54 +0000" MODIFIED_BY="Heather Maxwell" NOTES="&lt;p&gt;Martin RW, McColgin SW, Perry KG, McCaul JF, Hess LW, Martin JN, Morrison JC. Oral magnesium and the prevention of preterm labor in a high-risk group of patients . Proceedings of 10th Annual Meeting of Society of Perinatal Obstetricians;1990; Houston, Texas, USA 1990:181&lt;/p&gt;" NOTES_MODIFIED="2014-03-19 13:25:54 +0000" NOTES_MODIFIED_BY="Heather Maxwell" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Martin RW, McColgin SW, Perry KG, McCaul JF, Hess LW, Martin JN, et al</AU>
<TI>Oral magnesium and the prevention of preterm labor in a high-risk group of patients</TI>
<SO>Proceedings of 10th Annual Meeting of Society of Perinatal Obstetricians, Houston, Texas, USA</SO>
<YR>1990</YR>
<PG>181</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2014-03-19 13:26:13 +0000" MODIFIED_BY="Heather Maxwell" NOTES="&lt;p&gt;[7024]&lt;/p&gt;" NOTES_MODIFIED="2014-03-19 13:26:13 +0000" NOTES_MODIFIED_BY="Heather Maxwell" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Martin RW, Perry KG, Hess LW, Martin JN, Morrison JC</AU>
<TI>Oral magnesium and the prevention of preterm labor in a high-risk group of patients</TI>
<SO>American Journal of Obstetrics and Gynaecology</SO>
<YR>1992</YR>
<VL>166</VL>
<PG>144-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-South-Africa-2007" MODIFIED="2010-05-19 01:34:34 +0100" MODIFIED_BY="[Empty name]" NAME="South Africa 2007" YEAR="">
<REFERENCE MODIFIED="2010-05-19 01:34:30 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Fawcus S, Harrison V, Jordaan E</AU>
<TI>The prevention of neonatal encephalopathy: could magnesium supplementation during pregnancy play a role? [abstract]</TI>
<SO>31st British International Congress of Obstetrics and Gynaecology</SO>
<YR>2007 July 4-6</YR>
<PG>102</PG>
<CY>London, UK</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Harrison V, Fawcus S, Jordaan E</AU>
<TI>Magnesium supplementation and perinatal hypoxia: outcome of a parallel group randomised trial in pregnancy</TI>
<SO>British Journal of Obstetrics and Gynaecology</SO>
<YR>2007</YR>
<VL>114</VL>
<PG>994-1002</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zurich-1988" MODIFIED="2014-03-19 13:28:40 +0000" MODIFIED_BY="Heather Maxwell" NAME="Zurich 1988" YEAR="1988">
<REFERENCE MODIFIED="2014-03-19 13:28:40 +0000" MODIFIED_BY="Heather Maxwell" NOTES="&lt;p&gt;[6459]&lt;/p&gt;" NOTES_MODIFIED="2014-03-19 13:28:40 +0000" NOTES_MODIFIED_BY="Heather Maxwell" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Jaspers V, Spatling L, Fallenstein F, Quakernack K</AU>
<TI>Magnesium, calcium, haemoglobin, haematocrit, oestriol and HPL following magnesium substitution [supplementation] during pregnancy</TI>
<TO>Magnesium, kalzium, hamoglobin, hamatokrit, ostriol und HPL unter magnesium substitution in der schwangerschaft</TO>
<SO>Geburtshilfe und Frauenheilkunde</SO>
<YR>1990</YR>
<VL>50</VL>
<PG>628-33</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2014-01-14 22:29:23 +0000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;[3906]&lt;/p&gt;" NOTES_MODIFIED="2014-01-14 22:29:23 +0000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Spatling L, Spatling G</AU>
<TI>Magnesium supplementation in pregnancy. A double-blind study</TI>
<SO>British Journal of Obstetrics and Gynaecology</SO>
<YR>1988</YR>
<VL>95</VL>
<PG>120-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE NOTES="&lt;p&gt;[6356]&lt;/p&gt;" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Spatling L</AU>
<TI>Magnesium supplementation in pregnancy in pregnancy: a double-blind study</TI>
<SO>Proceedings of International Symposium on Advances in the Prevention of Low Birthweight, Cape Cod, Massachusetts, USA</SO>
<YR>1988</YR>
<PG>197-201</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2013-05-03 01:44:09 +0100" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;[9533]&lt;/p&gt;" NOTES_MODIFIED="2013-05-03 01:44:09 +0100" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Vetter K, Spaetling L</AU>
<TI>Magnesium substitution in pregnancy a double-blind study</TI>
<TO>Magnesium substitution in der schwangerschaft eine doppelblindstudie</TO>
<SO>Archives of Gynaecology</SO>
<YR>1986</YR>
<VL>239</VL>
<PG>176-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES MODIFIED="2014-03-19 13:39:13 +0000" MODIFIED_BY="Heather Maxwell">
<STUDY DATA_SOURCE="PUB" ID="STD-Denmark-1990" MODIFIED="2013-05-03 01:44:02 +0100" MODIFIED_BY="[Empty name]" NAME="Denmark 1990" YEAR="1990">
<REFERENCE MODIFIED="2013-05-03 01:44:02 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Rudnicki M, Junge J, Frolich A, Ornvold K, Fischer-Rasmussen W</AU>
<TI>Magnesium supplement in pregnancy-induced hypertension A clinicopathological study</TI>
<SO>Acta Pathologica, Microbiologica, et Immunologica Scandinavica</SO>
<YR>1990</YR>
<VL>98</VL>
<PG>1123-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Denmark-1991" MODIFIED="2012-11-05 00:53:27 +0000" MODIFIED_BY="[Empty name]" NAME="Denmark 1991" YEAR="1991">
<REFERENCE MODIFIED="2012-11-05 00:53:27 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Rudnicki M, Frølich A, Fischer-Rasmussen W</AU>
<TI>Magnesium supplement in pregnancy-induced hypertension: effects on maternal and neonatal magnesium and calcium homeostasis</TI>
<SO>Mineral and Electrolyte Metabolism</SO>
<YR>1991</YR>
<VL>17</VL>
<NO>6</NO>
<PG>399-403</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Detroit-1999" MODIFIED="2014-03-19 13:32:07 +0000" MODIFIED_BY="Heather Maxwell" NAME="Detroit 1999" YEAR="1999">
<REFERENCE MODIFIED="2013-09-06 09:18:08 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hallak M, Martinez-Poyer J, Brish L, Poole-Bryant K, Mammen EF, Sorokin Y</AU>
<TI>Magnesium sulfate impairs platelet function in normal pregnant women</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>1999</YR>
<VL>180</VL>
<NO>1 Pt 2</NO>
<PG>S142</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2014-03-19 13:32:07 +0000" MODIFIED_BY="Heather Maxwell" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Hallak M, Martinez-Poyer J, Kruger M, Hassan S, Blackwell S, Sorokin Y</AU>
<TI>The effect of magnesium sulfate on fetal heart rate parameters: A randomized, placebo-controlled trial</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>1999</YR>
<VL>181</VL>
<NO>5</NO>
<PG>1122-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2013-09-06 09:18:30 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hallak M, Martinez-Poyer J, Kruger ML, Hassan S, Blackwell SC, Sorokin Y</AU>
<TI>Magnesium sulfate effect on fetal heart rate (FHR) parameters: A randomized, placebo controlled trial</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>1999</YR>
<VL>180</VL>
<NO>1 Pt 2</NO>
<PG>S155</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2013-09-06 09:18:43 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hallak M, Martinez-Poyer J, Kruger ML, King M, Russell E, Sorokin Y</AU>
<TI>Magnesium sulfate transiently increases fetal breathing movements but not body movements</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>1999</YR>
<VL>180</VL>
<NO>1 Pt 2</NO>
<PG>S155</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2013-09-06 09:18:55 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Martinez-Poyer J, Hallak M, King M, Kruger M, Sorokin Y</AU>
<TI>Magnesium sulfate increases impedance to flow in the fetal systemic circulation but has no effect on the cerebral circulation</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>1999</YR>
<VL>180</VL>
<NO>1 Pt 2</NO>
<PG>S114</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2013-09-06 09:19:07 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Martinez-Poyer J, Hallak M, Russell E, Poole-Bryant K, Sorokin Y</AU>
<TI>Magnesium sulfate prolongs ventricular repolarisation in normal gravidas: A randomised, double-blind, placebo controlled study</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>1999</YR>
<VL>180</VL>
<NO>1 Pt 2</NO>
<PG>S142</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-India-2012" MODIFIED="2013-05-03 01:43:55 +0100" MODIFIED_BY="[Empty name]" NAME="India 2012" YEAR="2012">
<REFERENCE MODIFIED="2013-05-03 01:43:55 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Dasgupta S, Ghosh D, Seal SL, Kamilya G, Karmakar M, Saha D</AU>
<TI>Randomized controlled study comparing effect of magnesium sulfate with placebo on fetal umbilical artery and middle cerebral artery blood flow in mild preeclampsia at &#8805; 34 weeks gestational age</TI>
<SO>Journal of Obstetrics and Gynaecology Research</SO>
<YR>2012</YR>
<VL>38</VL>
<NO>5</NO>
<PG>763-71</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-ISRCTN03989660" MODIFIED="2013-05-03 01:43:51 +0100" MODIFIED_BY="[Empty name]" NAME="ISRCTN03989660" YEAR="2011">
<REFERENCE MODIFIED="2013-05-03 01:43:51 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>ISRCTN03989660</AU>
<TI>A randomized, double-blinded, placebo-controlled trial of oral magnesium for relief in pregnancy-induced leg cramps</TI>
<SO>http://www.controlled-trials.com/ISRCTN03989660/</SO>
<YR>(accessed 7 February 2013)</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-NCT01709968" MODIFIED="2014-03-19 13:38:35 +0000" MODIFIED_BY="Heather Maxwell" NAME="NCT01709968" YEAR="2012">
<REFERENCE MODIFIED="2014-03-19 13:38:35 +0000" MODIFIED_BY="Heather Maxwell" PRIMARY="NO" TYPE="OTHER">
<AU>NCT01709968</AU>
<TI>Magnesium oxide monohydrate for nocturnal leg cramps (mgnlc); a prospective, randomized, double blind, placebo controlled clinical trial</TI>
<SO>http://clinicaltrials.gov/ct2/show/NCT01709968</SO>
<YR>(accessed 7 February 2013)</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Norway-2008" MODIFIED="2012-11-05 00:53:49 +0000" MODIFIED_BY="[Empty name]" NAME="Norway 2008" YEAR="2008">
<REFERENCE MODIFIED="2012-11-05 00:53:49 +0000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Nygaard IH, Valbø A, Pethick SV, Bøhmer T</AU>
<TI>Does oral magnesium substitution relieve pregnancy-induced leg cramps?</TI>
<SO>European Journal of Obstetrics, Gynecology, and Reproductive Biology</SO>
<YR>2008</YR>
<VL>141</VL>
<NO>1</NO>
<PG>23-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sweden-1987" MODIFIED="2013-05-03 06:19:27 +0100" MODIFIED_BY="[Empty name]" NAME="Sweden 1987" YEAR="1987">
<REFERENCE MODIFIED="2013-05-03 06:19:27 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hammar M, Berg G, Solheim F, Larsson L</AU>
<TI>Calcium and magnesium status in pregnant women. A comparison between treatment with calcium and vitamin C in pregnant women with leg cramps</TI>
<SO>International Journal of Vitamin and Nutrition Research</SO>
<YR>1987</YR>
<VL>57</VL>
<PG>179-83</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sweden-1995" MODIFIED="2014-03-19 13:39:13 +0000" MODIFIED_BY="Heather Maxwell" NAME="Sweden 1995" YEAR="1995">
<REFERENCE MODIFIED="2014-03-19 13:39:13 +0000" MODIFIED_BY="Heather Maxwell" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Dahle LO, Berg G, Hammar M, Hurtig M, Larsson L</AU>
<TI>The effect of oral magnesium substitution on pregnancy-induced leg cramps</TI>
<SO>American Journal of Obstetrics and Gynecology</SO>
<YR>1995</YR>
<VL>173</VL>
<NO>1</NO>
<PG>175-80</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES MODIFIED="2013-02-07 04:17:08 +0000" MODIFIED_BY="[Empty name]"/>
<ONGOING_STUDIES MODIFIED="2013-05-03 01:43:35 +0100" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-ISRCTN98365455" MODIFIED="2013-05-03 01:43:35 +0100" MODIFIED_BY="[Empty name]" NAME="ISRCTN98365455" YEAR="2011">
<REFERENCE MODIFIED="2013-05-03 01:43:35 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>ISRCTN98365455</AU>
<TI>Magnesium intervention during pregnancy</TI>
<SO>http://www.controlled-trials.com/isrctn/pf/98365455</SO>
<YR>(accessed 25 August 2011)</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-NCT01510665" MODIFIED="2013-05-03 01:43:31 +0100" MODIFIED_BY="[Empty name]" NAME="NCT01510665" YEAR="2011">
<REFERENCE MODIFIED="2013-05-03 01:43:31 +0100" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="OTHER">
<AU>NCT01510665</AU>
<TI>Magnesium supplementation in the second trimester of pregnancy to overweight and obese individuals</TI>
<SO>http://clinicaltrials.gov/ct2/show/NCT01510665</SO>
<YR>(accessed 7 February 2013)</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</ONGOING_STUDIES>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2014-03-19 13:19:06 +0000" MODIFIED_BY="Heather Maxwell">
<ADDITIONAL_REFERENCES MODIFIED="2013-09-20 10:41:03 +0100" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-Arikan-1999" MODIFIED="2013-08-28 09:01:21 +0100" MODIFIED_BY="[Empty name]" NAME="Arikan 1999" TYPE="JOURNAL_ARTICLE">
<AU>Arikan GM, Panzitt T, Gücer F, Scholz HS, Reinisch S, Haas J, et al</AU>
<TI>Course of maternal serum magnesium levels in low-risk gestations and in preterm labor and delivery</TI>
<SO>Fetal Diagnosis and Therapy</SO>
<YR>1999</YR>
<VL>14</VL>
<NO>6</NO>
<PG>332-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Conradt-1984" MODIFIED="2013-08-28 09:01:32 +0100" MODIFIED_BY="[Empty name]" NAME="Conradt 1984" TYPE="JOURNAL_ARTICLE">
<AU>Conradt A, Weidinger H, Algayer</AU>
<TI>On the role of magnesium in fetal hypotrophy, pregnancy induced hypertension and pre-eclampsia</TI>
<SO>Magnesium Bulletin</SO>
<YR>1984</YR>
<VL>6</VL>
<PG>68-76</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Doyle-1989" NAME="Doyle 1989" TYPE="JOURNAL_ARTICLE">
<AU>Doyle W, Crawford MA, Wynn AH, Wynn SW</AU>
<TI>Maternal magnesium intake and pregnancy outcome</TI>
<SO>Magnesium Research</SO>
<YR>1989</YR>
<VL>2</VL>
<PG>205-10</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Duley-2010" MODIFIED="2013-05-03 01:43:20 +0100" MODIFIED_BY="[Empty name]" NAME="Duley 2010" TYPE="COCHRANE_REVIEW">
<AU>Duley L, Gülmezoglu AM, Henderson-Smart DJ, Chou D</AU>
<TI>Magnesium sulphate and other anticonvulsants for women with pre-eclampsia</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2010</YR>
<NO>11</NO>
<IDENTIFIERS MODIFIED="2012-11-01 04:59:07 +0000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2012-11-01 04:59:07 +0000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD000025.pub2"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Garrison-2012" MODIFIED="2013-05-03 06:20:06 +0100" MODIFIED_BY="[Empty name]" NAME="Garrison 2012" TYPE="COCHRANE_REVIEW">
<AU>Garrison SR, Allan GM, Sekhon RK, Musini VM, Khan KM</AU>
<TI>Magnesium for skeletal muscle cramps</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2012</YR>
<NO>9</NO>
<IDENTIFIERS MODIFIED="2012-10-25 04:02:14 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2012-10-25 04:02:14 +0100" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD009402.pub2"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2011" MODIFIED="2013-05-03 01:42:53 +0100" MODIFIED_BY="[Empty name]" NAME="Higgins 2011" TYPE="OTHER">
<AU>Higgins JPT, Green S, editors</AU>
<TI>Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011</TI>
<SO>Available from www.cochrane-handbook.org</SO>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Inst-Med-1990" MODIFIED="2013-09-06 09:19:38 +0100" MODIFIED_BY="[Empty name]" NAME="Inst Med 1990" TYPE="BOOK">
<AU>Subcommittee on Nutritional Status and Weight Gain During Pregnancy, Subcommittee on Dietary Intake and Nutrient Supplements During Pregnancy, Committee on Nutritional Status During Pregnancy and Lactation, Food and Nutrition Board, Institute of Medicine, National Academy of Sciences</AU>
<SO>Nutrition During Pregnancy</SO>
<YR>1990</YR>
<PB>National Academy Press</PB>
<CY>Washington DC</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-RevMan-2012" MODIFIED="2013-09-20 10:41:03 +0100" MODIFIED_BY="[Empty name]" NAME="RevMan 2012" TYPE="COMPUTER_PROGRAM">
<TI>Review Manager (RevMan)</TI>
<YR>2012</YR>
<EN>5.2</EN>
<PB>The Nordic Cochrane Centre, The Cochrane Collaboration</PB>
<CY>Copenhagen</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-US-FDA-2009" MODIFIED="2013-05-03 01:42:40 +0100" MODIFIED_BY="[Empty name]" NAME="US FDA 2009" TYPE="OTHER">
<AU>US Department of Health and Human Services: US FDA</AU>
<TI>Overview of dietary supplements: What is a dietary supplement?</TI>
<SO>http://www.fda.gov/Food/DietarySupplements/ConsumerInformation/ucm110417.htm#what</SO>
<YR>2009 [accessed 25 Aug 2011]</YR>
<IDENTIFIERS/>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES MODIFIED="2014-03-19 13:19:06 +0000" MODIFIED_BY="Heather Maxwell">
<REFERENCE ID="REF-Keirse-1995" MODIFIED="2012-10-25 00:28:42 +0100" MODIFIED_BY="[Empty name]" NAME="Keirse 1995" TYPE="OTHER">
<AU>Keirse MJNC</AU>
<TI>Routine magnesium supplementation in pregnancy</TI>
<SO>Pregnancy and Childbirth Module; The Cochrane Pregnancy and Childbirth Database [database on disk and CDROM]</SO>
<YR>1995 [revised 16 June 1993]</YR>
<NO>2</NO>
<ED>Enkin MW, Keirse MJNC, Renfrew MJ, Neilson JP, Crowther C</ED>
<PB>The Cochrane Collaboration; Oxford</PB>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Makrides-1998" MODIFIED="2013-05-03 06:22:01 +0100" MODIFIED_BY="[Empty name]" NAME="Makrides 1998" TYPE="COCHRANE_REVIEW">
<AU>Makrides M, Crowther CA</AU>
<TI>Magnesium supplementation in pregnancy</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>1998</YR>
<NO>2</NO>
<IDENTIFIERS MODIFIED="2013-05-03 06:22:01 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2013-05-03 06:22:01 +0100" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD000937"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Makrides-2001" MODIFIED="2014-03-19 13:19:06 +0000" MODIFIED_BY="Heather Maxwell" NAME="Makrides 2001" TYPE="COCHRANE_REVIEW">
<AU>Makrides M, Crowther CA</AU>
<TI>Magnesium supplementation in pregnancy</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2001</YR>
<NO>4</NO>
<PB>Update Software</PB>
<CY>Oxford</CY>
<IDENTIFIERS MODIFIED="2012-10-25 00:27:04 +0100" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2012-10-25 00:27:04 +0100" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD000937"/>
</IDENTIFIERS>
</REFERENCE>
</OTHER_VERSIONS_REFERENCES>
<PENDING_REFERENCES MODIFIED="2010-05-18 05:22:19 +0100" MODIFIED_BY="[Empty name]"/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES MODIFIED="2014-03-20 10:01:37 +0000" MODIFIED_BY="Heather Maxwell">
<CHARACTERISTICS_OF_INCLUDED_STUDIES MODIFIED="2014-03-20 10:01:37 +0000" MODIFIED_BY="Heather Maxwell" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR MODIFIED="2013-08-27 13:37:47 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Angola-1992">
<CHAR_METHODS MODIFIED="2013-05-03 01:39:18 +0100" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trial.<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-08-27 13:36:12 +0100" MODIFIED_BY="[Empty name]">
<P>150 women completed the study; 100 women from the placebo and magnesium oxide groups (50 from another treatment group).</P>
<P>
<B>Setting:</B> Maternidade Central de Luanda, Angola from 1986 to 1987.</P>
<P>
<B>Inclusion criteria:</B> &#8220;150 women were selected from a population of similar ethnic background and socio-economic status.&#8221; Women were primiparous and multiparous, aged 14 to 40 years, and had to be in the first 4 months of pregnancy to be eligible.</P>
<P>
<B>Exclusion criteria:</B> none detailed. Whilst not specified, the trial was designed for the prevention of pre-eclampsia, thus it was assumed that no woman had pre-eclampsia at randomisation.</P>
<P>
<B>Other:</B> considering the 150 women: 67% had a history of malaria or fever of unknown origin; 77% had a history of anaemia; 34% personal or family history of sickle cell trait or disease.<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-08-27 13:37:37 +0100" MODIFIED_BY="[Empty name]">
<P>There were 3 study groups; for the purpose of the review 2 groups were considered.</P>
<P>
<B>Treatment group (n = 50)</B>
</P>
<P>Women received 60 tablets per month or 2 per day (500 mg magnesium oxide).</P>
<P>
<B>Control group (n = 50)</B>
</P>
<P>Women received 240 placebo capsules at the start of the study period (8 per day) containing olive oil without vitamin E.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-08-27 13:37:47 +0100" MODIFIED_BY="[Empty name]">
<P>Adverse effects of supplements; weight gain between the 1st and 3rd trimesters; pregnancy-associated hypertension (increase in systolic blood pressure &gt; 30 mmHg and/or increase in diastolic blood pressure &gt; 15 mmHg); oedema; proteinuria; pre-eclampsia (hypertension, oedema and proteinuria); severe pre-eclampsia with 1 or 2 convulsions; babies&#8217; condition (after 24 hours: skin colour, heart rate, respiratory effort and muscle tone); birthweight (&gt; 3000 g; &lt; 2000 g).</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-05-03 01:39:23 +0100" MODIFIED_BY="[Empty name]">
<P>The trial was designed for the prevention of pre-eclampsia. There was no sample size calculation.<BR/>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-03-19 13:49:08 +0000" MODIFIED_BY="Heather Maxwell" STUDY_ID="STD-Austria-1997">
<CHAR_METHODS MODIFIED="2013-05-03 01:39:34 +0100" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trial.<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-03-19 13:49:08 +0000" MODIFIED_BY="Heather Maxwell">
<P>530 women were randomised.</P>
<P>
<B>Setting:</B> Obstetric and Gynaecological University Clinic, Graz, Austria from 1993 to 1996.</P>
<P>
<B>Inclusion criteria:</B> women with &#8220;non-risk&#8221; pregnancies, recruited before their 18th week of pregnancy.</P>
<P>
<B>Exclusion criteria:</B> women with serious pre-existing conditions, IVF, multiple pregnancy, uterine abnormalities, historical tendency towards preterm labour, hypertensive pregnancy-related illness were excluded.<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-08-27 13:38:26 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Treatment group (n = 265)</B>
</P>
<P>Women were given oral magnesium citrate supplements (365 mg (15 mmol) once daily) from recruitment (&lt; 18 weeks' gestation) until hospitalisation from 38 weeks due to contractions or rupture of membranes.</P>
<P>
<B>Control group (n = 265)</B>
</P>
<P>No placebo supplement was used.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-07-23 02:26:15 +0100" MODIFIED_BY="[Empty name]">
<P>Threatened preterm labour (and cervical changes before 37 weeks); hospitalisation due to threatened preterm labour; duration of hospitalisation; use of cerclage, pessaries, parental tocolysis; spontaneous delivery; caesarean section; forceps birth; gestational age at birth; premature rupture of membranes; administration of oxytocin; birthweight; birth length; preterm birth (&lt; 37 weeks); birthweight &lt; 2500 g; admission to the neonatal intensive care unit. Additional outcomes reported in text included: Apgar score; umbilical arterial and venous pH; rate of infections requiring treatment (maternal); pregnancy induced hypertension.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-05-03 01:39:34 +0100" MODIFIED_BY="[Empty name]">
<P>No sample size calculation presented.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-03-19 13:50:50 +0000" MODIFIED_BY="Heather Maxwell" STUDY_ID="STD-China-1997">
<CHAR_METHODS MODIFIED="2013-05-03 01:39:46 +0100" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trial.<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-08-27 12:29:26 +0100" MODIFIED_BY="[Empty name]">
<P>102 women were included.</P>
<P>
<B>Setting:</B> The Third Hospital of Beijing Medical University, Beijing from 1994 to 1996.</P>
<P>
<B>Inclusion criteria:</B> first time mothers with singleton pregnancies.</P>
<P>
<B>Exclusion criteria:</B> women with heart or kidney problems, with high blood pressure or a history of diabetes were excluded.</P>
<P>There were 50 women with normal pregnancies and 52 with high-risk pregnancies (normal pregnancies: 28 women in control group, 22 women in treatment group; high-risk pregnancies: 23 women in control group, 29 women in treatment group).</P>
<P>
<B>Other: </B>women were aged between 24 and 35 years and at 22 and 41 weeks' gestation.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2014-03-19 13:50:50 +0000" MODIFIED_BY="Heather Maxwell">
<P>
<B>Treatment group (for high- and low-risk pregnancies) (n = 51)</B>
</P>
<P>Women were given 2 g per day magnesium gluconate from 28 weeks' gestation to 30 weeks and then 3 g per day magnesium gluconate from 30 weeks until delivery.</P>
<P>
<B>Control group (for high- and low-risk pregnancies) (n = 51)</B>
</P>
<P>Women received the same regimen as the treatment group, but of a placebo.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-08-27 13:39:11 +0100" MODIFIED_BY="[Empty name]">
<P>Pregnancy-induced hypertension; 6-keto-PGF1&#945;, TXB<SUB>2</SUB>, 6-keto/TXB<SUB>2</SUB> ratio; serum magnesium.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-05-03 01:39:46 +0100" MODIFIED_BY="[Empty name]">
<P>No sample size calculation presented.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-08-27 13:39:27 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Hungary-1979">
<CHAR_METHODS MODIFIED="2013-05-03 01:39:57 +0100" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trial.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-05-03 01:40:00 +0100" MODIFIED_BY="[Empty name]">
<P>1763 women were randomised.</P>
<P>
<B>Setting:</B> Hungary.</P>
<P>
<B>Inclusion criteria:</B> pregnant women.</P>
<P>No further details provided.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-08-27 13:39:27 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Treatment group 1 (group II) (n = 407)</B>
</P>
<P>Women received a magnesium supplement from the 4th to the 9th week of pregnancy.</P>
<P>
<B>Treatment group 2 (group III) (n = 682)</B>
</P>
<P>Women received a magnesium supplement from weeks 10 to 27 of their pregnancy.</P>
<P>
<B>Control group (group I) (n = 674)</B>
</P>
<P>Women received no magnesium supplementation.</P>
<P>The preparation of magnesium citrate used contained 16 mg per g of magnesium citrate.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-05-03 01:39:57 +0100" MODIFIED_BY="[Empty name]">
<P>Miscarriage.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-07-23 02:29:36 +0100" MODIFIED_BY="[Empty name]">
<P>No sample size calculation presented. An additional paper presents further data relating to women included in this trial. The outcomes reported included: duration of gestation; infant weight (and birthweight &lt; 2500 g; &gt; 3000 g); infant size measurements and head circumference. This paper concluded that magnesium supplementation increased the duration of gestation, birthweight, length at birth and head circumference, however we were unable to extract the data to include in this review.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-01-17 03:09:01 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Hungary-1988">
<CHAR_METHODS MODIFIED="2013-05-03 01:44:35 +0100" MODIFIED_BY="[Empty name]">
<P>Cluster-randomised controlled trial.<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-07-22 05:18:20 +0100" MODIFIED_BY="[Empty name]">
<P>997 women were enrolled.</P>
<P>
<B>Setting: </B>15 pregnancy clinics run by the city of Szeged, the Medical Faculty of Szeged University, and the Obstetrics and Gynaecology ward of the Municipal Hospital of Szeged from 1984 to 1985.</P>
<P>
<B>Inclusion criteria:</B> women with singleton pregnancies.</P>
<P>
<B>Exclusions: </B>multiple pregnancies.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-08-27 13:40:04 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Treatment group (n = 490; 485 treated)</B>
</P>
<P>Women received 1 tablet of 5 mmol magnesium aspartate 3 times per day (15 mmol per day). The tablets were chewable.</P>
<P>
<B>Control group (n = 507; 500 treated)</B>
</P>
<P>Women received placebo tablets (the content of the tablets were not reported).</P>
<P>Treatment began between 6 to 21 weeks and lasted until birth.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-08-27 13:40:12 +0100" MODIFIED_BY="[Empty name]">
<P>Perinatal mortality (antenatal, during delivery, postnatal)/miscarriage; preterm birth (&lt; 285 days); duration of gestation; birthweight percentiles (e.g. &lt; 10th percentile); low birthweight (&lt; 2500 g); EPH gestosis.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-01-17 03:09:01 +0000" MODIFIED_BY="[Empty name]">
<P>No sample size calculation presented.</P>
<P>We were unable to include the data relating to <I>"EPH gestosis" </I>as this was reported for 1321 women in the magnesium group and 1089 in the placebo group according to the translation, which was considered incorrect given that this far exceed the total number of women in the trial.<BR/>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-03-19 13:54:59 +0000" MODIFIED_BY="Heather Maxwell" STUDY_ID="STD-Italy-1994">
<CHAR_METHODS MODIFIED="2013-05-03 01:40:16 +0100" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trial.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-08-27 12:29:32 +0100" MODIFIED_BY="[Empty name]">
<P>100 women were included.</P>
<P>
<B>Setting:</B> Italy.</P>
<P>
<B>Inclusion criteria: </B>primigravidas, of not more than 12 weeks' gestation (aged 18 to 28 years old).</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-08-27 13:40:47 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Treatment group (n = 50)</B>
</P>
<P>Women received 15 mmol magnesium hydrochlorate aspartate.</P>
<P>
<B>Control group (n = 50)</B>
</P>
<P>Women received a placebo.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-03-19 13:54:59 +0000" MODIFIED_BY="Heather Maxwell">
<P>Arterial pressure; maternal weight gain; hospitalisation rate; duration of pregnancy; premature labour; 5-minute Apgar index; birthweight (&lt; 2500 g); mean length; cranial circumference; placental weight; serum magnesium concentration/magnesaemia. Side effects and miscarriage were reported (as these women were subsequently excluded).</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-05-03 01:40:16 +0100" MODIFIED_BY="[Empty name]">
<P>Sample size calculation was not performed. It was presumed that participants were randomised equally to the treatment and control groups.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-03-20 10:01:09 +0000" MODIFIED_BY="Heather Maxwell" STUDY_ID="STD-Memphis-1989">
<CHAR_METHODS MODIFIED="2013-05-03 01:40:25 +0100" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trial.<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-08-27 12:29:37 +0100" MODIFIED_BY="[Empty name]">
<P>400 women were randomised.</P>
<P>
<B>Setting:</B> prenatal clinics in Memphis, USA.</P>
<P>
<B>Inclusion criteria:</B> normotensive primigravid women (enrolled at 13 to 24 weeks' gestation).</P>
<P>
<B>Exclusion criteria: </B>women with medical and obstetric complications, and those &gt; 24 weeks' gestation at the time of the first prenatal visit were excluded.<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-08-27 13:41:19 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Treatment group (n = 200)</B>
</P>
<P>Women received 6 tablets of magnesium-aspartate hydrochloride per day (each containing 60.8 mg of elemental magnesium: 365 mg/day) from 13 to 24 weeks until birth.</P>
<P>
<B>Control group (n = 200)</B>
</P>
<P>Women received identically appearing aspartic acid tablets.</P>
<P>
<B>All women: </B>received prenatal vitamins containing 200 mg of elemental calcium and 100 mg of elemental magnesium per day.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2014-03-20 10:01:09 +0000" MODIFIED_BY="Heather Maxwell">
<P>Maternal blood pressure; pre-eclampsia (mild or severe); preterm labour (with or without preterm prelabour rupture of membranes); post-term pregnancy; gestational age at birth; birthweight; placental weight; Apgar scores; admission to special care nursery; small-for-gestational age.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-05-03 01:40:26 +0100" MODIFIED_BY="[Empty name]">
<P>Sample size calculation performed.<BR/>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-08-28 08:50:25 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Mississippi-1992">
<CHAR_METHODS MODIFIED="2013-05-03 01:40:36 +0100" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trial.<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-05-03 01:40:37 +0100" MODIFIED_BY="[Empty name]">
<P>54 women were randomised.</P>
<P>
<B>Setting:</B> Mississippi, USA.</P>
<P>
<B>Inclusion criteria: </B>women with risk factors for preterm delivery.<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-08-28 08:50:25 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Treatment group (n = 27)</B>
</P>
<P>Women received 2 500 mg tablets of magnesium gluconate 4 times daily (4 g daily, 215 mg elemental magnesium).</P>
<P>
<B>Control group (n = 27)</B>
</P>
<P>Women received 2 placebo tablets, 4 times daily. The tablets had the same physical appearance.</P>
<P>If preterm labour occurred: the study medication was discontinued and the woman was treated with standard tocolytic therapy (magnesium sulphate).</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-05-03 01:40:36 +0100" MODIFIED_BY="[Empty name]">
<P>Preterm labour; gestational age at birth; birthweight; major adverse effects; Apgar score &lt; 7 at 5 minutes; serum magnesium concentrations.</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-08-27 13:34:41 +0100" MODIFIED_BY="[Empty name]">
<P>Composition of placebo not reported. No sample size calculation performed.</P>
<P>After the study begun 31 consecutive women (16 in the treatment group; 15 in the placebo group) received home uterine ambulatory monitoring for 1 hour twice daily.<BR/>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2014-03-20 09:55:50 +0000" MODIFIED_BY="Heather Maxwell" STUDY_ID="STD-South-Africa-2007">
<CHAR_METHODS MODIFIED="2013-05-03 01:40:47 +0100" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trial.<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2014-03-20 09:55:22 +0000" MODIFIED_BY="Heather Maxwell">
<P>4476 women were randomised into the study.</P>
<P>
<B>Setting:</B> Midwife Obstetric Unit in Guguletu and its referral hospitals, South Africa.</P>
<P>
<B>Inclusion criteria:</B> women presenting to the above unit. (Black pregnant women of low socio-economic status.)</P>
<P>
<B>Exclusion criteria: </B>women with a multiple pregnancy.</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-08-28 08:56:38 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Treatment group (n = 2016)</B>
</P>
<P>Women were given slow-release magnesium stearate tablets (64 mg elemental magnesium).</P>
<P>
<B>Control group (n = 2066)</B>
</P>
<P>Women were given indistinguishable placebo tablets containing lactose sugar.</P>
<P>
<B>All women:</B> received the tablets from the time of enrolment until delivery. Both tablets were cherry-red, biconvex, enteric-coated and of similar-size. The tablets were packed into brown glass bottles with similar labels (A or B). Only the manufacturer knew the contents. Women received a bottle of 60 tablets and were instructed to swallow 2 whole tablets with water each morning (not to be chewed or sucked).</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-08-27 13:34:48 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Pre-specified:</B> hypoxic ischaemic encephalopathy classified by altered muscle tone and consciousness; bulging anterior fontanelle; inadequate suck reflex; haematuria and ultrasound signs of cerebral oedema with compression of the ventricles as assessed by the hospital's neonatologists; low Apgar scores (&#8804; 4 at 1 minute; &#8804; 6 at 5 minutes); fetal heart rate abnormalities scored from cardiotocograph tracings; meconium aspiration pneumonia diagnosed by respiratory distress from birth and radiological evidence as assess by the hospital's neonatologists; term stillbirth.</P>
<P>
<B>Other outcome data reported relating to delivery and infant characteristics</B>: adverse effects from tablets; discontinuation of tablets due to discomfort; red blood cell magnesium; additional antenatal assessment or treatment in hospital; labour (including spontaneous onset, need for induction &#8211; and use of oxytocin/prostaglandin gel/other); duration of labour; labour complications; mode of birth (normal vaginal; caesarean); live-births; neonatal deaths (and reasons); birthweight; placental weight; gestational age at birth; head circumference; premature birth; birthweight &lt; 2500 g; congenital abnormalities<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2014-03-20 09:55:50 +0000" MODIFIED_BY="Heather Maxwell">
<P>Sample size calculation: 4372 pregnant women would be needed to have 80% power for a 50% reduction in hypoxic ischaemic encephalopathy. However, a 2% dropout rate was also allowed for, therefore 4459 women were required.</P>
<P>Authors attributed the higher mortality rate of preterm infants in the supplemented group to the deaths of 2 sets of twins of less than 750 g at birth.</P>
<P>* Trial authors were contacted and responded 31/08/2013 regarding the numbers of neonatal deaths in each group.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2013-08-28 08:58:09 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Zurich-1988">
<CHAR_METHODS MODIFIED="2013-05-03 01:40:59 +0100" MODIFIED_BY="[Empty name]">
<P>Quasi-randomised controlled trial.<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-08-27 12:29:40 +0100" MODIFIED_BY="[Empty name]">
<P>568 women were randomised.</P>
<P>
<B>Setting:</B> Outpatients clinic at the Department of Obstetrics, University of Zurich, from 1983 to 1985.</P>
<P>
<B>Inclusion criteria</B>: women with normal and high-risk pregnancies, at no later than 16 weeks' gestation.<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-08-28 08:58:09 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Treatment group (n = 278)</B>
</P>
<P>Women received 15 mmol of magnesium aspartate-hydrochloride daily from &#8804; 16 weeks' gestation until delivery.</P>
<P>
<B>Control group (n = 290)</B>
</P>
<P>Women received a control tablet containing 13.5 mmol of aspartic acid per day. No detail of the appearance/taste of these tablets being similar to the treatment tablets.</P>
<P>The doses were divided into 6 tablets to be taken daily.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-05-03 01:41:02 +0100" MODIFIED_BY="[Empty name]">
<P>Adverse effects; miscarriage; maternal weight increase; blood pressure; oedema; hospitalisation (and indication for hospitalisation); median gestation; preterm birth; duration of the first and second stage of labour; operative birth; placental weight; infant weight; low birthweight; infant length; head circumference; neonatal acid-base values; admission to the neonatal intensive care unit; perinatal death; low Apgar score (&#8804; 7).</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2013-08-27 13:35:28 +0100" MODIFIED_BY="[Empty name]">
<P>Sample size was determined by the duration of the study&#8217;s recruitment period (2 years). Groups were comparable at baseline.</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<FOOTNOTES>
<P>EPH: edema, proteinuria, hypertension<BR/>GI: gastrointestinal<BR/>IVF: in vitro fertilisation<BR/>
</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES MODIFIED="2013-05-03 01:41:27 +0100" MODIFIED_BY="[Empty name]" SORT_BY="STUDY">
<EXCLUDED_CHAR MODIFIED="2013-02-07 04:41:23 +0000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Denmark-1990">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-02-07 04:41:23 +0000" MODIFIED_BY="[Empty name]">
<P>This trial compared light and electron microscope changes in the placenta and umbilical cord of 28 women with pregnancy-induced hypertension randomised to intravenous and oral magnesium sulphate or placebo. This trial may be considered for inclusion in a future update of the <LINK REF="REF-Duley-2010" TYPE="REFERENCE">Duley 2010</LINK> Cochrane review.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-05-03 01:41:09 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Denmark-1991">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-05-03 01:41:09 +0100" MODIFIED_BY="[Empty name]">
<P>This trial recruited 58 women with pregnancy-induced hypertension to determine effects of intravenous and oral magnesium versus placebo on maternal blood pressure. This study may be considered for inclusion in a future update of the <LINK REF="REF-Duley-2010" TYPE="REFERENCE">Duley 2010</LINK> Cochrane review.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-05-03 01:41:11 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Detroit-1999">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-05-03 01:41:11 +0100" MODIFIED_BY="[Empty name]">
<P>This trial assessed the effects of intravenous magnesium sulphate on fetal heart rate parameters.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-05-03 01:41:14 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-India-2012">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-05-03 01:41:14 +0100" MODIFIED_BY="[Empty name]">
<P>This randomised trial recruited 48 women with gestational age greater than 34 weeks with mild pre-eclampsia or gestational hypertension and randomly assigned them to receive either intravenous magnesium sulphate or placebo, to assess the effects on fetal umbilical artery and middle cerebral artery blood flow. This trial may be considered for inclusion in a future update of the <LINK REF="REF-Duley-2010" TYPE="REFERENCE">Duley 2010</LINK> Cochrane review.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-05-03 01:41:17 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-ISRCTN03989660">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-05-03 01:41:17 +0100" MODIFIED_BY="[Empty name]">
<P>This study will assess the effects of oral magnesium supplementation on pregnancy-related leg cramps, which is the focus of another relevant Cochrane review (<LINK REF="REF-Garrison-2012" TYPE="REFERENCE">Garrison 2012</LINK>).</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-05-03 01:41:19 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-NCT01709968">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-05-03 01:41:19 +0100" MODIFIED_BY="[Empty name]">
<P>This study will assess the effects of oral magnesium supplementation on pregnancy-related leg cramps, which is the focus of another relevant Cochrane review (<LINK REF="REF-Garrison-2012" TYPE="REFERENCE">Garrison 2012</LINK>).</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-05-03 01:41:23 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Norway-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-05-03 01:41:23 +0100" MODIFIED_BY="[Empty name]">
<P>This study examined the effects of oral magnesium supplementation on pregnancy-related leg cramps and has been assessed in the relevant Cochrane review (<LINK REF="REF-Garrison-2012" TYPE="REFERENCE">Garrison 2012</LINK>).</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-05-03 01:41:25 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Sweden-1987">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-05-03 01:41:25 +0100" MODIFIED_BY="[Empty name]">
<P>This randomised controlled trial randomised 60 pregnant women to either calcium or ascorbic acid (1 g twice daily) as treatment for leg cramps. There was no magnesium arm in this trial.</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2013-05-03 01:41:27 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Sweden-1995">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2013-05-03 01:41:27 +0100" MODIFIED_BY="[Empty name]">
<P>This study examined the effects of oral magnesium supplementation on pregnancy-related leg cramps and has been assessed in the relevant Cochrane review (<LINK REF="REF-Garrison-2012" TYPE="REFERENCE">Garrison 2012</LINK>).</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES/>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES MODIFIED="2013-02-07 04:17:08 +0000" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES MODIFIED="2014-03-19 14:07:48 +0000" MODIFIED_BY="Heather Maxwell" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<ONGOING_CHAR MODIFIED="2014-03-19 14:06:52 +0000" MODIFIED_BY="Heather Maxwell" STUDY_ID="STD-ISRCTN98365455">
<CHAR_STUDY_NAME MODIFIED="2014-03-19 14:06:52 +0000" MODIFIED_BY="Heather Maxwell">
<P>Acid-base balance and blood pressure during pregnancy: a double-blinded randomised controlled trial.</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2013-05-03 01:41:31 +0100" MODIFIED_BY="[Empty name]">
<P>Randomised controlled trial.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-08-28 08:59:34 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Inclusion criteria</B>
</P>
<UL>
<LI>First time pregnancies.</LI>
<LI>Urinary calcium excretion in excess of 6 mmol around pregnancy week 20.</LI>
</UL>
<P>
<B>Exclusion criteria</B>
</P>
<UL>
<LI>History of blood pressure or renal dysfunction.</LI>
</UL>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-07-23 03:02:29 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Intervention group:</B> magnesium citrate powder (Diasporal), 12 mmol magnesium daily, taken at week 25 of pregnancy until delivery.<BR/>
<B>Control group: </B>no supplements.</P>
<P>Blood pressure and proteinuria will be measured routinely in all pregnancies.</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-05-03 01:41:31 +0100" MODIFIED_BY="[Empty name]">
<P>Primary outcome measure(s):<B> </B>blood pressure increase during final weeks of pregnancy.</P>
<P>Secondary outcome measure(s):<B> </B>symptoms of pre-eclampsia during final weeks of pregnancy.</P>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2013-05-03 01:41:31 +0100" MODIFIED_BY="[Empty name]">
<P>October 2010.</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2013-05-03 01:41:31 +0100" MODIFIED_BY="[Empty name]">
<P>Professor Ragnar Rylander, Sodra Alvsaborg&#8217;s Hospital, Sweden.</P>
<P>envhealth@biofact.se.</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES MODIFIED="2013-05-03 06:16:52 +0100" MODIFIED_BY="[Empty name]">
<P>Estimated enrolment: 60 women.</P>
</CHAR_NOTES>
</ONGOING_CHAR>
<ONGOING_CHAR MODIFIED="2013-08-28 09:00:39 +0100" MODIFIED_BY="[Empty name]" STUDY_ID="STD-NCT01510665">
<CHAR_STUDY_NAME MODIFIED="2013-05-03 01:41:37 +0100" MODIFIED_BY="[Empty name]">
<P>Magnesium supplementation in the second trimester of pregnancy for overweight individuals.</P>
</CHAR_STUDY_NAME>
<CHAR_METHODS MODIFIED="2013-05-03 01:41:37 +0100" MODIFIED_BY="[Empty name]">
<P>Randomised, double-blind, controlled trial.</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2013-08-28 09:00:20 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Inclusion criteria</B>
</P>
<UL>
<LI>Between 18 and 40 years of age.</LI>
<LI>Pregnant in the first trimester.</LI>
<LI>Able to give informed consent.</LI>
<LI>Planning to deliver at the University of California, Los Angeles.</LI>
<LI>BMI greater than or equal to 25.</LI>
</UL>
<P>
<B>Exclusion criteria</B>
</P>
<UL>
<LI>On insulin therapy or other oral hypoglycaemic agents.</LI>
<LI>Multiple gestation.</LI>
<LI>Baseline HgbA1C &gt; 6.5%.</LI>
<LI>Prior history of clinically diagnosed type 2 diabetes.</LI>
<LI>Multiple dietary restrictions/food allergies.</LI>
<LI>Heart, renal, or liver failure.</LI>
<LI>Clinical history of psychiatric illness or substance abuse.</LI>
<LI>Out of town travel planned at study visits.</LI>
</UL>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2013-08-28 09:00:24 +0100" MODIFIED_BY="[Empty name]">
<P>
<B>Intervention group:</B> magnesium citrate dietary supplement (300 mg elemental magnesium daily dose) given week 13 to week 28 (2 pills daily).</P>
<P>
<B>Control group: </B>identical appearing pill with inactive ingredients given week 13 to week 28 (2 pills daily).</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2013-08-28 09:00:39 +0100" MODIFIED_BY="[Empty name]">
<P>Primary outcome measure(s): change in maternal biomarkers during pregnancy up to 28 weeks; neonatal birthweight/height; change in maternal biomarkers in pregnancy in the third trimester.</P>
<P>Secondary outcome measure(s): macrosomia, preterm birth, head circumference, and Apgar score; endothelial progenitor cell presence in cord blood, and DNA expression from the placental tissue; gestational diabetes, hypertension, proteinuria, shoulder dystocia, caesarean section, weight gain.</P>
</CHAR_OUTCOMES>
<CHAR_STARTING_DATE MODIFIED="2013-05-03 01:41:37 +0100" MODIFIED_BY="[Empty name]">
<P>January 2012.</P>
</CHAR_STARTING_DATE>
<CHAR_CONTACT_INFORMATION MODIFIED="2013-05-03 01:41:37 +0100" MODIFIED_BY="[Empty name]">
<P>Dr Simin Liu, University of California, Los Angeles.</P>
</CHAR_CONTACT_INFORMATION>
<CHAR_NOTES MODIFIED="2013-05-03 06:17:03 +0100" MODIFIED_BY="[Empty name]">
<P>Estimated enrolment: 60 women.</P>
</CHAR_NOTES>
</ONGOING_CHAR>
<FOOTNOTES>
<P>BMI: body mass index<BR/>HgbA1C: glycated haemoglobin</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS MODIFIED="2014-03-20 10:01:37 +0000" MODIFIED_BY="Heather Maxwell">
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" MODIFIED="2014-03-19 14:01:01 +0000" MODIFIED_BY="Heather Maxwell" NO="1">
<NAME>Random sequence generation (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate generation of a randomised sequence</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-05-03 01:39:27 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Angola-1992">
<DESCRIPTION>
<P>Women were randomised using a table of random numbers.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-08-27 13:38:44 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Austria-1997">
<DESCRIPTION>
<P>Randomisation according to a computer-generated randomisation list.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-03-19 13:51:09 +0000" MODIFIED_BY="Heather Maxwell" RESULT="UNKNOWN" STUDY_ID="STD-China-1997">
<DESCRIPTION>
<P>
<I>"Random allocation"</I> - method not stated. Separate randomisation for high-risk and low-risk pregnancies.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-01-17 03:08:55 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hungary-1979">
<DESCRIPTION>
<P>Method of randomisation not stated; quote <I>"By randomisation, 3 groups were determined".</I>
</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-01-17 03:09:06 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hungary-1988">
<DESCRIPTION>
<P>Randomisation by centre - 8 <I>"magnesium" </I>centres, 7 placebo centres. Method not stated.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-07-23 02:53:10 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Italy-1994">
<DESCRIPTION>
<P>&#8220;A double-blind protocol was used and... each was assigned a code number on the basis of which she received tablets.&#8221; No detail provided re: the generation of the random sequence.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-08-28 08:44:17 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Memphis-1989">
<DESCRIPTION>
<P>Computer-generated randomisation chart using a randomisation schedule.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-05-03 01:40:42 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Mississippi-1992">
<DESCRIPTION>
<P>Randomly selected - methods not given.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-05-03 01:40:53 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-South-Africa-2007">
<DESCRIPTION>
<P>The allocation sequence was provided by the Medical Research Council from computer-generated random numbers linked to the letters A and B.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-03-19 14:01:01 +0000" MODIFIED_BY="Heather Maxwell" RESULT="NO" STUDY_ID="STD-Zurich-1988">
<DESCRIPTION>
<P>Allocation was based on the women's date of birth.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" MODIFIED="2013-05-03 01:44:35 +0100" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Allocation concealment (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate concealment of allocations prior to assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-05-03 01:39:27 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Angola-1992">
<DESCRIPTION>
<P>Not detailed.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-05-03 01:39:41 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Austria-1997">
<DESCRIPTION>
<P>Not detailed.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-05-03 01:44:35 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-China-1997">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-05-03 01:40:03 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hungary-1979">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-05-03 01:40:12 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hungary-1988">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-05-03 01:44:35 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Italy-1994">
<DESCRIPTION>
<P>As above, no further detail provided.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-05-03 01:40:31 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Memphis-1989">
<DESCRIPTION>
<P>Allocation by pharmacy.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-05-03 01:44:35 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Mississippi-1992">
<DESCRIPTION>
<P>Not reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-05-03 01:44:35 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-South-Africa-2007">
<DESCRIPTION>
<P>&#8220;Simple randomisation was conducted by the research assistants who issued consecutive numbers to each participant.&#8221;</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-05-03 01:41:05 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Zurich-1988">
<DESCRIPTION>
<P>Women with even birth date given magnesium-aspartate-hydrochloride, women with odd birth date given aspartic acid.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" MODIFIED="2012-10-25 05:08:35 +0100" MODIFIED_BY="[Empty name]" NO="3">
<NAME>Blinding (performance bias and detection bias)</NAME>
<DESCRIPTION>
<P>Performance bias or detection bias due to knowledge of the allocated interventions after assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-03.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-07" LEVEL="GROUP" MODIFIED="2014-03-19 14:01:29 +0000" MODIFIED_BY="Heather Maxwell" NO="7">
<NAME>Blinding of participants and personnel (performance bias)</NAME>
<DESCRIPTION>
<P>Performance bias due to knowledge of the allocated interventions by participants and personnel during the study</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-07.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2014-01-17 03:08:35 +0000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Angola-1992">
<DESCRIPTION>
<P>The trial was described as <I>"partially double-blinded" </I>with the magnesium oxide tablets having a different appearance to the oil-containing capsules. The code of the capsules was not known to the manufacturer until the end of the treatment period. Women in groups 1 (placebo) and 2 (primrose oil and fish oil) received 240 capsules at the beginning of the supplementation period (eight per day), whereas women in group 3 (magnesium) received 60 tablets per month (2 per day).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-05-03 01:39:41 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Austria-1997">
<DESCRIPTION>
<P>No placebo.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-05-03 01:44:35 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-China-1997">
<DESCRIPTION>
<P>Placebo used.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-05-03 01:40:03 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Hungary-1979">
<DESCRIPTION>
<P>No placebo was used.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-07-23 02:51:34 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hungary-1988">
<DESCRIPTION>
<P>A placebo was used however the composition of placebo not reported. Only the leader of the study knew the composition of the magnesium/placebo tablet bottles &#8211; there were identification marks on the tablets known to the leader of the study.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-05-03 01:44:35 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Italy-1994">
<DESCRIPTION>
<P>Only the chemist knew the association between the code number and the treatment/placebo group.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-05-03 01:40:31 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Memphis-1989">
<DESCRIPTION>
<P>The control treatment matched the magnesium aspartate hydrochloride tablets.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-08-28 08:50:39 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Mississippi-1992">
<DESCRIPTION>
<P>The healthcare providers were blinded to the treatment allocation. Placebo used had identical appearance to the magnesium tablets.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2013-05-03 01:44:35 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-South-Africa-2007">
<DESCRIPTION>
<P>Nurses and medical staff were unaware of the participants' status. Bottles of tablets were marked A or B and only the manufacturer knew the contents of the bottles. The placebo tablets used appeared identical to the magnesium tablets.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2014-03-19 14:01:29 +0000" MODIFIED_BY="Heather Maxwell" RESULT="UNKNOWN" STUDY_ID="STD-Zurich-1988">
<DESCRIPTION>
<P>The study was described as &#8220;double-blind&#8221; with the use of a placebo; however allocation was based on the women's date of birth, and thus it is unclear as to whether blinding would have been successfully achieved for women and personnel.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-08" LEVEL="GROUP" MODIFIED="2014-03-19 14:01:44 +0000" MODIFIED_BY="Heather Maxwell" NO="8">
<NAME>Blinding of outcome assessment (detection bias)</NAME>
<DESCRIPTION>
<P>Detection bias due to knowledge of the allocated interventions by outcome assessors</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-08.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-05-03 01:39:27 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Angola-1992">
<DESCRIPTION>
<P>Blinding of outcome assessment not detailed; however considered unlikely to have been effective in view of the differing interventions.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-05-03 01:39:41 +0100" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Austria-1997">
<DESCRIPTION>
<P>Non-blinded outcome assessment.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-05-03 01:44:35 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-China-1997">
<DESCRIPTION>
<P>Blinded outcome assessment (from translation).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-05-03 01:40:03 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hungary-1979">
<DESCRIPTION>
<P>Blinded outcome assessment (from translation).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-05-03 01:40:12 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hungary-1988">
<DESCRIPTION>
<P>Blinded outcome assessment (as per translations).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-05-03 01:44:35 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Italy-1994">
<DESCRIPTION>
<P>Blind outcome assessment.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-05-03 01:40:31 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Memphis-1989">
<DESCRIPTION>
<P>Blinded outcome assessment.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-05-03 01:44:35 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Mississippi-1992">
<DESCRIPTION>
<P>Blinded outcome assessment.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2013-05-03 01:44:35 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-South-Africa-2007">
<DESCRIPTION>
<P>Blinded outcome assessment.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2014-03-19 14:01:44 +0000" MODIFIED_BY="Heather Maxwell" RESULT="UNKNOWN" STUDY_ID="STD-Zurich-1988">
<DESCRIPTION>
<P>The study was described as &#8220;double-blind&#8221; with the use of a placebo; however allocation was based on the women's date of birth, and thus it is unclear as to whether blinding would have been successfully achieved for outcome assessment.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" MODIFIED="2014-03-20 10:01:37 +0000" MODIFIED_BY="Heather Maxwell" NO="4">
<NAME>Incomplete outcome data (attrition bias)</NAME>
<DESCRIPTION>
<P>Attrition bias due to amount, nature or handling of incomplete outcome data</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-04.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-05-03 01:39:27 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Angola-1992">
<DESCRIPTION>
<P>Post-randomisation exclusions not stated.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-05-03 01:39:41 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Austria-1997">
<DESCRIPTION>
<P>7.5% (40/530) post-randomisation exclusions. 25 women from the treatment group and 15 women from the control group were excluded due to lack of adherence, termination of pregnancy, GI problems with supplementation, controls treated with magnesium for cramps, spontaneous abortion, intrauterine fetal death, missed abortion.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-05-03 01:44:35 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-China-1997">
<DESCRIPTION>
<P>No post-randomisation exclusions.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-08-27 13:36:30 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hungary-1979">
<DESCRIPTION>
<P>Post-randomisation exclusion of 6 women (0.3%) because they moved away from the area where the study was being conducted (placebo group: 3 women; magnesium &lt; 9th week group: 1 woman; magnesium between 10 to 27 weeks: 2 women).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-08-27 13:36:44 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hungary-1988">
<DESCRIPTION>
<P>7/507 (1.4%) women from the placebo group and 5/490 (1.0%) from the magnesium group were excluded initially (in total 12/997 (1.2%) were excluded). 4 were not pregnant, 7 were multiple pregnancies and 1 pregnancy was terminated due to anencephaly. A further 104/500 (20.8%) women were excluded from the placebo group and 85/485 (17.5%) women were excluded from the magnesium group. 189/985 (19.2%) women were excluded in total due to miscarriage, death of the infant prior to discharge or loss to follow-up. No significant difference was found in exclusions between the magnesium and placebo groups.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-08-27 13:35:56 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Italy-1994">
<DESCRIPTION>
<P>Post-randomisation exclusion due to side effects of the treatment or miscarriage (4 in placebo and 3 in treatment group due to side effects such as diarrhoea, nausea, emesis; 1 in placebo and 1 in treatment group due to miscarriage).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-05-03 01:40:31 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Memphis-1989">
<DESCRIPTION>
<P>11/200 (5.5%) of women excluded from the placebo group and 15/200 (7.5%) of women excluded from the treatment group because they never started the medication (6.5% total post-randomisation exclusions).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2013-08-27 13:36:46 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Mississippi-1992">
<DESCRIPTION>
<P>Assuming equal randomisation into the treatment and placebo groups, 2/27 (7.4%) women were excluded from the placebo group and 5/27 (18.5%) women were excluded from the treatment group (13% women excluded in total). This assumption had to be made as the original report did not report which group the women who were excluded were assigned to. 7 women were excluded &#8211; 4 moved away, 2 experienced an early pregnancy loss, and 1 &#8220;violated protocol&#8221;.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-03-20 10:01:37 +0000" MODIFIED_BY="Heather Maxwell" RESULT="UNKNOWN" STUDY_ID="STD-South-Africa-2007">
<DESCRIPTION>
<P>8.8% post-randomisation exclusions. 204 women lost to follow-up. 190 women excluded post-randomisation. The analysis was not performed on women lost to follow-up or those excluded post-randomisation. It is also difficult to determine which group the excluded women were randomised to.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2014-03-20 09:54:06 +0000" MODIFIED_BY="Heather Maxwell" RESULT="UNKNOWN" STUDY_ID="STD-Zurich-1988">
<DESCRIPTION>
<P>Actual group values (total number per group) are not reported in the outcome data tables, and thus it is difficult to determine the exclusions and attrition and where there is missing data; quote &#8220;For various reasons such as refusal to take further tablets, delivery in other hospitals or abortion, some data were not available for analysis."</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" MODIFIED="2013-09-04 02:11:00 +0100" MODIFIED_BY="[Empty name]" NO="5">
<NAME>Selective reporting (reporting bias)</NAME>
<DESCRIPTION>
<P>Reporting bias due to selective outcome reporting</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-08-27 13:38:10 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Angola-1992">
<DESCRIPTION>
<P>Outcomes were not pre-specified in the methods, and for some outcomes such as adverse effects only P values were reported (with no event values per group reported).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-05-03 01:39:41 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Austria-1997">
<DESCRIPTION>
<P>Insufficient information to determine (from translation).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-07-23 02:28:57 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-China-1997">
<DESCRIPTION>
<P>Insufficient information to determine (from translation).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-05-03 01:40:03 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hungary-1979">
<DESCRIPTION>
<P>Miscarriage was the only outcome presented.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-05-03 01:40:12 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hungary-1988">
<DESCRIPTION>
<P>Insufficient information to determine (from translation).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-05-03 01:44:35 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Italy-1994">
<DESCRIPTION>
<P>Outcomes not clearly pre-specified in the methods. Mean duration of pregnancy and birth length were reported with no standard deviations/errors.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-05-03 01:40:31 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Memphis-1989">
<DESCRIPTION>
<P>All pre-specified outcomes were reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-05-03 01:44:35 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Mississippi-1992">
<DESCRIPTION>
<P>Not all reported outcomes were clearly pre-specified in methods.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-09-04 02:11:00 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-South-Africa-2007">
<DESCRIPTION>
<P>While pre-specified/expected outcomes were reported, the reporting of outcome data related to stillbirths and neonatal deaths in the manuscript was unclear, and further with no access to a trial protocol, it is not possible to confidently assess selective reporting. In the text it suggests that there were 16 treatment group and 7 control group neonatal deaths, however the table indicated that there were 17 treatment group and 7 control group neonatal deaths. Trial authors were contacted and were able to confirm the numbers of neonatal deaths per group (17 and 7). In regards to stillbirths, only the values for stillbirth at greater than 28 weeks and at term were provided by group allocation.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-05-03 01:41:05 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zurich-1988">
<DESCRIPTION>
<P>Outcome data reported for a range of important outcomes &#8211; these however were not pre-specified in the methods, and it is therefore difficult to assess selective reporting.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" MODIFIED="2014-03-19 13:56:13 +0000" MODIFIED_BY="Heather Maxwell" NO="6">
<NAME>Other bias</NAME>
<DESCRIPTION>
<P>Bias due to problems not covered elsewhere in the table</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-05-03 01:39:27 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Angola-1992">
<DESCRIPTION>
<P>The placebo group had significantly better dietary intake than the treatment group and the magnesium oxide group had poor pregnancy weight gain at baseline.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-05-03 01:39:41 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Austria-1997">
<DESCRIPTION>
<P>There was no significant difference between the magnesium and control groups at baseline. No other obvious risk of bias sources identified.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-05-03 06:16:51 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-China-1997">
<DESCRIPTION>
<P>No other obvious risk of bias evident.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-05-03 01:40:03 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hungary-1979">
<DESCRIPTION>
<P>No other bias reported.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-05-03 01:40:12 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hungary-1988">
<DESCRIPTION>
<P>High non-adherence rate. Difficult to determine other bias due to translation.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-05-03 01:44:35 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Italy-1994">
<DESCRIPTION>
<P>No other obvious source of bias identified.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2014-03-19 13:56:13 +0000" MODIFIED_BY="Heather Maxwell" RESULT="UNKNOWN" STUDY_ID="STD-Memphis-1989">
<DESCRIPTION>
<P>14 women in the placebo group and 11 in the treatment group stopped taking the tablets prior to the commencement of the third trimester. The remaining women took approximately 90% of the tablets. Reasons for ceasing the medication included gastrointestinal symptoms and trouble swallowing the tablets. There was no difference in the incidence of side effects between the placebo and treatment groups.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-05-03 01:44:35 +0100" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Mississippi-1992">
<DESCRIPTION>
<P>No other obvious sources of bias identified. Risk factors for preterm birth and other baseline characteristics were comparable between groups.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-08-28 08:57:53 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-South-Africa-2007">
<DESCRIPTION>
<P>The authors reported poor adherence (one-quarter of women on average took all the prescribed tablets).</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2013-05-03 01:41:05 +0100" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zurich-1988">
<DESCRIPTION>
<P>No other obvious sources of bias identified.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES/>
<ADDITIONAL_TABLES MODIFIED="2014-01-21 03:58:43 +0000" MODIFIED_BY="[Empty name]">
<ADDITIONAL_TABLE ID="TBL-01" MODIFIED="2014-01-21 03:58:43 +0000" MODIFIED_BY="[Empty name]" NO="1">
<TITLE MODIFIED="2013-07-21 23:18:52 +0100" MODIFIED_BY="[Empty name]">The original data and adjusted data for dichotomous data of the cluster-randomised trial</TITLE>
<TABLE COLS="9" ROWS="10">
<TR>
<TD>
<P>
<B>Outcomes</B>
</P>
</TD>
<TD COLSPAN="2">
<P>
<B>Intervention (original data)</B>
</P>
</TD>
<TD COLSPAN="2">
<P>
<B>Control (original data)</B>
</P>
</TD>
<TD COLSPAN="2">
<P>
<B>Intervention (adjusted data)<SUP>1</SUP>
</B>
</P>
</TD>
<TD COLSPAN="2">
<P>
<B>Control (original data)<SUP>1</SUP>
</B>
</P>
</TD>
</TR>
<TR>
<TD>
<P/>
</TD>
<TD>
<P>Total number</P>
</TD>
<TD>
<P>Event number</P>
</TD>
<TD>
<P>Total number</P>
</TD>
<TD>
<P>Event number</P>
</TD>
<TD>
<P>Total number</P>
</TD>
<TD>
<P>Event number</P>
</TD>
<TD>
<P>Total number</P>
</TD>
<TD>
<P>Event number</P>
</TD>
</TR>
<TR>
<TD>
<P>Perinatal mortality</P>
</TD>
<TD>
<P>6</P>
</TD>
<TD>
<P>400</P>
</TD>
<TD>
<P>5</P>
</TD>
<TD>
<P>396</P>
</TD>
<TD>
<P>3</P>
</TD>
<TD>
<P>174</P>
</TD>
<TD>
<P>2</P>
</TD>
<TD>
<P>172</P>
</TD>
</TR>
<TR>
<TD>
<P>Small-for-gestational age &lt; 10th percentile</P>
</TD>
<TD>
<P>33</P>
</TD>
<TD>
<P>400</P>
</TD>
<TD>
<P>59</P>
</TD>
<TD>
<P>396</P>
</TD>
<TD>
<P>14</P>
</TD>
<TD>
<P>174</P>
</TD>
<TD>
<P>26</P>
</TD>
<TD>
<P>172</P>
</TD>
</TR>
<TR>
<TD>
<P>Stillbirth</P>
</TD>
<TD>
<P>3</P>
</TD>
<TD>
<P>400</P>
</TD>
<TD>
<P>3</P>
</TD>
<TD>
<P>396</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>174</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>172</P>
</TD>
</TR>
<TR>
<TD>
<P>Neonatal death prior to discharge</P>
</TD>
<TD>
<P>3</P>
</TD>
<TD>
<P>400</P>
</TD>
<TD>
<P>2</P>
</TD>
<TD>
<P>396</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>174</P>
</TD>
<TD>
<P>1</P>
</TD>
<TD>
<P>172</P>
</TD>
</TR>
<TR>
<TD>
<P>Miscarriage (&lt; 20 weeks' gestation)</P>
</TD>
<TD>
<P>28</P>
</TD>
<TD>
<P>428</P>
</TD>
<TD>
<P>32</P>
</TD>
<TD>
<P>428</P>
</TD>
<TD>
<P>12</P>
</TD>
<TD>
<P>186</P>
</TD>
<TD>
<P>14</P>
</TD>
<TD>
<P>186</P>
</TD>
</TR>
<TR>
<TD>
<P>Preterm birth &lt; 37 weeks' gestation</P>
</TD>
<TD>
<P>33</P>
</TD>
<TD>
<P>400</P>
</TD>
<TD>
<P>54</P>
</TD>
<TD>
<P>396</P>
</TD>
<TD>
<P>14</P>
</TD>
<TD>
<P>174</P>
</TD>
<TD>
<P>23</P>
</TD>
<TD>
<P>172</P>
</TD>
</TR>
<TR>
<TD>
<P>Low birthweight</P>
</TD>
<TD>
<P>18</P>
</TD>
<TD>
<P>400</P>
</TD>
<TD>
<P>31</P>
</TD>
<TD>
<P>396</P>
</TD>
<TD>
<P>8</P>
</TD>
<TD>
<P>174</P>
</TD>
<TD>
<P>13</P>
</TD>
<TD>
<P>172</P>
</TD>
</TR>
<TR>
<TD>
<P>Maternal side effects</P>
</TD>
<TD>
<P>140</P>
</TD>
<TD>
<P>400</P>
</TD>
<TD>
<P>156</P>
</TD>
<TD>
<P>396</P>
</TD>
<TD>
<P>61</P>
</TD>
<TD>
<P>174</P>
</TD>
<TD>
<P>68</P>
</TD>
<TD>
<P>172</P>
</TD>
</TR>
</TABLE>
<FOOTNOTES>
<P>1. Adjusted data = n / design effect, where:</P>
<UL>
<LI>design effect = 1 + (M - 1) x ICC = 2.3</LI>
<LI>M = average cluster size = (total number of intervention + total number of control randomised)/(cluster number of intervention + cluster number of control) = 66</LI>
<LI>ICC = intracluster correlation co-efficient = 0.02</LI>
</UL>
</FOOTNOTES>
</ADDITIONAL_TABLE>
</ADDITIONAL_TABLES>
<ANALYSES_AND_DATA CALCULATED_DATA="YES" MODIFIED="2014-01-21 04:55:43 +0000" MODIFIED_BY="[Empty name]">
<COMPARISON ID="CMP-001" MODIFIED="2014-01-21 03:58:57 +0000" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Magnesium supplementation versus no magnesium</NAME>
<DICH_OUTCOME CHI2="0.5655974449207929" CI_END="1.6665180825953367" CI_START="0.7202263786543306" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="RR" EFFECT_SIZE="1.0955684750802197" ESTIMABLE="YES" EVENTS_1="44" EVENTS_2="41" I2="0.0" I2_Q="0.0" ID="CMP-001.01" LOG_CI_END="0.22181003034504423" LOG_CI_START="-0.14253097641902332" LOG_EFFECT_SIZE="0.039639526963010464" METHOD="MH" MODIFIED="2014-01-21 03:58:57 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.9668088209498874" P_Q="0.8486630843669184" P_Z="0.669758243869332" Q="0.3281860747944912" RANDOM="NO" SCALE="44.188634414834844" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="2920" TOTAL_2="2983" WEIGHT="100.0" Z="0.4264798294418454">
<NAME>Perinatal mortality</NAME>
<GROUP_LABEL_1>Magnesium</GROUP_LABEL_1>
<GROUP_LABEL_2>No magnesium</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours magnesium</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours no magnesium</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="7.04666099030381" CI_START="0.14191118337834013" DF="0" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" I2="0.0" ID="CMP-001.01.01" LOG_CI_END="0.8479833784105825" LOG_CI_START="-0.8479833784105826" LOG_EFFECT_SIZE="0.0" MODIFIED="2014-01-14 03:34:55 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="1.0" STUDIES="1" TAU2="0.0" TOTAL_1="265" TOTAL_2="265" WEIGHT="4.871855997426977" Z="0.0">
<NAME>Magnesium citrate</NAME>
<DICH_DATA CI_END="7.04666099030381" CI_START="0.14191118337834013" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.8479833784105825" LOG_CI_START="-0.8479833784105826" LOG_EFFECT_SIZE="0.0" MODIFIED="2014-01-14 03:34:55 +0000" MODIFIED_BY="[Empty name]" ORDER="424" O_E="0.0" SE="0.9962192681275941" STUDY_ID="STD-Austria-1997" TOTAL_1="265" TOTAL_2="265" VAR="0.9924528301886792" WEIGHT="4.871855997426977"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.2784925007193233" CI_END="5.991430123949501" CI_START="0.41713514146526454" DF="2" EFFECT_SIZE="1.5808972301616961" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="3" I2="0.0" ID="CMP-001.01.02" LOG_CI_END="0.7775304986510314" LOG_CI_START="-0.3797232215625334" LOG_EFFECT_SIZE="0.19890363854424906" MODIFIED="2014-01-14 03:34:56 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.8700137698627421" P_Z="0.5004767329428759" STUDIES="3" TAU2="0.0" TOTAL_1="639" TOTAL_2="652" WEIGHT="8.508883623038418" Z="0.6737398396416604">
<NAME>Magnesium aspartate</NAME>
<DICH_DATA CI_END="8.763926831284566" CI_START="0.2508662120935615" EFFECT_SIZE="1.4827586206896552" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.942698743044075" LOG_CI_START="-0.6005578276828142" LOG_EFFECT_SIZE="0.17107045768063045" MODIFIED="2012-11-01 06:09:45 +0000" MODIFIED_BY="[Empty name]" ORDER="425" O_E="0.0" SE="0.906516548888204" STUDY_ID="STD-Hungary-1988" TOTAL_1="174" TOTAL_2="172" VAR="0.8217722534081795" WEIGHT="4.9000170147531446"/>
<DICH_DATA CI_END="16.124834277434395" CI_START="0.06402192509700207" EFFECT_SIZE="1.0160427807486632" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.2074952598799804" LOG_CI_START="-1.1936712710473203" LOG_EFFECT_SIZE="0.006911994416330019" MODIFIED="2014-01-14 03:34:56 +0000" MODIFIED_BY="[Empty name]" ORDER="426" O_E="0.0" SE="1.410457106232719" STUDY_ID="STD-Memphis-1989" TOTAL_1="187" TOTAL_2="190" VAR="1.9893892485223754" WEIGHT="2.4165439562834075"/>
<DICH_DATA CI_END="76.48660199368314" CI_START="0.12800729300037317" EFFECT_SIZE="3.129032258064516" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.883585367313023" LOG_CI_START="-0.8927652864490786" LOG_EFFECT_SIZE="0.4954100404319722" MODIFIED="2010-07-15 06:28:46 +0100" MODIFIED_BY="[Empty name]" ORDER="427" O_E="0.0" SE="1.6308421171772414" STUDY_ID="STD-Zurich-1988" TOTAL_1="278" TOTAL_2="290" VAR="2.659646011159147" WEIGHT="1.1923226520018655"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.6596600463332982" CI_START="0.6684345448630188" DF="0" EFFECT_SIZE="1.0532682980599648" ESTIMABLE="YES" EVENTS_1="37" EVENTS_2="36" I2="0.0" ID="CMP-001.01.03" LOG_CI_END="0.22001913917179342" LOG_CI_START="-0.17494111375214969" LOG_EFFECT_SIZE="0.022539012709821855" MODIFIED="2013-09-04 01:27:39 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Z="0.8229933118905178" STUDIES="1" TAU2="0.0" TOTAL_1="2016" TOTAL_2="2066" WEIGHT="86.61926037953461" Z="0.22369670280137385">
<NAME>Magnesium stearate</NAME>
<DICH_DATA CI_END="1.6596600463332982" CI_START="0.6684345448630188" EFFECT_SIZE="1.0532682980599648" ESTIMABLE="YES" EVENTS_1="37" EVENTS_2="36" LOG_CI_END="0.22001913917179342" LOG_CI_START="-0.17494111375214969" LOG_EFFECT_SIZE="0.022539012709821855" MODIFIED="2013-09-04 01:27:39 +0100" MODIFIED_BY="[Empty name]" ORDER="393" O_E="0.0" SE="0.23200160765230735" STUDY_ID="STD-South-Africa-2007" TOTAL_1="2016" TOTAL_2="2066" VAR="0.05382474595325515" WEIGHT="86.61926037953461"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="2.1547262994001017" CI_END="1.0677656472593606" CI_START="0.5440368050624227" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="RR" EFFECT_SIZE="0.7621704607831455" ESTIMABLE="YES" EVENTS_1="53" EVENTS_2="71" I2="7.18078669403066" I2_Q="0.0" ID="CMP-001.02" LOG_CI_END="0.028475944386949253" LOG_CI_START="-0.264371718509866" LOG_EFFECT_SIZE="-0.11794788706145835" METHOD="MH" MODIFIED="2014-01-14 01:37:54 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.3404923887840554" P_Q="1.0" P_Z="0.1143824626089458" Q="0.0" RANDOM="NO" SCALE="11.517294570529291" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="639" TOTAL_2="652" WEIGHT="100.0" Z="1.578797716234534">
<NAME>Small-for-gestational age (&lt; 10th percentile)</NAME>
<GROUP_LABEL_1>Magnesium</GROUP_LABEL_1>
<GROUP_LABEL_2>No magnesium</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours magnesium</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours no magnesium</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="2.1547262994001017" CI_END="1.0677656472593606" CI_START="0.5440368050624227" DF="2" EFFECT_SIZE="0.7621704607831455" ESTIMABLE="YES" EVENTS_1="53" EVENTS_2="71" I2="7.18078669403066" ID="CMP-001.02.01" LOG_CI_END="0.028475944386949253" LOG_CI_START="-0.264371718509866" LOG_EFFECT_SIZE="-0.11794788706145835" MODIFIED="2013-05-03 05:01:13 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.3404923887840554" P_Z="0.1143824626089458" STUDIES="3" TAU2="0.0" TOTAL_1="639" TOTAL_2="652" WEIGHT="100.0" Z="1.578797716234534">
<NAME>Magnesium aspartate</NAME>
<DICH_DATA CI_END="0.9841222934249257" CI_START="0.2878847783997957" EFFECT_SIZE="0.5322723253757736" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="26" LOG_CI_END="-0.006950929963475118" LOG_CI_START="-0.5407812973717864" LOG_EFFECT_SIZE="-0.27386611366763075" MODIFIED="2013-05-03 05:01:13 +0100" MODIFIED_BY="[Empty name]" ORDER="432" O_E="0.0" SE="0.3135746003185784" STUDY_ID="STD-Hungary-1988" TOTAL_1="174" TOTAL_2="172" VAR="0.0983290299649562" WEIGHT="37.167673949793226"/>
<DICH_DATA CI_END="1.7657653791687549" CI_START="0.32886186708370624" EFFECT_SIZE="0.7620320855614974" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="12" LOG_CI_END="0.24693299748531183" LOG_CI_START="-0.48298648186925175" LOG_EFFECT_SIZE="-0.11802674219196993" MODIFIED="2010-12-23 01:15:51 +0000" MODIFIED_BY="[Empty name]" ORDER="433" O_E="0.0" SE="0.42875831533256575" STUDY_ID="STD-Memphis-1989" TOTAL_1="187" TOTAL_2="190" VAR="0.1838336929668199" WEIGHT="16.92000112503093"/>
<DICH_DATA CI_END="1.5116513056621947" CI_START="0.594934850588031" EFFECT_SIZE="0.9483322432962721" ESTIMABLE="YES" EVENTS_1="30" EVENTS_2="33" LOG_CI_END="0.17945162351214686" LOG_CI_START="-0.22553058986683733" LOG_EFFECT_SIZE="-0.023039483177345225" MODIFIED="2010-12-23 01:15:54 +0000" MODIFIED_BY="[Empty name]" ORDER="434" O_E="0.0" SE="0.23788855683310284" STUDY_ID="STD-Zurich-1988" TOTAL_1="278" TOTAL_2="290" VAR="0.05659096547213639" WEIGHT="45.91232492517584"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="1.0463195351065426" CI_END="1.3158793911459008" CI_START="0.5818036238160493" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="RR" EFFECT_SIZE="0.8749762272619421" ESTIMABLE="YES" EVENTS_1="36" EVENTS_2="42" I2="0.0" I2_Q="3.143282074169406" ID="CMP-001.03" LOG_CI_END="0.11921608520483452" LOG_CI_START="-0.23522357803840555" LOG_EFFECT_SIZE="-0.05800374641678548" METHOD="MH" MODIFIED="2014-01-14 06:01:29 +0000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.592645053532797" P_Q="0.30958356348641114" P_Z="0.5212025320371831" Q="1.032452907154839" RANDOM="NO" SCALE="97.58481193467937" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="513" TOTAL_2="529" WEIGHT="100.0" Z="0.6414928448189806">
<NAME>Pre-eclampsia</NAME>
<GROUP_LABEL_1>Magnesium</GROUP_LABEL_1>
<GROUP_LABEL_2>No magnesium</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours magnesium</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours no magnesium</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.01173550367596569" CI_END="1.436810939690293" CI_START="0.6148331889873888" DF="1" EFFECT_SIZE="0.9398931066997723" ESTIMABLE="YES" EVENTS_1="34" EVENTS_2="37" I2="0.0" ID="CMP-001.03.01" LOG_CI_END="0.1573996259971163" LOG_CI_START="-0.21124269711724336" LOG_EFFECT_SIZE="-0.02692153556006355" MODIFIED="2013-02-05 00:28:50 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.9137335072004054" P_Z="0.7746729079001938" STUDIES="2" TAU2="0.0" TOTAL_1="463" TOTAL_2="479" WEIGHT="87.97597549732568" Z="0.28626794482233214">
<NAME>Magnesium aspartate</NAME>
<DICH_DATA CI_END="1.4422273204057743" CI_START="0.6049372131220935" EFFECT_SIZE="0.9340540540540541" ESTIMABLE="YES" EVENTS_1="32" EVENTS_2="35" LOG_CI_END="0.15903371823162332" LOG_CI_START="-0.218289698751902" LOG_EFFECT_SIZE="-0.029627990260139316" MODIFIED="2010-07-15 06:46:29 +0100" MODIFIED_BY="[Empty name]" ORDER="442" O_E="0.0" SE="0.22164164291716001" STUDY_ID="STD-Memphis-1989" TOTAL_1="185" TOTAL_2="189" VAR="0.04912501787501787" WEIGHT="83.26797717092644"/>
<DICH_DATA CI_END="7.3544621663214365" CI_START="0.14796380323096495" EFFECT_SIZE="1.0431654676258992" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.866550918159485" LOG_CI_START="-0.8298445141977253" LOG_EFFECT_SIZE="0.018353201980879794" MODIFIED="2010-07-15 06:46:33 +0100" MODIFIED_BY="[Empty name]" ORDER="443" O_E="0.0" SE="0.9964710742594453" STUDY_ID="STD-Zurich-1988" TOTAL_1="278" TOTAL_2="290" VAR="0.9929546018357728" WEIGHT="4.707998326399241"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.9659813518147353" CI_START="0.08138429179519381" DF="0" EFFECT_SIZE="0.4" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="5" I2="0.0" ID="CMP-001.03.02" LOG_CI_END="0.29357939404425104" LOG_CI_START="-1.0894594113883262" LOG_EFFECT_SIZE="-0.3979400086720376" MODIFIED="2012-11-01 05:20:26 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.25937234174702095" STUDIES="1" TAU2="0.0" TOTAL_1="50" TOTAL_2="50" WEIGHT="12.024024502674319" Z="1.1278759235693374">
<NAME>Magnesium oxide</NAME>
<DICH_DATA CI_END="1.9659813518147353" CI_START="0.08138429179519381" EFFECT_SIZE="0.4" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="5" LOG_CI_END="0.29357939404425104" LOG_CI_START="-1.0894594113883262" LOG_EFFECT_SIZE="-0.3979400086720376" MODIFIED="2010-07-15 06:46:18 +0100" MODIFIED_BY="[Empty name]" ORDER="440" O_E="0.0" SE="0.812403840463596" STUDY_ID="STD-Angola-1992" TOTAL_1="50" TOTAL_2="50" VAR="0.6599999999999999" WEIGHT="12.024024502674319"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.15805019065779824" CI_END="1.2510986048055455" CI_START="0.43091127454606654" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="RR" EFFECT_SIZE="0.734242803423747" ESTIMABLE="YES" EVENTS_1="23" EVENTS_2="32" I2="0.0" I2_Q="0.0" ID="CMP-001.04" LOG_CI_END="0.09729153977762005" LOG_CI_START="-0.36561214269723125" LOG_EFFECT_SIZE="-0.13416030145980556" METHOD="MH" MODIFIED="2014-01-14 04:40:42 +0000" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.9240167596977805" P_Q="1.0" P_Z="0.2559202987178877" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="2733" TOTAL_2="2793" WEIGHT="99.99999999999999" Z="1.136086702142582">
<NAME>Stillbirth</NAME>
<GROUP_LABEL_1>Magnesium</GROUP_LABEL_1>
<GROUP_LABEL_2>No magnesium</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours magnesium</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours no magnesium</GRAPH_LABEL_2>
<DICH_DATA CI_END="7.04666099030381" CI_START="0.14191118337834013" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.8479833784105825" LOG_CI_START="-0.8479833784105826" LOG_EFFECT_SIZE="0.0" MODIFIED="2014-01-14 04:38:34 +0000" MODIFIED_BY="[Empty name]" ORDER="331" O_E="0.0" SE="0.9962192681275941" STUDY_ID="STD-Austria-1997" TOTAL_1="265" TOTAL_2="265" VAR="0.9924528301886792" WEIGHT="6.319003055945492"/>
<DICH_DATA CI_END="15.677458916680134" CI_START="0.06232793319983488" EFFECT_SIZE="0.9885057471264368" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1952756713652637" LOG_CI_START="-1.2053172741153653" LOG_EFFECT_SIZE="-0.005020801375050797" MODIFIED="2014-01-14 04:38:43 +0000" MODIFIED_BY="[Empty name]" ORDER="332" O_E="0.0" SE="1.4101201793020501" STUDY_ID="STD-Hungary-1988" TOTAL_1="174" TOTAL_2="172" VAR="1.9884389200748462" WEIGHT="3.1777645425853054"/>
<DICH_DATA CI_END="1.2452085142050775" CI_START="0.4011451010704584" EFFECT_SIZE="0.706759715380405" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="29" LOG_CI_END="0.0952420815411887" LOG_CI_START="-0.39669850719091027" LOG_EFFECT_SIZE="-0.1507282128248608" MODIFIED="2014-01-14 04:38:57 +0000" MODIFIED_BY="[Empty name]" ORDER="333" O_E="0.0" SE="0.28896833696642266" STUDY_ID="STD-South-Africa-2007" TOTAL_1="2016" TOTAL_2="2066" VAR="0.08350269976914" WEIGHT="90.50323240146919">
<FOOTNOTE>This refers to stillbirths from 28 weeks or more</FOOTNOTE>
</DICH_DATA>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2014-01-14 04:39:03 +0000" MODIFIED_BY="[Empty name]" ORDER="334" O_E="0.0" SE="0.0" STUDY_ID="STD-Zurich-1988" TOTAL_1="278" TOTAL_2="290" VAR="0.0" WEIGHT="0.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="1.6227571403204484" CI_END="3.201818081810791" CI_START="1.04524068348504" CI_STUDY="95" CI_TOTAL="95" DF="7" EFFECT_MEASURE="RR" EFFECT_SIZE="1.8293907511044958" ESTIMABLE="YES" EVENTS_1="33" EVENTS_2="18" I2="0.0" I2_Q="0.0" ID="CMP-001.05" LOG_CI_END="0.5053966529080346" LOG_CI_START="0.01921630525467461" LOG_EFFECT_SIZE="0.2623064790813546" METHOD="MH" MODIFIED="2014-01-21 03:58:57 +0000" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.9777530938810286" P_Q="0.4678424389511229" P_Z="0.034438526157025716" Q="0.5270674846262624" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="5310" TOTAL_2="5436" WEIGHT="199.99999999999997" Z="2.1148993553212008">
<NAME>Neonatal death prior to hospital discharge</NAME>
<GROUP_LABEL_1>Magnesium</GROUP_LABEL_1>
<GROUP_LABEL_2>No magnesium</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours magnesium</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours no magnesium</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.7446364115718009" CI_END="4.749904937241808" CI_START="1.0247466518351966" DF="3" EFFECT_SIZE="2.2062296301550326" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="9" I2="0.0" ID="CMP-001.05.01" LOG_CI_END="0.676684917910246" LOG_CI_START="0.01061650801622994" LOG_EFFECT_SIZE="0.3436507129632379" MODIFIED="2014-01-21 03:58:57 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.8626581447452888" P_Z="0.043130506133749046" STUDIES="4" TAU2="0.0" TOTAL_1="2655" TOTAL_2="2718" WEIGHT="99.99999999999999" Z="2.0224439732147985">
<NAME>All deaths</NAME>
<DICH_DATA CI_END="15.677458916680134" CI_START="0.06232793319983488" EFFECT_SIZE="0.9885057471264368" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1952756713652637" LOG_CI_START="-1.2053172741153653" LOG_EFFECT_SIZE="-0.005020801375050797" MODIFIED="2014-01-14 04:43:36 +0000" MODIFIED_BY="[Empty name]" ORDER="335" O_E="0.0" SE="1.4101201793020501" STUDY_ID="STD-Hungary-1988" TOTAL_1="174" TOTAL_2="172" VAR="1.9884389200748462" WEIGHT="10.698022121576203"/>
<DICH_DATA CI_END="16.124834277434395" CI_START="0.06402192509700207" EFFECT_SIZE="1.0160427807486632" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.2074952598799804" LOG_CI_START="-1.1936712710473203" LOG_EFFECT_SIZE="0.006911994416330019" MODIFIED="2014-01-14 04:43:39 +0000" MODIFIED_BY="[Empty name]" ORDER="336" O_E="0.0" SE="1.410457106232719" STUDY_ID="STD-Memphis-1989" TOTAL_1="187" TOTAL_2="190" VAR="1.9893892485223754" WEIGHT="10.55189834004426"/>
<DICH_DATA CI_END="5.988606051962803" CI_START="1.0343216057786768" EFFECT_SIZE="2.4888038548752833" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="7" LOG_CI_END="0.777325744861472" LOG_CI_START="0.014655596686790229" LOG_EFFECT_SIZE="0.3959906707741312" MODIFIED="2014-01-14 04:43:44 +0000" MODIFIED_BY="[Empty name]" ORDER="337" O_E="0.0" SE="0.44799622031592845" STUDY_ID="STD-South-Africa-2007" TOTAL_1="2016" TOTAL_2="2066" VAR="0.20070061341735793" WEIGHT="73.54377349137289"/>
<DICH_DATA CI_END="76.48660199368314" CI_START="0.12800729300037317" EFFECT_SIZE="3.129032258064516" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.883585367313023" LOG_CI_START="-0.8927652864490786" LOG_EFFECT_SIZE="0.4954100404319722" MODIFIED="2014-01-14 04:43:49 +0000" MODIFIED_BY="[Empty name]" ORDER="338" O_E="0.0" SE="1.6308421171772414" STUDY_ID="STD-Zurich-1988" TOTAL_1="278" TOTAL_2="290" VAR="2.659646011159147" WEIGHT="5.20630604700664"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.3603858039808623" CI_END="3.3237056371688105" CI_START="0.6348055969254595" DF="3" EFFECT_SIZE="1.4525518720539592" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="9" I2="0.0" ID="CMP-001.05.02" LOG_CI_END="0.5216225536758052" LOG_CI_START="-0.19735925283223804" LOG_EFFECT_SIZE="0.16213165042178362" MODIFIED="2014-01-21 03:58:57 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.9482986167669619" P_Z="0.3767228961480955" STUDIES="4" TAU2="0.0" TOTAL_1="2655" TOTAL_2="2718" WEIGHT="99.99999999999999" Z="0.8839505887474198">
<NAME>Excluding deaths due to "congenital abnormalities incompatible with life"</NAME>
<DICH_DATA CI_END="15.677458916680134" CI_START="0.06232793319983488" EFFECT_SIZE="0.9885057471264368" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1952756713652637" LOG_CI_START="-1.2053172741153653" LOG_EFFECT_SIZE="-0.005020801375050797" MODIFIED="2014-01-14 05:35:37 +0000" MODIFIED_BY="[Empty name]" ORDER="492" O_E="0.0" SE="1.4101201793020501" STUDY_ID="STD-Hungary-1988" TOTAL_1="174" TOTAL_2="172" VAR="1.9884389200748462" WEIGHT="10.698022121576203"/>
<DICH_DATA CI_END="16.124834277434395" CI_START="0.06402192509700207" EFFECT_SIZE="1.0160427807486632" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.2074952598799804" LOG_CI_START="-1.1936712710473203" LOG_EFFECT_SIZE="0.006911994416330019" MODIFIED="2014-01-14 05:35:37 +0000" MODIFIED_BY="[Empty name]" ORDER="493" O_E="0.0" SE="1.410457106232719" STUDY_ID="STD-Memphis-1989" TOTAL_1="187" TOTAL_2="190" VAR="1.9893892485223754" WEIGHT="10.55189834004426"/>
<DICH_DATA CI_END="3.8385852238243494" CI_START="0.5583574453833723" EFFECT_SIZE="1.4640022675736961" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="7" LOG_CI_END="0.5841711872056693" LOG_CI_START="-0.25308768841395485" LOG_EFFECT_SIZE="0.16554174939585725" MODIFIED="2014-01-14 05:35:44 +0000" MODIFIED_BY="[Empty name]" ORDER="494" O_E="0.0" SE="0.4918100080372432" STUDY_ID="STD-South-Africa-2007" TOTAL_1="2016" TOTAL_2="2066" VAR="0.2418770840055932" WEIGHT="73.54377349137289"/>
<DICH_DATA CI_END="76.48660199368314" CI_START="0.12800729300037317" EFFECT_SIZE="3.129032258064516" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.883585367313023" LOG_CI_START="-0.8927652864490786" LOG_EFFECT_SIZE="0.4954100404319722" MODIFIED="2014-01-14 05:35:37 +0000" MODIFIED_BY="[Empty name]" ORDER="495" O_E="0.0" SE="1.6308421171772414" STUDY_ID="STD-Zurich-1988" TOTAL_1="278" TOTAL_2="290" VAR="2.659646011159147" WEIGHT="5.20630604700664"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="8.984637743453206" CI_END="1.4928522701272489" CI_START="0.48515435768354775" CI_STUDY="95" CI_TOTAL="95" DF="5" EFFECT_MEASURE="RR" EFFECT_SIZE="0.8510368877022967" ESTIMABLE="YES" EVENTS_1="77" EVENTS_2="88" I2="44.34945355873333" I2_Q="0.0" ID="CMP-001.06" LOG_CI_END="0.17401683288046105" LOG_CI_START="-0.3141200634084393" LOG_EFFECT_SIZE="-0.07005161526398912" METHOD="MH" MODIFIED="2014-01-14 04:45:09 +0000" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="0.10967861748517238" P_Q="1.0" P_Z="0.5737471058376395" Q="0.0" RANDOM="YES" SCALE="144.16731028426037" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.18553734009926443" TOTALS="YES" TOTAL_1="2052" TOTAL_2="1652" WEIGHT="99.99999999999999" Z="0.562541549389521">
<NAME>Miscarriage (&lt; 20 weeks' gestation)</NAME>
<GROUP_LABEL_1>Magnesium</GROUP_LABEL_1>
<GROUP_LABEL_2>No magnesium</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours magnesium</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours no magnesium</GRAPH_LABEL_2>
<DICH_DATA CI_END="4.520042549762059" CI_START="0.6145468205656613" EFFECT_SIZE="1.6666666666666667" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="6" LOG_CI_END="0.6551425230945438" LOG_CI_START="-0.21144502386183098" LOG_EFFECT_SIZE="0.2218487496163564" MODIFIED="2010-12-22 22:57:22 +0000" MODIFIED_BY="[Empty name]" ORDER="385" O_E="0.0" SE="0.509037814759715" STUDY_ID="STD-Austria-1997" TOTAL_1="265" TOTAL_2="265" VAR="0.2591194968553459" WEIGHT="18.48985479734572"/>
<DICH_DATA CI_END="0.6767482531559762" CI_START="0.3274610290365376" EFFECT_SIZE="0.47075331053231606" ESTIMABLE="YES" EVENTS_1="48" EVENTS_2="63" LOG_CI_END="-0.16957285657068005" LOG_CI_START="-0.48484037775298094" LOG_EFFECT_SIZE="-0.3272066171618305" MODIFIED="2010-12-22 22:57:24 +0000" MODIFIED_BY="[Empty name]" ORDER="386" O_E="0.0" SE="0.18518970254188244" STUDY_ID="STD-Hungary-1979" TOTAL_1="1086" TOTAL_2="671" VAR="0.034295225927550896" WEIGHT="37.39955593719856"/>
<DICH_DATA CI_END="1.8033159421059497" CI_START="0.40741273361839725" EFFECT_SIZE="0.8571428571428571" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="14" LOG_CI_END="0.2560718220594543" LOG_CI_START="-0.38996540132068075" LOG_EFFECT_SIZE="-0.06694678963061322" MODIFIED="2012-11-01 06:11:24 +0000" MODIFIED_BY="[Empty name]" ORDER="387" O_E="0.0" SE="0.37948546294932267" STUDY_ID="STD-Hungary-1988" TOTAL_1="186" TOTAL_2="186" VAR="0.14400921658986177" WEIGHT="24.948342451332497"/>
<DICH_DATA CI_END="15.548273108710726" CI_START="0.06431582420814068" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1916821605007981" LOG_CI_START="-1.1916821605007981" LOG_EFFECT_SIZE="0.0" MODIFIED="2010-12-22 22:57:27 +0000" MODIFIED_BY="[Empty name]" ORDER="388" O_E="0.0" SE="1.4" STUDY_ID="STD-Italy-1994" TOTAL_1="50" TOTAL_2="50" VAR="1.96" WEIGHT="3.8319726234908593"/>
<DICH_DATA CI_END="16.124834277434395" CI_START="0.06402192509700207" EFFECT_SIZE="1.0160427807486632" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.2074952598799804" LOG_CI_START="-1.1936712710473203" LOG_EFFECT_SIZE="0.006911994416330019" MODIFIED="2010-12-22 22:57:28 +0000" MODIFIED_BY="[Empty name]" ORDER="389" O_E="0.0" SE="1.410457106232719" STUDY_ID="STD-Memphis-1989" TOTAL_1="187" TOTAL_2="190" VAR="1.9893892485223754" WEIGHT="3.780192119104233"/>
<DICH_DATA CI_END="7.2062962891349365" CI_START="0.41946119414422944" EFFECT_SIZE="1.7386091127098322" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="3" LOG_CI_END="0.8577121143076463" LOG_CI_START="-0.377308211113174" LOG_EFFECT_SIZE="0.2402019515972362" MODIFIED="2010-12-22 22:57:30 +0000" MODIFIED_BY="[Empty name]" ORDER="390" O_E="0.0" SE="0.725457052601397" STUDY_ID="STD-Zurich-1988" TOTAL_1="278" TOTAL_2="290" VAR="0.5262879351691061" WEIGHT="11.550082071528124"/>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.9026381134677469" CI_END="0.19571110161448413" CI_START="-0.06854517507980024" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="MD" EFFECT_SIZE="0.06358296326734195" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.07" MODIFIED="2014-01-21 03:58:57 +0000" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="0.9241820632851174" P_Q="1.0" P_Z="0.345590012105486" Q="0.0" RANDOM="NO" SCALE="3.4664124269973295" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="2743" TOTAL_2="2821" UNITS="" WEIGHT="100.00000000000001" Z="0.9431777333220775">
<NAME>Gestational age at birth (weeks)</NAME>
<GROUP_LABEL_1>Magnesium</GROUP_LABEL_1>
<GROUP_LABEL_2>No magnesium</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours magnesium</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours no magnesium</GRAPH_LABEL_2>
<CONT_DATA CI_END="0.4037821939264883" CI_START="-0.20378219392648544" EFFECT_SIZE="0.10000000000000142" ESTIMABLE="YES" MEAN_1="39.9" MEAN_2="39.8" MODIFIED="2010-12-22 23:50:51 +0000" MODIFIED_BY="[Empty name]" ORDER="394" SD_1="1.72" SD_2="1.71" SE="0.15499376331538847" STUDY_ID="STD-Austria-1997" TOTAL_1="240" TOTAL_2="250" WEIGHT="18.917598473381602"/>
<CONT_DATA CI_END="0.5351918604807893" CI_START="-0.5351918604807893" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="39.0" MEAN_2="39.0" MODIFIED="2010-12-22 23:51:01 +0000" MODIFIED_BY="[Empty name]" ORDER="395" SD_1="2.7" SD_2="2.6" SE="0.27306208925384057" STUDY_ID="STD-Memphis-1989" TOTAL_1="187" TOTAL_2="190" WEIGHT="6.094970841229998"/>
<CONT_DATA CI_END="1.8634750023801845" CI_START="-1.8634750023801845" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="35.6" MEAN_2="35.6" MODIFIED="2010-12-22 23:51:19 +0000" MODIFIED_BY="[Empty name]" ORDER="396" SD_1="2.8" SD_2="3.7" SE="0.9507700228570716" STUDY_ID="STD-Mississippi-1992" TOTAL_1="22" TOTAL_2="25" WEIGHT="0.5027400561458681"/>
<CONT_DATA CI_END="0.20248278640843329" CI_START="-0.20248278640843329" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="38.2" MEAN_2="38.2" MODIFIED="2010-12-22 23:51:38 +0000" MODIFIED_BY="[Empty name]" ORDER="397" SD_1="3.3" SD_2="3.3" SE="0.10330944242118308" STUDY_ID="STD-South-Africa-2007" TOTAL_1="2016" TOTAL_2="2066" WEIGHT="42.5808586335569"/>
<CONT_DATA CI_END="0.37392352035602394" CI_START="-0.09392352035602283" EFFECT_SIZE="0.14000000000000057" ESTIMABLE="YES" MEAN_1="40.0" MEAN_2="39.86" MODIFIED="2010-12-22 23:52:07 +0000" MODIFIED_BY="[Empty name]" ORDER="398" SD_1="1.12" SD_2="1.68" SE="0.11935092797683135" STUDY_ID="STD-Zurich-1988" TOTAL_1="278" TOTAL_2="290" WEIGHT="31.90383199568564"/>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="9.50980959176742" CI_END="1.1423493426597058" CI_START="0.685685749755812" CI_STUDY="95" CI_TOTAL="95" DF="6" EFFECT_MEASURE="RR" EFFECT_SIZE="0.8850382282730387" ESTIMABLE="YES" EVENTS_1="302" EVENTS_2="329" I2="36.90725411375049" I2_Q="0.0" ID="CMP-001.08" LOG_CI_END="0.05779893612402091" LOG_CI_START="-0.16387487615330024" LOG_EFFECT_SIZE="-0.05303797001463966" METHOD="MH" MODIFIED="2014-01-14 04:45:09 +0000" MODIFIED_BY="[Empty name]" NO="8" P_CHI2="0.146871304633733" P_Q="1.0" P_Z="0.34830241403001705" Q="0.0" RANDOM="YES" SCALE="4.079756249643216" SORT_BY="STUDY" STUDIES="7" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.03852425714649268" TOTALS="YES" TOTAL_1="2949" TOTAL_2="3032" WEIGHT="100.0" Z="0.9378871592803314">
<NAME>Preterm birth &lt; 37 weeks' gestation</NAME>
<GROUP_LABEL_1>Magnesium</GROUP_LABEL_1>
<GROUP_LABEL_2>No magnesium</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours magnesium</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours no magnesium</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.1700833828232295" CI_START="0.28052146689962204" EFFECT_SIZE="0.5729166666666666" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="20" LOG_CI_END="0.06821681166896802" LOG_CI_START="-0.5520338987596173" LOG_EFFECT_SIZE="-0.2419085435453246" MODIFIED="2010-12-22 23:54:01 +0000" MODIFIED_BY="[Empty name]" ORDER="399" O_E="0.0" SE="0.3643383375962846" STUDY_ID="STD-Austria-1997" TOTAL_1="240" TOTAL_2="250" VAR="0.13274242424242425" WEIGHT="9.899906704882527"/>
<DICH_DATA CI_END="1.1298449636203332" CI_START="0.32043499708298884" EFFECT_SIZE="0.6016991504247876" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="23" LOG_CI_END="0.05301885404664585" LOG_CI_START="-0.49426005747545726" LOG_EFFECT_SIZE="-0.22062060171440565" MODIFIED="2012-11-01 05:34:07 +0000" MODIFIED_BY="[Empty name]" ORDER="400" O_E="0.0" SE="0.3214743417023868" STUDY_ID="STD-Hungary-1988" TOTAL_1="174" TOTAL_2="172" VAR="0.10334575237298295" WEIGHT="11.951251523475511"/>
<DICH_DATA CI_END="2.1046624157508362" CI_START="0.028418878538446293" EFFECT_SIZE="0.24456521739130435" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="4" LOG_CI_END="0.3231824456662071" LOG_CI_START="-1.5463930641345924" LOG_EFFECT_SIZE="-0.6116053092341928" MODIFIED="2013-07-22 01:12:22 +0100" MODIFIED_BY="[Empty name]" ORDER="401" O_E="0.0" SE="1.0981979090050187" STUDY_ID="STD-Italy-1994" TOTAL_1="46" TOTAL_2="45" VAR="1.2060386473429952" WEIGHT="1.3623450942406257"/>
<DICH_DATA CI_END="1.9885939986263674" CI_START="0.5847849926919527" EFFECT_SIZE="1.0783783783783785" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="18" LOG_CI_END="0.2985461244242832" LOG_CI_START="-0.23300378118477658" LOG_EFFECT_SIZE="0.03277117161975327" MODIFIED="2010-12-22 23:54:25 +0000" MODIFIED_BY="[Empty name]" ORDER="402" O_E="0.0" SE="0.31223504576923017" STUDY_ID="STD-Memphis-1989" TOTAL_1="185" TOTAL_2="189" VAR="0.09749072380651327" WEIGHT="12.465716316873452"/>
<DICH_DATA CI_END="1.8260410522182835" CI_START="0.8046028489279358" EFFECT_SIZE="1.2121212121212122" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="15" LOG_CI_END="0.26151053691759013" LOG_CI_START="-0.09441843401744031" LOG_EFFECT_SIZE="0.08354605145007492" MODIFIED="2010-12-22 23:54:32 +0000" MODIFIED_BY="[Empty name]" ORDER="403" O_E="0.0" SE="0.20907443940405818" STUDY_ID="STD-Mississippi-1992" TOTAL_1="22" TOTAL_2="25" VAR="0.043712121212121195" WEIGHT="20.617690142084427"/>
<DICH_DATA CI_END="1.2141251127211237" CI_START="0.8637600179316081" EFFECT_SIZE="1.0240667600968276" ESTIMABLE="YES" EVENTS_1="234" EVENTS_2="235" LOG_CI_END="0.08426344206437694" LOG_CI_START="-0.06360690261955432" LOG_EFFECT_SIZE="0.010328269722411331" MODIFIED="2010-12-22 23:56:11 +0000" MODIFIED_BY="[Empty name]" ORDER="404" O_E="0.0" SE="0.08685977243735248" STUDY_ID="STD-South-Africa-2007" TOTAL_1="2004" TOTAL_2="2061" VAR="0.007544620067868658" WEIGHT="36.80411310038531"/>
<DICH_DATA CI_END="1.2729790604437876" CI_START="0.21371015177339084" EFFECT_SIZE="0.5215827338129496" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="14" LOG_CI_END="0.10482125989206047" LOG_CI_START="-0.6701748472582632" LOG_EFFECT_SIZE="-0.2826767936831014" MODIFIED="2010-12-22 23:54:47 +0000" MODIFIED_BY="[Empty name]" ORDER="405" O_E="0.0" SE="0.45523654963270144" STUDY_ID="STD-Zurich-1988" TOTAL_1="278" TOTAL_2="290" VAR="0.20724031612148702" WEIGHT="6.898977118058152"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="6.3614275801011075" CI_END="1.0882410259056052" CI_START="0.833196566510828" CI_STUDY="95" CI_TOTAL="95" DF="6" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9522177725293576" ESTIMABLE="YES" EVENTS_1="356" EVENTS_2="383" I2="5.681548293211303" I2_Q="0.0" ID="CMP-001.09" LOG_CI_END="0.036725094468769266" LOG_CI_START="-0.07925252838880625" LOG_EFFECT_SIZE="-0.02126371696001847" METHOD="MH" MODIFIED="2014-01-14 04:45:09 +0000" MODIFIED_BY="[Empty name]" NO="9" P_CHI2="0.383943629761872" P_Q="0.5418808475614685" P_Z="0.4723304579139842" Q="1.2254193369934618" RANDOM="NO" SCALE="2.0" SORT_BY="STUDY" STUDIES="6" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="3082" TOTAL_2="3163" WEIGHT="300.0" Z="0.7186924234560217">
<NAME>Low birthweight</NAME>
<GROUP_LABEL_1>Magnesium</GROUP_LABEL_1>
<GROUP_LABEL_2>No magnesium</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours magnesium</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours no magnesium</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="2.0651803679089475" CI_START="0.13173113227259997" DF="0" EFFECT_SIZE="0.5215827338129496" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="6" I2="0.0" ID="CMP-001.09.01" LOG_CI_END="0.3149579878891606" LOG_CI_START="-0.8803115752553634" LOG_EFFECT_SIZE="-0.2826767936831014" MODIFIED="2013-05-03 04:47:01 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.35390144499985354" STUDIES="1" TAU2="0.0" TOTAL_1="278" TOTAL_2="290" WEIGHT="100.0" Z="0.9270483445200016">
<NAME>Low birthweight (&lt; 1500 g)</NAME>
<DICH_DATA CI_END="2.0651803679089475" CI_START="0.13173113227259997" EFFECT_SIZE="0.5215827338129496" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="6" LOG_CI_END="0.3149579878891606" LOG_CI_START="-0.8803115752553634" LOG_EFFECT_SIZE="-0.2826767936831014" MODIFIED="2008-04-07 05:37:26 +0100" MODIFIED_BY="[Empty name]" ORDER="238" O_E="0.0" SE="0.702107258070854" STUDY_ID="STD-Zurich-1988" TOTAL_1="278" TOTAL_2="290" VAR="0.4929546018357728" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="4.116851171324752" CI_START="0.47609202238158543" DF="0" EFFECT_SIZE="1.4" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="5" I2="0.0" ID="CMP-001.09.02" LOG_CI_END="0.6145651670604648" LOG_CI_START="-0.3223090957039887" LOG_EFFECT_SIZE="0.146128035678238" MODIFIED="2013-05-03 04:47:05 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.540930249435428" STUDIES="1" TAU2="0.0" TOTAL_1="50" TOTAL_2="50" WEIGHT="100.0" Z="0.6114068844539023">
<NAME>Low birthweight (&lt; 2000 g)</NAME>
<DICH_DATA CI_END="4.116851171324752" CI_START="0.47609202238158543" EFFECT_SIZE="1.4" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="5" LOG_CI_END="0.6145651670604648" LOG_CI_START="-0.3223090957039887" LOG_EFFECT_SIZE="0.146128035678238" ORDER="120" O_E="0.0" SE="0.550324579550235" STUDY_ID="STD-Angola-1992" TOTAL_1="50" TOTAL_2="50" VAR="0.3028571428571428" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="5.132690023440962" CI_END="1.0910654700432205" CI_START="0.8324190918851856" DF="4" EFFECT_SIZE="0.9530077270204376" ESTIMABLE="YES" EVENTS_1="346" EVENTS_2="372" I2="22.068155650701176" ID="CMP-001.09.03" LOG_CI_END="0.037850811473223216" LOG_CI_START="-0.07965796761790711" LOG_EFFECT_SIZE="-0.020903578072341934" MODIFIED="2013-05-03 04:47:10 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.2739517193076402" P_Z="0.4856062944372391" STUDIES="5" TAU2="0.0" TOTAL_1="2754" TOTAL_2="2823" WEIGHT="100.0" Z="0.6973140302655716">
<NAME>Low birthweight (&lt; 2500 g)</NAME>
<DICH_DATA CI_END="1.5173901682679218" CI_START="0.24332899145615808" EFFECT_SIZE="0.6076388888888888" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="12" LOG_CI_END="0.18109726578260085" LOG_CI_START="-0.6138061439284738" LOG_EFFECT_SIZE="-0.21635443907293644" MODIFIED="2008-04-07 05:36:33 +0100" MODIFIED_BY="[Empty name]" ORDER="234" O_E="0.0" SE="0.4669301976996235" STUDY_ID="STD-Austria-1997" TOTAL_1="240" TOTAL_2="250" VAR="0.21802380952380948" WEIGHT="3.1986310899007373"/>
<DICH_DATA CI_END="1.430570509282873" CI_START="0.2586678174388369" EFFECT_SIZE="0.6083112290008842" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="13" LOG_CI_END="0.15550926796989112" LOG_CI_START="-0.5872576013497791" LOG_EFFECT_SIZE="-0.21587416668994397" MODIFIED="2012-11-01 05:39:07 +0000" MODIFIED_BY="[Empty name]" ORDER="235" O_E="0.0" SE="0.4363049357936754" STUDY_ID="STD-Hungary-1988" TOTAL_1="174" TOTAL_2="172" VAR="0.19036199699792322" WEIGHT="3.5578222617856645"/>
<DICH_DATA CI_END="2.1046624157508362" CI_START="0.028418878538446293" EFFECT_SIZE="0.24456521739130435" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="4" LOG_CI_END="0.3231824456662071" LOG_CI_START="-1.5463930641345924" LOG_EFFECT_SIZE="-0.6116053092341928" MODIFIED="2010-05-20 01:06:00 +0100" MODIFIED_BY="[Empty name]" ORDER="368" O_E="0.0" SE="1.0981979090050187" STUDY_ID="STD-Italy-1994" TOTAL_1="46" TOTAL_2="45" VAR="1.2060386473429952" WEIGHT="1.1003837723803818"/>
<DICH_DATA CI_END="1.1593198502080513" CI_START="0.8726508706739646" EFFECT_SIZE="1.0058237801293357" ESTIMABLE="YES" EVENTS_1="318" EVENTS_2="324" LOG_CI_END="0.06420327204338558" LOG_CI_START="-0.05915947366751631" LOG_EFFECT_SIZE="0.002521899187934642" MODIFIED="2008-04-07 05:36:33 +0100" MODIFIED_BY="[Empty name]" ORDER="236" O_E="0.0" SE="0.07246388748602355" STUDY_ID="STD-South-Africa-2007" TOTAL_1="2016" TOTAL_2="2066" VAR="0.005251014989587079" WEIGHT="87.08237880520547"/>
<DICH_DATA CI_END="1.3317044679654853" CI_START="0.3259521404652821" EFFECT_SIZE="0.6588413479742522" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="19" LOG_CI_END="0.1244078568370922" LOG_CI_START="-0.4868461626857409" LOG_EFFECT_SIZE="-0.1812191529243243" MODIFIED="2008-04-07 05:36:33 +0100" MODIFIED_BY="[Empty name]" ORDER="237" O_E="0.0" SE="0.3590536368239075" STUDY_ID="STD-Zurich-1988" TOTAL_1="278" TOTAL_2="290" VAR="0.12891951411647448" WEIGHT="5.060784070727755"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="6.503355540063721" CI_END="71.64652984766767" CI_START="-27.2309912396152" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="MD" EFFECT_SIZE="22.207769304026236" ESTIMABLE="YES" I2="38.49329049660405" I2_Q="0.0" ID="CMP-001.10" MODIFIED="2014-01-14 04:45:09 +0000" MODIFIED_BY="[Empty name]" NO="10" P_CHI2="0.16457914717763744" P_Q="1.0" P_Z="0.3786367156003173" Q="0.0" RANDOM="YES" SCALE="227.07660455457375" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="1138.3386149657952" TOTALS="YES" TOTAL_1="2743" TOTAL_2="2821" UNITS="" WEIGHT="99.99999999999997" Z="0.8804109879422072">
<NAME>Birthweight (g)</NAME>
<GROUP_LABEL_1>Magnesium</GROUP_LABEL_1>
<GROUP_LABEL_2>No magnesium</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours magnesium</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours no magnesium</GRAPH_LABEL_2>
<CONT_DATA CI_END="176.8668810934813" CI_START="3.133118906518675" EFFECT_SIZE="90.0" ESTIMABLE="YES" MEAN_1="3377.0" MEAN_2="3287.0" MODIFIED="2010-12-23 00:25:05 +0000" MODIFIED_BY="[Empty name]" ORDER="423" SD_1="503.0" SD_2="477.0" SE="44.320651694967964" STUDY_ID="STD-Austria-1997" TOTAL_1="240" TOTAL_2="250" WEIGHT="20.507133101301488"/>
<CONT_DATA CI_END="187.79384475180126" CI_START="-67.79384475180126" EFFECT_SIZE="60.0" ESTIMABLE="YES" MEAN_1="3126.0" MEAN_2="3066.0" MODIFIED="2010-12-23 00:25:15 +0000" MODIFIED_BY="[Empty name]" ORDER="424" SD_1="670.0" SD_2="593.0" SE="65.20213930450906" STUDY_ID="STD-Memphis-1989" TOTAL_1="187" TOTAL_2="190" WEIGHT="11.805320765034256"/>
<CONT_DATA CI_END="299.47990692402124" CI_START="-565.4799069240212" EFFECT_SIZE="-133.0" ESTIMABLE="YES" MEAN_1="2479.0" MEAN_2="2612.0" MODIFIED="2010-12-23 00:25:26 +0000" MODIFIED_BY="[Empty name]" ORDER="425" SD_1="684.0" SD_2="828.0" SE="220.65706836215745" STUDY_ID="STD-Mississippi-1992" TOTAL_1="22" TOTAL_2="25" WEIGHT="1.2769284193861008"/>
<CONT_DATA CI_END="20.043926709646" CI_START="-58.043926709646" EFFECT_SIZE="-19.0" ESTIMABLE="YES" MEAN_1="3002.0" MEAN_2="3021.0" MODIFIED="2010-12-23 00:25:37 +0000" MODIFIED_BY="[Empty name]" ORDER="426" SD_1="650.0" SD_2="622.0" SE="19.920736818441313" STUDY_ID="STD-South-Africa-2007" TOTAL_1="2016" TOTAL_2="2066" WEIGHT="41.44586949307199"/>
<CONT_DATA CI_END="98.60494998767041" CI_START="-48.60494998767041" EFFECT_SIZE="25.0" ESTIMABLE="YES" MEAN_1="3325.0" MEAN_2="3300.0" MODIFIED="2010-12-23 00:25:48 +0000" MODIFIED_BY="[Empty name]" ORDER="427" SD_1="435.0" SD_2="460.0" SE="37.55423597997558" STUDY_ID="STD-Zurich-1988" TOTAL_1="278" TOTAL_2="290" WEIGHT="24.96474822120614"/>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="2.1927296435430508" CI_END="1.1069873257549971" CI_START="0.49712795286795286" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="RR" EFFECT_SIZE="0.7418317485140087" ESTIMABLE="YES" EVENTS_1="38" EVENTS_2="53" I2="8.789485019759885" I2_Q="0.0" ID="CMP-001.11" LOG_CI_END="0.04414264853348572" LOG_CI_START="-0.30353181635205523" LOG_EFFECT_SIZE="-0.12969458390928473" METHOD="MH" MODIFIED="2014-01-14 04:45:09 +0000" MODIFIED_BY="[Empty name]" NO="11" P_CHI2="0.33408358778550595" P_Q="1.0" P_Z="0.14366764012349686" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="705" TOTAL_2="730" WEIGHT="100.00000000000001" Z="1.4622685248730651">
<NAME>Baby admitted to the neonatal unit</NAME>
<GROUP_LABEL_1>Magnesium</GROUP_LABEL_1>
<GROUP_LABEL_2>No magnesium</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours magnesium</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours no magnesium</GRAPH_LABEL_2>
<DICH_DATA CI_END="4.1179728144021635" CI_START="0.26349601936407446" EFFECT_SIZE="1.0416666666666667" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="4" LOG_CI_END="0.6146834752120516" LOG_CI_START="-0.5792259412911883" LOG_EFFECT_SIZE="0.017728766960431616" MODIFIED="2010-12-23 00:28:19 +0000" MODIFIED_BY="[Empty name]" ORDER="428" O_E="0.0" SE="0.7013083012009292" STUDY_ID="STD-Austria-1997" TOTAL_1="240" TOTAL_2="250" VAR="0.49183333333333334" WEIGHT="7.527453360894594"/>
<DICH_DATA CI_END="2.2646809578430496" CI_START="0.5286720214661896" EFFECT_SIZE="1.0941999177293296" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="13" LOG_CI_END="0.3550070284205256" LOG_CI_START="-0.27681367284506303" LOG_EFFECT_SIZE="0.03909667778773128" MODIFIED="2010-12-23 00:28:25 +0000" MODIFIED_BY="[Empty name]" ORDER="429" O_E="0.0" SE="0.37113460748631866" STUDY_ID="STD-Memphis-1989" TOTAL_1="187" TOTAL_2="190" VAR="0.13774089687402383" WEIGHT="24.77516348630645"/>
<DICH_DATA CI_END="0.9760285276314276" CI_START="0.3441112587301045" EFFECT_SIZE="0.5795363709032774" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="36" LOG_CI_END="-0.010537488468709114" LOG_CI_START="-0.46330111777614336" LOG_EFFECT_SIZE="-0.23691930312242626" MODIFIED="2010-12-23 00:28:30 +0000" MODIFIED_BY="[Empty name]" ORDER="430" O_E="0.0" SE="0.26595559707129784" STUDY_ID="STD-Zurich-1988" TOTAL_1="278" TOTAL_2="290" VAR="0.07073237961355053" WEIGHT="67.69738315279896"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="3.4367358816345046" CI_END="0.9399353888850399" CI_START="0.32511790415396913" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="RR" EFFECT_SIZE="0.5528017942033565" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="36" I2="0.0" I2_Q="58.96825058618396" ID="CMP-001.12" LOG_CI_END="-0.026901998756795862" LOG_CI_START="-0.4879591133670974" LOG_EFFECT_SIZE="-0.2574305560619466" METHOD="MH" MODIFIED="2014-01-14 04:45:09 +0000" MODIFIED_BY="[Empty name]" NO="12" P_CHI2="0.48756304359354863" P_Q="0.11849252757488082" P_Z="0.028619672621382847" Q="2.4371371298716404" RANDOM="NO" SCALE="279.5938417612857" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="720" TOTAL_2="740" WEIGHT="200.0" Z="2.1886859671518075">
<NAME>Apgar score</NAME>
<GROUP_LABEL_1>Magnesium</GROUP_LABEL_1>
<GROUP_LABEL_2>No magnesium</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours magnesium</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours no magnesium</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.668150739572361" CI_START="0.40854080074529464" DF="0" EFFECT_SIZE="0.8255347593582888" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="16" I2="0.0" ID="CMP-001.12.01" LOG_CI_END="0.22223529234881773" LOG_CI_START="-0.38876456421433375" LOG_EFFECT_SIZE="-0.08326463593275801" MODIFIED="2013-02-05 01:50:18 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.5932085473701041" STUDIES="1" TAU2="0.0" TOTAL_1="187" TOTAL_2="190" WEIGHT="100.0" Z="0.5341922288886096">
<NAME>1 minute Apgar &lt; 5</NAME>
<DICH_DATA CI_END="1.6681507395723612" CI_START="0.4085408007452946" EFFECT_SIZE="0.8255347593582888" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="16" LOG_CI_END="0.2222352923488178" LOG_CI_START="-0.3887645642143338" LOG_EFFECT_SIZE="-0.08326463593275801" MODIFIED="2008-05-07 06:43:41 +0100" MODIFIED_BY="[Empty name]" ORDER="201" O_E="0.0" SE="0.35890434024326373" STUDY_ID="STD-Memphis-1989" TOTAL_1="187" TOTAL_2="190" VAR="0.1288123254454524" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="1.595161681511057" CI_END="0.800882921620885" CI_START="0.14745101123320908" DF="3" EFFECT_SIZE="0.3436437059985334" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="20" I2="0.0" ID="CMP-001.12.02" LOG_CI_END="-0.09643096732444853" LOG_CI_START="-0.8313522446686655" LOG_EFFECT_SIZE="-0.463891605996557" MODIFIED="2013-07-22 01:16:36 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.6604874231050992" P_Z="0.013349451057013432" STUDIES="4" TAU2="0.0" TOTAL_1="533" TOTAL_2="550" WEIGHT="100.0" Z="2.4743081157462457">
<NAME>5 minute Apgar &lt; 7</NAME>
<DICH_DATA CI_END="1.56357724005177" CI_START="0.005063085217307219" EFFECT_SIZE="0.08897485493230174" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="5" LOG_CI_END="0.19411934007188417" LOG_CI_START="-2.2955847628966213" LOG_EFFECT_SIZE="-1.0507327114123683" MODIFIED="2013-07-22 01:16:36 +0100" MODIFIED_BY="[Empty name]" ORDER="227" O_E="0.0" SE="1.4624645143177724" STUDY_ID="STD-Italy-1994" TOTAL_1="46" TOTAL_2="45" VAR="2.138802455638718" WEIGHT="26.859281399946624"/>
<DICH_DATA CI_END="2.5146536816483587" CI_START="0.14779110870985565" EFFECT_SIZE="0.6096256684491979" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="5" LOG_CI_END="0.4004781824315242" LOG_CI_START="-0.830351692831577" LOG_EFFECT_SIZE="-0.2149367552000264" ORDER="217" O_E="0.0" SE="0.7229955614356901" STUDY_ID="STD-Memphis-1989" TOTAL_1="187" TOTAL_2="190" VAR="0.5227225818557087" WEIGHT="23.965530725952714"/>
<DICH_DATA CI_END="4.469355890455309" CI_START="0.011436840824966266" EFFECT_SIZE="0.22608695652173913" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.6502449384838002" LOG_CI_START="-1.941693923249388" LOG_EFFECT_SIZE="-0.6457244923827937" ORDER="218" O_E="0.0" SE="1.5225177176863645" STUDY_ID="STD-Mississippi-1992" TOTAL_1="22" TOTAL_2="25" VAR="2.318060200668896" WEIGHT="11.339360303652516"/>
<DICH_DATA CI_END="1.4595009027155426" CI_START="0.10484906729719036" EFFECT_SIZE="0.39118705035971224" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="8" LOG_CI_END="0.16420436793948887" LOG_CI_START="-0.9794354285222916" LOG_EFFECT_SIZE="-0.40761553029140135" ORDER="219" O_E="0.0" SE="0.6717796775499435" STUDY_ID="STD-Zurich-1988" TOTAL_1="278" TOTAL_2="290" VAR="0.4512879351691061" WEIGHT="37.835827570448146"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="0.875984034652419" CI_START="0.5291252948779633" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.6808122433122433" ESTIMABLE="YES" EVENTS_1="95" EVENTS_2="143" I2="0.0" I2_Q="0.0" ID="CMP-001.13" LOG_CI_END="-0.05750380904372387" LOG_CI_START="-0.27644147648847595" LOG_EFFECT_SIZE="-0.16697264276609994" METHOD="MH" MODIFIED="2014-01-14 04:45:09 +0000" MODIFIED_BY="[Empty name]" NO="13" P_CHI2="1.0" P_Q="1.0" P_Z="0.0027940697699191737" Q="0.0" RANDOM="NO" SCALE="6.195645218818343" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="2016" TOTAL_2="2066" WEIGHT="100.0" Z="2.9895300342286784">
<NAME>Late fetal heart rate decelerations</NAME>
<GROUP_LABEL_1>Magnesium</GROUP_LABEL_1>
<GROUP_LABEL_2>No magnesium</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours magnesium</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours no magnesium</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.875984034652419" CI_START="0.5291252948779633" EFFECT_SIZE="0.6808122433122433" ESTIMABLE="YES" EVENTS_1="95" EVENTS_2="143" LOG_CI_END="-0.05750380904372387" LOG_CI_START="-0.27644147648847595" LOG_EFFECT_SIZE="-0.16697264276609994" MODIFIED="2008-03-04 05:34:45 +0000" MODIFIED_BY="[Empty name]" ORDER="109" O_E="0.0" SE="0.12860506961597984" STUDY_ID="STD-South-Africa-2007" TOTAL_1="2016" TOTAL_2="2066" VAR="0.01653926393093102" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="1.4866807554734921E-30" CI_END="0.9859200984316652" CI_START="0.6310698216590883" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.7887866762866762" ESTIMABLE="YES" EVENTS_1="127" EVENTS_2="165" I2="100.0" I2_Q="0.0" ID="CMP-001.14" LOG_CI_END="-0.006158280004334323" LOG_CI_START="-0.19992258769133642" LOG_EFFECT_SIZE="-0.10304043384783537" METHOD="MH" MODIFIED="2014-01-14 04:45:09 +0000" MODIFIED_BY="[Empty name]" NO="14" P_CHI2="0.0" P_Q="1.0" P_Z="0.037110312017849735" Q="0.0" RANDOM="NO" SCALE="2.1157147949238966" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="2016" TOTAL_2="2066" WEIGHT="100.0" Z="2.0845484052653176">
<NAME>Meconium-stained liquor</NAME>
<GROUP_LABEL_1>Magnesium</GROUP_LABEL_1>
<GROUP_LABEL_2>No magnesium</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours magnesium</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours no magnesium</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.9859200984316654" CI_START="0.6310698216590884" EFFECT_SIZE="0.7887866762866763" ESTIMABLE="YES" EVENTS_1="127" EVENTS_2="165" LOG_CI_END="-0.006158280004334225" LOG_CI_START="-0.19992258769133633" LOG_EFFECT_SIZE="-0.10304043384783532" MODIFIED="2008-03-04 05:33:00 +0000" MODIFIED_BY="[Empty name]" ORDER="108" O_E="0.0" SE="0.11381811348413706" STUDY_ID="STD-South-Africa-2007" TOTAL_1="2016" TOTAL_2="2066" VAR="0.012954562957087903" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="1.2634936806808896" CI_START="0.3185331378359819" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.6344009826152683" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="21" I2="0.0" I2_Q="0.0" ID="CMP-001.15" LOG_CI_END="0.10157307415282146" LOG_CI_START="-0.49684538018675833" LOG_EFFECT_SIZE="-0.1976361530169684" METHOD="MH" MODIFIED="2014-01-14 04:45:09 +0000" MODIFIED_BY="[Empty name]" NO="15" P_CHI2="1.0" P_Q="1.0" P_Z="0.19545424221928448" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="2016" TOTAL_2="2066" WEIGHT="100.0" Z="1.2946116188338446">
<NAME>Meconium aspiration</NAME>
<GROUP_LABEL_1>Magnesium</GROUP_LABEL_1>
<GROUP_LABEL_2>No magnesium</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours magnesium</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours no magnesium</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.2634936806808896" CI_START="0.3185331378359819" EFFECT_SIZE="0.6344009826152683" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="21" LOG_CI_END="0.10157307415282146" LOG_CI_START="-0.49684538018675833" LOG_EFFECT_SIZE="-0.1976361530169684" MODIFIED="2008-03-04 05:53:54 +0000" MODIFIED_BY="[Empty name]" ORDER="116" O_E="0.0" SE="0.3515139622981922" STUDY_ID="STD-South-Africa-2007" TOTAL_1="2016" TOTAL_2="2066" VAR="0.12356206569057489" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="1.917174702830411" CI_START="0.8102881141041168" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="1.246380308880309" ESTIMABLE="YES" EVENTS_1="45" EVENTS_2="37" I2="0.0" I2_Q="0.0" ID="CMP-001.16" LOG_CI_END="0.2826616898306813" LOG_CI_START="-0.0913605315937557" LOG_EFFECT_SIZE="0.0956505791184628" METHOD="MH" MODIFIED="2014-01-14 04:45:09 +0000" MODIFIED_BY="[Empty name]" NO="16" P_CHI2="1.0" P_Q="1.0" P_Z="0.3161201160605944" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="2016" TOTAL_2="2066" WEIGHT="100.0" Z="1.0024628454352977">
<NAME>Breech presentation</NAME>
<GROUP_LABEL_1>Magnesium</GROUP_LABEL_1>
<GROUP_LABEL_2>No magnesium</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours magnesium</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours no magnesium</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.917174702830411" CI_START="0.8102881141041168" EFFECT_SIZE="1.246380308880309" ESTIMABLE="YES" EVENTS_1="45" EVENTS_2="37" LOG_CI_END="0.2826616898306813" LOG_CI_START="-0.0913605315937557" LOG_EFFECT_SIZE="0.0956505791184628" MODIFIED="2008-03-04 05:35:28 +0000" MODIFIED_BY="[Empty name]" ORDER="110" O_E="0.0" SE="0.21970250430457" STUDY_ID="STD-South-Africa-2007" TOTAL_1="2016" TOTAL_2="2066" VAR="0.0482691903976996" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="1.9380639081474142" CI_START="0.47627088972496634" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9607514880952381" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="16" I2="0.0" I2_Q="0.0" ID="CMP-001.17" LOG_CI_END="0.2873680939212235" LOG_CI_START="-0.32214596230148235" LOG_EFFECT_SIZE="-0.017388934190129428" METHOD="MH" MODIFIED="2014-01-14 04:45:09 +0000" MODIFIED_BY="[Empty name]" NO="17" P_CHI2="1.0" P_Q="1.0" P_Z="0.9109563625619301" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="2016" TOTAL_2="2066" WEIGHT="100.0" Z="0.11183231754621917">
<NAME>Placental abruption</NAME>
<GROUP_LABEL_1>Magnesium</GROUP_LABEL_1>
<GROUP_LABEL_2>No magnesium</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours magnesium</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours no magnesium</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.9380639081474142" CI_START="0.47627088972496634" EFFECT_SIZE="0.9607514880952381" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="16" LOG_CI_END="0.2873680939212235" LOG_CI_START="-0.32214596230148235" LOG_EFFECT_SIZE="-0.017388934190129428" MODIFIED="2008-03-04 05:36:12 +0000" MODIFIED_BY="[Empty name]" ORDER="111" O_E="0.0" SE="0.3580315737684555" STUDY_ID="STD-South-Africa-2007" TOTAL_1="2016" TOTAL_2="2066" VAR="0.128186607815117" WEIGHT="100.0"/>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="1.5667476141165668" CI_END="22.140472545160115" CI_START="-22.157594624270907" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="MD" EFFECT_SIZE="-0.00856103955539708" ESTIMABLE="YES" I2="36.17351059035348" I2_Q="0.0" ID="CMP-001.18" MODIFIED="2014-01-21 03:58:57 +0000" MODIFIED_BY="[Empty name]" NO="18" P_CHI2="0.2106800111366014" P_Q="1.0" P_Z="0.9993955507639642" Q="0.0" RANDOM="YES" SCALE="100.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="113.94836703514316" TOTALS="YES" TOTAL_1="2203" TOTAL_2="2256" UNITS="" WEIGHT="100.00000000000001" Z="7.575648451939713E-4">
<NAME>Placental weight (g)</NAME>
<GROUP_LABEL_1>Magnesium</GROUP_LABEL_1>
<GROUP_LABEL_2>No magnesium</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours magnesium</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours no magnesium</GRAPH_LABEL_2>
<CONT_DATA CI_END="54.037044776864214" CI_START="-18.037044776864214" EFFECT_SIZE="18.0" ESTIMABLE="YES" MEAN_1="677.0" MEAN_2="659.0" MODIFIED="2010-12-23 00:22:57 +0000" MODIFIED_BY="[Empty name]" ORDER="421" SD_1="177.8" SD_2="179.2" SE="18.386585192952435" STUDY_ID="STD-Memphis-1989" TOTAL_1="187" TOTAL_2="190" WEIGHT="28.252744862329163"/>
<CONT_DATA CI_END="8.585437707444076" CI_START="-22.78543770744412" EFFECT_SIZE="-7.100000000000023" ESTIMABLE="YES" MEAN_1="600.9" MEAN_2="608.0" MODIFIED="2010-12-23 00:23:09 +0000" MODIFIED_BY="[Empty name]" ORDER="422" SD_1="188.0" SD_2="310.0" SE="8.002921396091372" STUDY_ID="STD-South-Africa-2007" TOTAL_1="2016" TOTAL_2="2066" WEIGHT="71.74725513767085"/>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="4.275248482168055" CI_END="1.1097987766223267" CI_START="0.43991877116377787" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="RR" EFFECT_SIZE="0.698728354978355" ESTIMABLE="YES" EVENTS_1="30" EVENTS_2="44" I2="29.828640077578694" I2_Q="29.828601800325526" ID="CMP-001.19" LOG_CI_END="0.04524424173741392" LOG_CI_START="-0.3566275064502358" LOG_EFFECT_SIZE="-0.15569163235641093" METHOD="MH" MODIFIED="2014-01-14 04:45:09 +0000" MODIFIED_BY="[Empty name]" NO="19" P_CHI2="0.23323540937975062" P_Q="0.23323563624735022" P_Z="0.1288522140410032" Q="4.275246150095834" RANDOM="NO" SCALE="42.11614869114755" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="8064" TOTAL_2="8264" WEIGHT="400.0" Z="1.518643664248475">
<NAME>Hypoxic-ischaemic encephalopathy</NAME>
<GROUP_LABEL_1>Magnesium</GROUP_LABEL_1>
<GROUP_LABEL_2>No magnesium</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours magnesium</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours no magnesium</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.343014095161109" CI_START="0.3635265748958433" DF="0" EFFECT_SIZE="0.698728354978355" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="22" I2="0.0" ID="CMP-001.19.01" LOG_CI_END="0.12808057068700887" LOG_CI_START="-0.4394638353998307" LOG_EFFECT_SIZE="-0.15569163235641093" MODIFIED="2013-07-22 03:23:15 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="1.0" P_Z="0.2822250873538039" STUDIES="1" TAU2="0.0" TOTAL_1="2016" TOTAL_2="2066" WEIGHT="100.0" Z="1.0753343309884569">
<NAME>Any HIE</NAME>
<DICH_DATA CI_END="1.3430140951611091" CI_START="0.36352657489584317" EFFECT_SIZE="0.698728354978355" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="22" LOG_CI_END="0.12808057068700895" LOG_CI_START="-0.4394638353998308" LOG_EFFECT_SIZE="-0.15569163235641093" MODIFIED="2013-07-22 03:23:15 +0100" MODIFIED_BY="[Empty name]" ORDER="228" O_E="0.0" SE="0.333378393525529" STUDY_ID="STD-South-Africa-2007" TOTAL_1="2016" TOTAL_2="2066" VAR="0.11114115326966247" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.9801228564699768" CI_START="0.1506820767676672" DF="0" EFFECT_SIZE="0.38430059523809523" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="16" I2="0.0" ID="CMP-001.19.02" LOG_CI_END="-0.008719482937291256" LOG_CI_START="-0.8219384027870429" LOG_EFFECT_SIZE="-0.41532894286216704" MODIFIED="2013-07-22 03:23:02 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.045285358152360775" STUDIES="1" TAU2="0.0" TOTAL_1="2016" TOTAL_2="2066" WEIGHT="100.0" Z="2.001994173714846">
<NAME>Mild HIE</NAME>
<DICH_DATA CI_END="0.9801228564699767" CI_START="0.1506820767676672" EFFECT_SIZE="0.38430059523809523" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="16" LOG_CI_END="-0.008719482937291306" LOG_CI_START="-0.8219384027870429" LOG_EFFECT_SIZE="-0.41532894286216704" MODIFIED="2008-04-07 06:15:51 +0100" MODIFIED_BY="[Empty name]" ORDER="240" O_E="0.0" SE="0.4776888190183197" STUDY_ID="STD-South-Africa-2007" TOTAL_1="2016" TOTAL_2="2066" VAR="0.22818660781511702" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="4.092041178797467" CI_START="0.2566490041149786" DF="0" EFFECT_SIZE="1.0248015873015872" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="4" I2="0.0" ID="CMP-001.19.03" LOG_CI_END="0.611939995429792" LOG_CI_START="-0.5906604166095638" LOG_EFFECT_SIZE="0.010639789410114056" MODIFIED="2013-07-22 03:23:00 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Z="0.9723342288416111" STUDIES="1" TAU2="0.0" TOTAL_1="2016" TOTAL_2="2066" WEIGHT="100.0" Z="0.03468085298848504">
<NAME>Moderate HIE</NAME>
<DICH_DATA CI_END="4.092041178797466" CI_START="0.25664900411497865" EFFECT_SIZE="1.0248015873015872" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="4" LOG_CI_END="0.6119399954297919" LOG_CI_START="-0.5906604166095638" LOG_EFFECT_SIZE="0.010639789410114056" ORDER="220" O_E="0.0" SE="0.7064134349999653" STUDY_ID="STD-South-Africa-2007" TOTAL_1="2016" TOTAL_2="2066" VAR="0.49901994114845033" WEIGHT="100.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="13.19007857914916" CI_START="0.4976364844198291" DF="0" EFFECT_SIZE="2.5620039682539684" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="2" I2="0.0" ID="CMP-001.19.04" LOG_CI_END="1.120247382838952" LOG_CI_START="-0.3030877866746485" LOG_EFFECT_SIZE="0.4085797980821517" MODIFIED="2013-07-22 03:22:58 +0100" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="1.0" P_Z="0.260484474989491" STUDIES="1" TAU2="0.0" TOTAL_1="2016" TOTAL_2="2066" WEIGHT="100.0" Z="1.12524682338219">
<NAME>Severe HIE</NAME>
<DICH_DATA CI_END="13.19007857914916" CI_START="0.4976364844198291" EFFECT_SIZE="2.5620039682539684" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="2" LOG_CI_END="1.120247382838952" LOG_CI_START="-0.3030877866746485" LOG_EFFECT_SIZE="0.4085797980821517" ORDER="221" O_E="0.0" SE="0.8360741241950084" STUDY_ID="STD-South-Africa-2007" TOTAL_1="2016" TOTAL_2="2066" VAR="0.6990199411484503" WEIGHT="100.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="5.450489531810387" CI_START="0.7707331880606483" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="2.0496031746031744" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="6" I2="0.0" I2_Q="0.0" ID="CMP-001.20" LOG_CI_END="0.7364355098759782" LOG_CI_START="-0.11309593972778777" LOG_EFFECT_SIZE="0.31166978507409526" METHOD="MH" MODIFIED="2014-01-14 04:45:09 +0000" MODIFIED_BY="[Empty name]" NO="20" P_CHI2="1.0" P_Q="1.0" P_Z="0.1504016987722922" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="2016" TOTAL_2="2066" WEIGHT="100.0" Z="1.4381140429809418">
<NAME>Significant congenital abnormality</NAME>
<GROUP_LABEL_1>Magnesium</GROUP_LABEL_1>
<GROUP_LABEL_2>No magnesium</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours magnesium</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours no magnesium</GRAPH_LABEL_2>
<DICH_DATA CI_END="5.450489531810387" CI_START="0.7707331880606483" EFFECT_SIZE="2.0496031746031744" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="6" LOG_CI_END="0.7364355098759782" LOG_CI_START="-0.11309593972778777" LOG_EFFECT_SIZE="0.31166978507409526" MODIFIED="2008-03-04 05:38:51 +0000" MODIFIED_BY="[Empty name]" ORDER="112" O_E="0.0" SE="0.4990189787457491" STUDY_ID="STD-South-Africa-2007" TOTAL_1="2016" TOTAL_2="2066" VAR="0.24901994114845036" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.05289272224655023" CI_END="1.1169780986146405" CI_START="0.6913839352368167" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="RR" EFFECT_SIZE="0.8787836556249367" ESTIMABLE="YES" EVENTS_1="92" EVENTS_2="105" I2="0.0" I2_Q="0.0" ID="CMP-001.21" LOG_CI_END="0.048044657677777436" LOG_CI_START="-0.160280715796011" LOG_EFFECT_SIZE="-0.056118029059116795" METHOD="MH" MODIFIED="2014-01-14 04:45:09 +0000" MODIFIED_BY="[Empty name]" NO="21" P_CHI2="0.9968155707788869" P_Q="1.0" P_Z="0.2909966592387401" Q="0.0" RANDOM="NO" SCALE="50.39284854774434" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="NO" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="709" TOTAL_2="726" WEIGHT="100.0" Z="1.055937776615387">
<NAME>Maternal side effects</NAME>
<GROUP_LABEL_1>Magnesium</GROUP_LABEL_1>
<GROUP_LABEL_2>No magnesium</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours magnesium</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours no magnesium</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.05289272224655023" CI_END="1.1169780986146405" CI_START="0.6913839352368167" DF="3" EFFECT_SIZE="0.8787836556249367" ESTIMABLE="YES" EVENTS_1="92" EVENTS_2="105" I2="0.0" ID="CMP-001.21.01" LOG_CI_END="0.048044657677777436" LOG_CI_START="-0.160280715796011" LOG_EFFECT_SIZE="-0.056118029059116795" MODIFIED="2013-05-03 04:47:30 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.9968155707788869" P_Z="0.2909966592387401" STUDIES="4" TAU2="0.0" TOTAL_1="687" TOTAL_2="701" WEIGHT="100.0" Z="1.055937776615387">
<NAME>Any gastrointestinal side effects</NAME>
<DICH_DATA CI_END="1.1662199152350954" CI_START="0.6742481886042704" EFFECT_SIZE="0.8867478025693036" ESTIMABLE="YES" EVENTS_1="61" EVENTS_2="68" LOG_CI_END="0.06678045348260604" LOG_CI_START="-0.1711802116236461" LOG_EFFECT_SIZE="-0.05219987907052007" MODIFIED="2012-11-01 05:42:08 +0000" MODIFIED_BY="[Empty name]" ORDER="32" O_E="0.0" SE="0.1397792726077021" STUDY_ID="STD-Hungary-1988" TOTAL_1="174" TOTAL_2="172" VAR="0.019538245050738295" WEIGHT="65.24095285772101"/>
<DICH_DATA CI_END="3.180472848141597" CI_START="0.17686049429055115" EFFECT_SIZE="0.75" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="4" LOG_CI_END="0.5024916923343051" LOG_CI_START="-0.7523691655509052" LOG_EFFECT_SIZE="-0.12493873660829995" MODIFIED="2010-05-20 01:04:35 +0100" MODIFIED_BY="[Empty name]" ORDER="384" O_E="0.0" SE="0.7371114795831993" STUDY_ID="STD-Italy-1994" TOTAL_1="50" TOTAL_2="50" VAR="0.5433333333333332" WEIGHT="3.815647344281857"/>
<DICH_DATA CI_END="1.8800036979818913" CI_START="0.3974844229450344" EFFECT_SIZE="0.8644490644490644" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="13" LOG_CI_END="0.27415870352514266" LOG_CI_START="-0.40067988628190543" LOG_EFFECT_SIZE="-0.06326059137838139" ORDER="33" O_E="0.0" SE="0.39640352815755453" STUDY_ID="STD-Memphis-1989" TOTAL_1="185" TOTAL_2="189" VAR="0.15713575713575714" WEIGHT="12.268224415772549"/>
<DICH_DATA CI_END="1.6570220020324316" CI_START="0.47447789067841595" EFFECT_SIZE="0.8866906474820144" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="20" LOG_CI_END="0.21932827504446473" LOG_CI_START="-0.3237840196541196" LOG_EFFECT_SIZE="-0.052227872304827436" ORDER="34" O_E="0.0" SE="0.319026850355166" STUDY_ID="STD-Zurich-1988" TOTAL_1="278" TOTAL_2="290" VAR="0.10177813124753746" WEIGHT="18.675175382224584"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-001.21.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" MODIFIED="2013-05-03 04:47:34 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="1" TAU2="0.0" TOTAL_1="22" TOTAL_2="25" WEIGHT="0.0" Z="0.0">
<NAME>Any side effects</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="35" O_E="0.0" SE="0.0" STUDY_ID="STD-Mississippi-1992" TOTAL_1="22" TOTAL_2="25" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="0.0" CI_END="1.9689054593984143" CI_START="0.031094540601585785" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="MD" EFFECT_SIZE="1.0" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.22" MODIFIED="2014-01-21 03:58:57 +0000" MODIFIED_BY="[Empty name]" NO="22" P_CHI2="1.0" P_Q="1.0" P_Z="0.04308716984414217" Q="0.0" RANDOM="NO" SCALE="3.4664124269973295" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="703" TOTAL_2="729" UNITS="" WEIGHT="100.0" Z="2.0228640116828123">
<NAME>Systolic blood pressure near birth (mm Hg)</NAME>
<GROUP_LABEL_1>Magnesium</GROUP_LABEL_1>
<GROUP_LABEL_2>No magnesium</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours magnesium</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours no magnesium</GRAPH_LABEL_2>
<CONT_DATA CI_END="3.0406227876882177" CI_START="-1.0406227876882177" EFFECT_SIZE="1.0" ESTIMABLE="YES" MEAN_1="126.0" MEAN_2="125.0" MODIFIED="2010-12-23 00:10:21 +0000" MODIFIED_BY="[Empty name]" ORDER="409" SD_1="12.0" SD_2="11.0" SE="1.0411532067856297" STUDY_ID="STD-Austria-1997" TOTAL_1="240" TOTAL_2="250" WEIGHT="22.544330456736247"/>
<CONT_DATA CI_END="4.752518332967187" CI_START="-2.7525183329671874" EFFECT_SIZE="1.0" ESTIMABLE="YES" MEAN_1="126.0" MEAN_2="125.0" MODIFIED="2010-12-23 00:10:30 +0000" MODIFIED_BY="[Empty name]" ORDER="410" SD_1="19.0" SD_2="18.0" SE="1.9145853508363282" STUDY_ID="STD-Memphis-1989" TOTAL_1="185" TOTAL_2="189" WEIGHT="6.666795915010999"/>
<CONT_DATA CI_END="2.1515926967640833" CI_START="-0.15159269676408327" EFFECT_SIZE="1.0" ESTIMABLE="YES" MEAN_1="125.0" MEAN_2="124.0" MODIFIED="2013-02-08 01:37:38 +0000" MODIFIED_BY="[Empty name]" ORDER="411" SD_1="7.0" SD_2="7.0" SE="0.5875580907851876" STUDY_ID="STD-Zurich-1988" TOTAL_1="278" TOTAL_2="290" WEIGHT="70.78887362825276"/>
</CONT_OUTCOME>
<CONT_OUTCOME CHI2="0.850049577408614" CI_END="1.1279473519573548" CI_START="-0.665120337771265" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="MD" EFFECT_SIZE="0.2314135070930449" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.23" MODIFIED="2014-01-21 03:58:57 +0000" MODIFIED_BY="[Empty name]" NO="23" P_CHI2="0.6537535973429152" P_Q="1.0" P_Z="0.6129224163761019" Q="0.0" RANDOM="NO" SCALE="7.373579630067805" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="703" TOTAL_2="729" UNITS="" WEIGHT="100.0" Z="0.5059063213694056">
<NAME>Diastolic blood pressure near birth (mm Hg)</NAME>
<GROUP_LABEL_1>Magnesium</GROUP_LABEL_1>
<GROUP_LABEL_2>No magnesium</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours magnesium</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours no magnesium</GRAPH_LABEL_2>
<CONT_DATA CI_END="2.8636842589463143" CI_START="-0.8636842589463141" EFFECT_SIZE="1.0" ESTIMABLE="YES" MEAN_1="76.0" MEAN_2="75.0" MODIFIED="2010-12-23 00:11:50 +0000" MODIFIED_BY="[Empty name]" ORDER="412" SD_1="11.0" SD_2="10.0" SE="0.9508767883730608" STUDY_ID="STD-Austria-1997" TOTAL_1="240" TOTAL_2="250" WEIGHT="23.14135070930449"/>
<CONT_DATA CI_END="3.4497980231431664" CI_START="-3.4497980231431664" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="77.0" MEAN_2="77.0" MODIFIED="2010-12-23 00:11:56 +0000" MODIFIED_BY="[Empty name]" ORDER="413" SD_1="16.0" SD_2="18.0" SE="1.7601333750797121" STUDY_ID="STD-Memphis-1989" TOTAL_1="185" TOTAL_2="189" WEIGHT="6.75376648136341"/>
<CONT_DATA CI_END="1.070761026411932" CI_START="-1.070761026411932" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="73.0" MEAN_2="73.0" MODIFIED="2010-12-23 00:12:03 +0000" MODIFIED_BY="[Empty name]" ORDER="414" SD_1="6.0" SD_2="7.0" SE="0.5463166848258225" STUDY_ID="STD-Zurich-1988" TOTAL_1="278" TOTAL_2="290" WEIGHT="70.1048828093321"/>
</CONT_OUTCOME>
<DICH_OUTCOME CHI2="8.822970519433325" CI_END="1.405257975510409" CI_START="0.1068393453148711" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="RR" EFFECT_SIZE="0.3874749567417658" ESTIMABLE="YES" EVENTS_1="205" EVENTS_2="242" I2="77.33189751008649" I2_Q="0.0" ID="CMP-001.24" LOG_CI_END="0.1477560588006501" LOG_CI_START="-0.9712687818918666" LOG_EFFECT_SIZE="-0.41175636154560824" METHOD="MH" MODIFIED="2014-01-14 04:45:09 +0000" MODIFIED_BY="[Empty name]" NO="24" P_CHI2="0.01213718719886081" P_Q="1.0" P_Z="0.14919615311516934" Q="0.0" RANDOM="YES" SCALE="38.68912948928023" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.9773600555499271" TOTALS="YES" TOTAL_1="2117" TOTAL_2="2167" WEIGHT="100.0" Z="1.4423766295218443">
<NAME>Pregnancy-induced hypertension</NAME>
<GROUP_LABEL_1>Magnesium</GROUP_LABEL_1>
<GROUP_LABEL_2>No magnesium</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours magnesium</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours no magnesium</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.6468519220394404" CI_START="0.0365905058744052" EFFECT_SIZE="0.15384615384615385" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="13" LOG_CI_END="-0.18919512706157823" LOG_CI_START="-1.4366315862241328" LOG_EFFECT_SIZE="-0.8129133566428556" MODIFIED="2010-12-22 23:57:22 +0000" MODIFIED_BY="[Empty name]" ORDER="406" O_E="0.0" SE="0.732750351022145" STUDY_ID="STD-Angola-1992" TOTAL_1="50" TOTAL_2="50" VAR="0.5369230769230768" WEIGHT="28.533009033967602"/>
<DICH_DATA CI_END="1.120521732296541" CI_START="0.055777588420266054" EFFECT_SIZE="0.25" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="8" LOG_CI_END="0.04942028400801898" LOG_CI_START="-1.2535402666639437" LOG_EFFECT_SIZE="-0.6020599913279624" MODIFIED="2010-12-22 23:57:27 +0000" MODIFIED_BY="[Empty name]" ORDER="407" O_E="0.0" SE="0.765365477223457" STUDY_ID="STD-China-1997" TOTAL_1="51" TOTAL_2="51" VAR="0.5857843137254901" WEIGHT="27.641115656428624"/>
<DICH_DATA CI_END="1.1168954710743824" CI_START="0.7778119592883415" EFFECT_SIZE="0.932059362206421" ESTIMABLE="YES" EVENTS_1="201" EVENTS_2="221" LOG_CI_END="0.048012529910753714" LOG_CI_START="-0.10912538361976913" LOG_EFFECT_SIZE="-0.030556426854507726" MODIFIED="2010-12-22 23:57:32 +0000" MODIFIED_BY="[Empty name]" ORDER="408" O_E="0.0" SE="0.092303588253046" STUDY_ID="STD-South-Africa-2007" TOTAL_1="2016" TOTAL_2="2066" VAR="0.008519952404387852" WEIGHT="43.82587530960377"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="2.695941239682091" CI_START="0.007569958486080607" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.14285714285714285" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="3" I2="0.0" I2_Q="0.0" ID="CMP-001.25" LOG_CI_END="0.4307104221511428" LOG_CI_START="-2.1209065021796567" LOG_EFFECT_SIZE="-0.8450980400142568" METHOD="MH" MODIFIED="2014-01-14 04:45:09 +0000" MODIFIED_BY="[Empty name]" NO="25" P_CHI2="1.0" P_Q="1.0" P_Z="0.19418976014097394" Q="0.0" RANDOM="NO" SCALE="1000.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="50" TOTAL_2="50" WEIGHT="100.0" Z="1.2982840065365528">
<NAME>Eclampsia</NAME>
<GROUP_LABEL_1>Magnesium</GROUP_LABEL_1>
<GROUP_LABEL_2>No magnesium</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours magnesium</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours no magnesium</GRAPH_LABEL_2>
<DICH_DATA CI_END="2.695941239682091" CI_START="0.007569958486080607" EFFECT_SIZE="0.14285714285714285" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="3" LOG_CI_END="0.4307104221511428" LOG_CI_START="-2.1209065021796567" LOG_EFFECT_SIZE="-0.8450980400142568" MODIFIED="2010-12-23 01:11:48 +0000" MODIFIED_BY="[Empty name]" ORDER="431" O_E="0.0" SE="1.4988324120593923" STUDY_ID="STD-Angola-1992" TOTAL_1="50" TOTAL_2="50" VAR="2.246498599439776" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.8635544199516585" CI_END="0.8640942160687188" CI_START="0.48201776100095917" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="RR" EFFECT_SIZE="0.6453748982748887" ESTIMABLE="YES" EVENTS_1="62" EVENTS_2="100" I2="0.0" I2_Q="0.0" ID="CMP-001.26" LOG_CI_END="-0.06343890186374582" LOG_CI_START="-0.31693695893418483" LOG_EFFECT_SIZE="-0.1901879303989653" METHOD="MH" MODIFIED="2014-01-14 04:45:09 +0000" MODIFIED_BY="[Empty name]" NO="26" P_CHI2="0.6493540506016021" P_Q="1.0" P_Z="0.0032721619297483412" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="568" TOTAL_2="590" WEIGHT="99.99999999999999" Z="2.9409416244370195">
<NAME>Need for maternal hospitalisation</NAME>
<GROUP_LABEL_1>Magnesium</GROUP_LABEL_1>
<GROUP_LABEL_2>No magnesium</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours magnesium</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours no magnesium</GRAPH_LABEL_2>
<DICH_DATA CI_END="0.9925582231114709" CI_START="0.31095604078631417" EFFECT_SIZE="0.5555555555555556" ESTIMABLE="YES" EVENTS_1="16" EVENTS_2="30" LOG_CI_END="-0.003244008258163817" LOG_CI_START="-0.5073010019484482" LOG_EFFECT_SIZE="-0.25527250510330607" MODIFIED="2010-12-23 00:19:35 +0000" MODIFIED_BY="[Empty name]" ORDER="415" O_E="0.0" SE="0.2960855732160327" STUDY_ID="STD-Austria-1997" TOTAL_1="240" TOTAL_2="250" VAR="0.08766666666666666" WEIGHT="29.98306414363952"/>
<DICH_DATA CI_END="1.9659813518147353" CI_START="0.08138429179519381" EFFECT_SIZE="0.4" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="5" LOG_CI_END="0.29357939404425104" LOG_CI_START="-1.0894594113883262" LOG_EFFECT_SIZE="-0.3979400086720376" MODIFIED="2010-12-23 00:19:40 +0000" MODIFIED_BY="[Empty name]" ORDER="416" O_E="0.0" SE="0.812403840463596" STUDY_ID="STD-Italy-1994" TOTAL_1="50" TOTAL_2="50" VAR="0.6599999999999999" WEIGHT="5.101285218883112"/>
<DICH_DATA CI_END="0.997522396711712" CI_START="0.49987611775500446" EFFECT_SIZE="0.7061427780852241" ESTIMABLE="YES" EVENTS_1="44" EVENTS_2="65" LOG_CI_END="-0.001077344604508291" LOG_CI_START="-0.30113761174706843" LOG_EFFECT_SIZE="-0.15110747817578837" MODIFIED="2013-02-08 01:37:31 +0000" MODIFIED_BY="[Empty name]" ORDER="417" O_E="0.0" SE="0.17625688624181715" STUDY_ID="STD-Zurich-1988" TOTAL_1="278" TOTAL_2="290" VAR="0.031066489947660876" WEIGHT="64.91565063747736"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="2.994013851080933" CI_END="3.1450847394451578" CI_START="0.09008412961708454" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="RR" EFFECT_SIZE="0.5322802094056214" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="19" I2="66.60002091710535" I2_Q="0.0" ID="CMP-001.27" LOG_CI_END="0.4976323513322074" LOG_CI_START="-1.0453517132031682" LOG_EFFECT_SIZE="-0.2738596809354804" METHOD="MH" MODIFIED="2014-01-14 04:45:09 +0000" MODIFIED_BY="[Empty name]" NO="27" P_CHI2="0.08357297236874761" P_Q="1.0" P_Z="0.4865939121738646" Q="0.0" RANDOM="YES" SCALE="61.80097841387084" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="1.1210495959047628" TOTALS="YES" TOTAL_1="463" TOTAL_2="479" WEIGHT="100.0" Z="0.6957364288953953">
<NAME>Antepartum haemorrhage</NAME>
<GROUP_LABEL_1>Magnesium</GROUP_LABEL_1>
<GROUP_LABEL_2>No magnesium</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours magnesium</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours no magnesium</GRAPH_LABEL_2>
<DICH_DATA CI_END="9.065994835368741" CI_START="0.2590282922740345" EFFECT_SIZE="1.5324324324324323" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.9574154673179155" LOG_CI_START="-0.5866527976660922" LOG_EFFECT_SIZE="0.18538133482591154" MODIFIED="2010-12-23 00:20:29 +0000" MODIFIED_BY="[Empty name]" ORDER="418" O_E="0.0" SE="0.9069933421127867" STUDY_ID="STD-Memphis-1989" TOTAL_1="185" TOTAL_2="189" VAR="0.8226369226369226" WEIGHT="42.26412316455216"/>
<DICH_DATA CI_END="0.7203875372189479" CI_START="0.08363004933610468" EFFECT_SIZE="0.24545069826491747" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="17" LOG_CI_END="-0.14243380912826553" LOG_CI_START="-1.077637647010598" LOG_EFFECT_SIZE="-0.6100357280694317" MODIFIED="2010-12-23 00:20:33 +0000" MODIFIED_BY="[Empty name]" ORDER="419" O_E="0.0" SE="0.5493433637057406" STUDY_ID="STD-Zurich-1988" TOTAL_1="278" TOTAL_2="290" VAR="0.3017781312475375" WEIGHT="57.73587683544783"/>
</DICH_OUTCOME>
<CONT_OUTCOME CHI2="1.3124101421521439E-4" CI_END="0.5024274864823097" CI_START="-0.5025425466396198" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="MD" EFFECT_SIZE="-5.753007865501811E-5" ESTIMABLE="YES" I2="0.0" I2_Q="0.0" ID="CMP-001.28" MODIFIED="2014-01-21 03:58:57 +0000" MODIFIED_BY="[Empty name]" NO="28" P_CHI2="0.9908595968674532" P_Q="1.0" P_Z="0.9998209559057198" Q="0.0" RANDOM="NO" SCALE="1.8479273938559575" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" TAU2="0.0" TOTALS="YES" TOTAL_1="2294" TOTAL_2="2356" UNITS="" WEIGHT="100.0" Z="2.2439849642344833E-4">
<NAME>Length of labour (hours)</NAME>
<GROUP_LABEL_1>Magnesium</GROUP_LABEL_1>
<GROUP_LABEL_2>No magnesium</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours magnesium</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours no magnesium</GRAPH_LABEL_2>
<CONT_DATA CI_END="25.5079090782749" CI_START="-25.807909078274896" EFFECT_SIZE="-0.15000000000000036" ESTIMABLE="YES" MEAN_1="9.2" MEAN_2="9.35" MODIFIED="2014-01-14 00:40:08 +0000" MODIFIED_BY="[Empty name]" ORDER="225" SD_1="5.83" SD_2="595.0" SE="13.091010488285097" STUDY_ID="STD-South-Africa-2007" TOTAL_1="2016" TOTAL_2="2066" WEIGHT="0.03835338577001198"/>
<CONT_DATA CI_END="0.50258140429624" CI_START="-0.50258140429624" EFFECT_SIZE="0.0" ESTIMABLE="YES" MEAN_1="6.0" MEAN_2="6.0" MODIFIED="2014-01-14 00:41:23 +0000" MODIFIED_BY="[Empty name]" ORDER="226" SD_1="2.8" SD_2="3.3" SE="0.2564237956720317" STUDY_ID="STD-Zurich-1988" TOTAL_1="278" TOTAL_2="290" WEIGHT="99.96164661422999"/>
</CONT_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-002" MODIFIED="2014-01-21 03:58:57 +0000" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Subgroup analysis based on study design</NAME>
<DICH_OUTCOME CHI2="0.565597444920793" CI_END="1.6665180825953376" CI_START="0.720226378654331" CI_STUDY="95" CI_TOTAL="95" DF="4" EFFECT_MEASURE="RR" EFFECT_SIZE="1.0955684750802204" ESTIMABLE="YES" EVENTS_1="44" EVENTS_2="41" I2="0.0" I2_Q="0.0" ID="CMP-002.01" LOG_CI_END="0.22181003034504448" LOG_CI_START="-0.14253097641902307" LOG_EFFECT_SIZE="0.03963952696301073" METHOD="MH" MODIFIED="2014-01-21 03:58:57 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.9668088209498874" P_Q="0.7307799815284259" P_Z="0.6697582438693299" Q="0.11839671647204021" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="2920" TOTAL_2="2983" WEIGHT="100.00000000000001" Z="0.42647982944184826">
<NAME>Perinatal mortality</NAME>
<GROUP_LABEL_1>Magnesium</GROUP_LABEL_1>
<GROUP_LABEL_2>No magnesium</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours magnesium</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours no magnesium</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.4439027474967641" CI_END="1.6567733291643039" CI_START="0.6983183682501233" DF="3" EFFECT_SIZE="1.0756185419479998" ESTIMABLE="YES" EVENTS_1="41" EVENTS_2="39" I2="0.0" ID="CMP-002.01.01" LOG_CI_END="0.21926309464324145" LOG_CI_START="-0.15594653432336109" LOG_EFFECT_SIZE="0.03165828015994016" MODIFIED="2013-09-04 01:29:45 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.9310311170958863" P_Z="0.7408381777371942" STUDIES="4" TAU2="0.0" TOTAL_1="2746" TOTAL_2="2811" WEIGHT="95.09998298524687" Z="0.3307435851092439">
<NAME>Individually-randomised</NAME>
<DICH_DATA CI_END="7.04666099030381" CI_START="0.14191118337834013" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.8479833784105825" LOG_CI_START="-0.8479833784105826" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-07-17 04:18:55 +0100" MODIFIED_BY="[Empty name]" ORDER="281" O_E="0.0" SE="0.9962192681275941" STUDY_ID="STD-Austria-1997" TOTAL_1="265" TOTAL_2="265" VAR="0.9924528301886792" WEIGHT="4.8718559974269775"/>
<DICH_DATA CI_END="16.124834277434395" CI_START="0.06402192509700207" EFFECT_SIZE="1.0160427807486632" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.2074952598799804" LOG_CI_START="-1.1936712710473203" LOG_EFFECT_SIZE="0.006911994416330019" MODIFIED="2013-07-17 04:19:07 +0100" MODIFIED_BY="[Empty name]" ORDER="282" O_E="0.0" SE="1.410457106232719" STUDY_ID="STD-Memphis-1989" TOTAL_1="187" TOTAL_2="190" VAR="1.9893892485223754" WEIGHT="2.416543956283408"/>
<DICH_DATA CI_END="1.6596600463332982" CI_START="0.6684345448630188" EFFECT_SIZE="1.0532682980599648" ESTIMABLE="YES" EVENTS_1="37" EVENTS_2="36" LOG_CI_END="0.22001913917179342" LOG_CI_START="-0.17494111375214969" LOG_EFFECT_SIZE="0.022539012709821855" MODIFIED="2013-09-04 01:29:45 +0100" MODIFIED_BY="[Empty name]" ORDER="283" O_E="0.0" SE="0.23200160765230735" STUDY_ID="STD-South-Africa-2007" TOTAL_1="2016" TOTAL_2="2066" VAR="0.05382474595325515" WEIGHT="86.61926037953462"/>
<DICH_DATA CI_END="76.48660199368314" CI_START="0.12800729300037317" EFFECT_SIZE="3.129032258064516" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.883585367313023" LOG_CI_START="-0.8927652864490786" LOG_EFFECT_SIZE="0.4954100404319722" MODIFIED="2013-07-17 04:19:14 +0100" MODIFIED_BY="[Empty name]" ORDER="284" O_E="0.0" SE="1.6308421171772414" STUDY_ID="STD-Zurich-1988" TOTAL_1="278" TOTAL_2="290" VAR="2.659646011159147" WEIGHT="1.1923226520018657"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="8.763926831284566" CI_START="0.2508662120935615" DF="0" EFFECT_SIZE="1.4827586206896552" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" I2="0.0" ID="CMP-002.01.02" LOG_CI_END="0.942698743044075" LOG_CI_START="-0.6005578276828142" LOG_EFFECT_SIZE="0.17107045768063045" MODIFIED="2013-07-17 04:18:36 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.6639070998088705" STUDIES="1" TAU2="0.0" TOTAL_1="174" TOTAL_2="172" WEIGHT="4.900017014753145" Z="0.434525201101063">
<NAME>Cluster-randomised</NAME>
<DICH_DATA CI_END="8.763926831284566" CI_START="0.2508662120935615" EFFECT_SIZE="1.4827586206896552" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.942698743044075" LOG_CI_START="-0.6005578276828142" LOG_EFFECT_SIZE="0.17107045768063045" MODIFIED="2013-07-17 04:18:36 +0100" MODIFIED_BY="[Empty name]" ORDER="280" O_E="0.0" SE="0.906516548888204" STUDY_ID="STD-Hungary-1988" TOTAL_1="174" TOTAL_2="172" VAR="0.8217722534081795" WEIGHT="4.900017014753145"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="2.1547262994001017" CI_END="1.0677656472593606" CI_START="0.5440368050624227" CI_STUDY="95" CI_TOTAL="95" DF="2" EFFECT_MEASURE="RR" EFFECT_SIZE="0.7621704607831455" ESTIMABLE="YES" EVENTS_1="53" EVENTS_2="71" I2="7.18078669403066" I2_Q="48.29189536602844" ID="CMP-002.02" LOG_CI_END="0.028475944386949253" LOG_CI_START="-0.264371718509866" LOG_EFFECT_SIZE="-0.11794788706145835" METHOD="MH" MODIFIED="2014-01-14 03:37:17 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.3404923887840554" P_Q="0.16432908575013772" P_Z="0.1143824626089458" Q="1.9339328081714542" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="3" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="639" TOTAL_2="652" WEIGHT="100.0" Z="1.578797716234534">
<NAME>Small-for-gestational age (&lt; 10th percentile)</NAME>
<GROUP_LABEL_1>Magnesium</GROUP_LABEL_1>
<GROUP_LABEL_2>No magnesium</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours magnesium</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours no magnesium</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.19915844338265337" CI_END="1.3499068668963339" CI_START="0.5975954809138238" DF="1" EFFECT_SIZE="0.8981638176367314" ESTIMABLE="YES" EVENTS_1="39" EVENTS_2="45" I2="0.0" ID="CMP-002.02.01" LOG_CI_END="0.1303038065777884" LOG_CI_START="-0.2235926953653657" LOG_EFFECT_SIZE="-0.04664444439378867" MODIFIED="2013-07-17 04:19:54 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.6554009952975497" P_Z="0.6053960991811218" STUDIES="2" TAU2="0.0" TOTAL_1="465" TOTAL_2="480" WEIGHT="62.83232605020677" Z="0.5166563138586315">
<NAME>Individually-randomised</NAME>
<DICH_DATA CI_END="1.7657653791687549" CI_START="0.32886186708370624" EFFECT_SIZE="0.7620320855614974" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="12" LOG_CI_END="0.24693299748531183" LOG_CI_START="-0.48298648186925175" LOG_EFFECT_SIZE="-0.11802674219196993" MODIFIED="2013-07-17 04:19:54 +0100" MODIFIED_BY="[Empty name]" ORDER="286" O_E="0.0" SE="0.42875831533256575" STUDY_ID="STD-Memphis-1989" TOTAL_1="187" TOTAL_2="190" VAR="0.1838336929668199" WEIGHT="16.92000112503093"/>
<DICH_DATA CI_END="1.5116513056621947" CI_START="0.594934850588031" EFFECT_SIZE="0.9483322432962721" ESTIMABLE="YES" EVENTS_1="30" EVENTS_2="33" LOG_CI_END="0.17945162351214686" LOG_CI_START="-0.22553058986683733" LOG_EFFECT_SIZE="-0.023039483177345225" MODIFIED="2013-07-17 04:19:54 +0100" MODIFIED_BY="[Empty name]" ORDER="287" O_E="0.0" SE="0.23788855683310284" STUDY_ID="STD-Zurich-1988" TOTAL_1="278" TOTAL_2="290" VAR="0.05659096547213639" WEIGHT="45.91232492517584"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.9841222934249256" CI_START="0.28788477839979576" DF="0" EFFECT_SIZE="0.5322723253757736" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="26" I2="0.0" ID="CMP-002.02.02" LOG_CI_END="-0.006950929963475167" LOG_CI_START="-0.5407812973717863" LOG_EFFECT_SIZE="-0.27386611366763075" MODIFIED="2013-07-17 04:19:38 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Z="0.0443249482323083" STUDIES="1" TAU2="0.0" TOTAL_1="174" TOTAL_2="172" WEIGHT="37.167673949793226" Z="2.011004814059037">
<NAME>Cluster-randomised</NAME>
<DICH_DATA CI_END="0.9841222934249257" CI_START="0.2878847783997957" EFFECT_SIZE="0.5322723253757736" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="26" LOG_CI_END="-0.006950929963475118" LOG_CI_START="-0.5407812973717864" LOG_EFFECT_SIZE="-0.27386611366763075" MODIFIED="2013-07-17 04:19:38 +0100" MODIFIED_BY="[Empty name]" ORDER="285" O_E="0.0" SE="0.3135746003185784" STUDY_ID="STD-South-Africa-2007" TOTAL_1="174" TOTAL_2="172" VAR="0.0983290299649562" WEIGHT="37.167673949793226"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-003" MODIFIED="2014-01-21 04:55:43 +0000" MODIFIED_BY="[Empty name]" NO="3">
<NAME>Sensitivity analysis based on the ICC</NAME>
<DICH_OUTCOME CHI2="1.5215709808683524" CI_END="1.3841841447114023" CI_START="0.860604586141234" CI_STUDY="95" CI_TOTAL="95" DF="14" EFFECT_MEASURE="RR" EFFECT_SIZE="1.0914372281549747" ESTIMABLE="YES" EVENTS_1="137" EVENTS_2="128" I2="0.0" I2_Q="0.0" ID="CMP-003.01" LOG_CI_END="0.1411938702596105" LOG_CI_START="-0.06519634390240102" LOG_EFFECT_SIZE="0.03799876317860472" METHOD="MH" MODIFIED="2014-01-21 04:55:43 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.9999849030947993" P_Q="0.9997476698293978" P_Z="0.47047716864982847" Q="5.047240277898402E-4" RANDOM="NO" SCALE="16.992414634880884" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="SUB" TOTAL_1="9161" TOTAL_2="9346" WEIGHT="300.0" Z="0.7217028926446091">
<NAME>Perinatal mortality</NAME>
<GROUP_LABEL_1>Magnesium</GROUP_LABEL_1>
<GROUP_LABEL_2>No magnesium</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours magnesium</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours no magnesium</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.47004762063465366" CI_END="1.6327461293735777" CI_START="0.7255585303623889" DF="4" EFFECT_SIZE="1.0884176046367369" ESTIMABLE="YES" EVENTS_1="47" EVENTS_2="44" I2="0.0" ID="CMP-003.01.01" LOG_CI_END="0.2129186628852891" LOG_CI_START="-0.1393275475431337" LOG_EFFECT_SIZE="0.03679555767107773" MODIFIED="2013-09-04 01:30:07 +0100" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.9763505819406327" P_Z="0.6821912802403884" STUDIES="5" TAU2="0.0" TOTAL_1="3141" TOTAL_2="3202" WEIGHT="100.0" Z="0.4094747690183221">
<NAME>ICC: 0.0002</NAME>
<DICH_DATA CI_END="7.04666099030381" CI_START="0.14191118337834013" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.8479833784105825" LOG_CI_START="-0.8479833784105826" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-07-17 08:35:41 +0100" MODIFIED_BY="[Empty name]" ORDER="325" O_E="0.0" SE="0.9962192681275941" STUDY_ID="STD-Austria-1997" TOTAL_1="265" TOTAL_2="265" VAR="0.9924528301886792" WEIGHT="4.538646461926429"/>
<DICH_DATA CI_END="3.860109008563871" CI_START="0.365529343484983" EFFECT_SIZE="1.1878481012658229" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="5" LOG_CI_END="0.5865995692182063" LOG_CI_START="-0.43707775358414347" LOG_EFFECT_SIZE="0.07476090781703143" MODIFIED="2013-07-21 22:58:41 +0100" MODIFIED_BY="[Empty name]" ORDER="326" O_E="0.0" SE="0.6013131266985723" STUDY_ID="STD-Hungary-1988" TOTAL_1="395" TOTAL_2="391" VAR="0.3615774763400132" WEIGHT="11.404359748479257"/>
<DICH_DATA CI_END="16.124834277434395" CI_START="0.06402192509700207" EFFECT_SIZE="1.0160427807486632" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.2074952598799804" LOG_CI_START="-1.1936712710473203" LOG_EFFECT_SIZE="0.006911994416330019" MODIFIED="2013-07-17 08:35:41 +0100" MODIFIED_BY="[Empty name]" ORDER="327" O_E="0.0" SE="1.410457106232719" STUDY_ID="STD-Memphis-1989" TOTAL_1="187" TOTAL_2="190" VAR="1.9893892485223754" WEIGHT="2.2512649559157616"/>
<DICH_DATA CI_END="1.6596600463332982" CI_START="0.6684345448630188" EFFECT_SIZE="1.0532682980599648" ESTIMABLE="YES" EVENTS_1="37" EVENTS_2="36" LOG_CI_END="0.22001913917179342" LOG_CI_START="-0.17494111375214969" LOG_EFFECT_SIZE="0.022539012709821855" MODIFIED="2013-09-04 01:30:07 +0100" MODIFIED_BY="[Empty name]" ORDER="328" O_E="0.0" SE="0.23200160765230735" STUDY_ID="STD-South-Africa-2007" TOTAL_1="2016" TOTAL_2="2066" VAR="0.05382474595325515" WEIGHT="80.69495483115445"/>
<DICH_DATA CI_END="76.48660199368314" CI_START="0.12800729300037317" EFFECT_SIZE="3.129032258064516" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.883585367313023" LOG_CI_START="-0.8927652864490786" LOG_EFFECT_SIZE="0.4954100404319722" MODIFIED="2013-07-17 08:35:41 +0100" MODIFIED_BY="[Empty name]" ORDER="329" O_E="0.0" SE="1.6308421171772414" STUDY_ID="STD-Zurich-1988" TOTAL_1="278" TOTAL_2="290" VAR="2.659646011159147" WEIGHT="1.1107740025240997"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.48552137973434684" CI_END="1.6434026967523145" CI_START="0.7237325671007039" DF="4" EFFECT_SIZE="1.090588855848423" ESTIMABLE="YES" EVENTS_1="46" EVENTS_2="43" I2="0.0" ID="CMP-003.01.02" LOG_CI_END="0.2157439952965367" LOG_CI_START="-0.14042188420150287" LOG_EFFECT_SIZE="0.03766105554751691" MODIFIED="2013-09-04 01:30:09 +0100" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.9748950898307571" P_Z="0.6785123512136894" STUDIES="5" TAU2="0.0" TOTAL_1="3100" TOTAL_2="3161" WEIGHT="100.0" Z="0.41449401383942425">
<NAME>ICC: 0.002</NAME>
<DICH_DATA CI_END="7.04666099030381" CI_START="0.14191118337834013" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.8479833784105825" LOG_CI_START="-0.8479833784105826" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-07-17 08:35:18 +0100" MODIFIED_BY="[Empty name]" ORDER="315" O_E="0.0" SE="0.9962192681275941" STUDY_ID="STD-Austria-1997" TOTAL_1="265" TOTAL_2="265" VAR="0.9924528301886792" WEIGHT="4.644327735331805"/>
<DICH_DATA CI_END="4.564169471363371" CI_START="0.3346476879955572" EFFECT_SIZE="1.2358757062146892" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="4" LOG_CI_END="0.6593617617565873" LOG_CI_START="-0.4754121710914989" LOG_EFFECT_SIZE="0.09197479533254421" MODIFIED="2013-07-17 08:36:32 +0100" MODIFIED_BY="[Empty name]" ORDER="316" O_E="0.0" SE="0.6665718253765269" STUDY_ID="STD-Hungary-1988" TOTAL_1="354" TOTAL_2="350" VAR="0.44431799838579505" WEIGHT="9.34143192220147"/>
<DICH_DATA CI_END="16.124834277434395" CI_START="0.06402192509700207" EFFECT_SIZE="1.0160427807486632" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.2074952598799804" LOG_CI_START="-1.1936712710473203" LOG_EFFECT_SIZE="0.006911994416330019" MODIFIED="2013-07-17 08:35:22 +0100" MODIFIED_BY="[Empty name]" ORDER="317" O_E="0.0" SE="1.410457106232719" STUDY_ID="STD-Memphis-1989" TOTAL_1="187" TOTAL_2="190" VAR="1.9893892485223754" WEIGHT="2.3036851100982694"/>
<DICH_DATA CI_END="1.6596600463332982" CI_START="0.6684345448630188" EFFECT_SIZE="1.0532682980599648" ESTIMABLE="YES" EVENTS_1="37" EVENTS_2="36" LOG_CI_END="0.22001913917179342" LOG_CI_START="-0.17494111375214969" LOG_EFFECT_SIZE="0.022539012709821855" MODIFIED="2013-09-04 01:30:09 +0100" MODIFIED_BY="[Empty name]" ORDER="318" O_E="0.0" SE="0.23200160765230735" STUDY_ID="STD-South-Africa-2007" TOTAL_1="2016" TOTAL_2="2066" VAR="0.05382474595325515" WEIGHT="82.57391712872148"/>
<DICH_DATA CI_END="76.48660199368314" CI_START="0.12800729300037317" EFFECT_SIZE="3.129032258064516" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.883585367313023" LOG_CI_START="-0.8927652864490786" LOG_EFFECT_SIZE="0.4954100404319722" MODIFIED="2013-07-17 08:35:12 +0100" MODIFIED_BY="[Empty name]" ORDER="319" O_E="0.0" SE="1.6308421171772414" STUDY_ID="STD-Zurich-1988" TOTAL_1="278" TOTAL_2="290" VAR="2.659646011159147" WEIGHT="1.1366381036469944"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.5655974449207929" CI_END="1.6665180825953376" CI_START="0.7202263786543308" DF="4" EFFECT_SIZE="1.0955684750802201" ESTIMABLE="YES" EVENTS_1="44" EVENTS_2="41" I2="0.0" ID="CMP-003.01.03" LOG_CI_END="0.22181003034504448" LOG_CI_START="-0.14253097641902318" LOG_EFFECT_SIZE="0.03963952696301064" MODIFIED="2013-09-04 01:30:12 +0100" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.9668088209498874" P_Z="0.6697582438693307" STUDIES="5" TAU2="0.0" TOTAL_1="2920" TOTAL_2="2983" WEIGHT="100.00000000000001" Z="0.4264798294418473">
<NAME>ICC: 0.02</NAME>
<DICH_DATA CI_END="7.04666099030381" CI_START="0.14191118337834013" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.8479833784105825" LOG_CI_START="-0.8479833784105826" LOG_EFFECT_SIZE="0.0" MODIFIED="2013-07-17 08:35:40 +0100" MODIFIED_BY="[Empty name]" ORDER="320" O_E="0.0" SE="0.9962192681275941" STUDY_ID="STD-Austria-1997" TOTAL_1="265" TOTAL_2="265" VAR="0.9924528301886792" WEIGHT="4.8718559974269775"/>
<DICH_DATA CI_END="8.763926831284566" CI_START="0.2508662120935615" EFFECT_SIZE="1.4827586206896552" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.942698743044075" LOG_CI_START="-0.6005578276828142" LOG_EFFECT_SIZE="0.17107045768063045" MODIFIED="2013-07-17 08:36:00 +0100" MODIFIED_BY="[Empty name]" ORDER="321" O_E="0.0" SE="0.906516548888204" STUDY_ID="STD-Hungary-1988" TOTAL_1="174" TOTAL_2="172" VAR="0.8217722534081795" WEIGHT="4.900017014753145"/>
<DICH_DATA CI_END="16.124834277434395" CI_START="0.06402192509700207" EFFECT_SIZE="1.0160427807486632" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.2074952598799804" LOG_CI_START="-1.1936712710473203" LOG_EFFECT_SIZE="0.006911994416330019" MODIFIED="2013-07-17 08:35:40 +0100" MODIFIED_BY="[Empty name]" ORDER="322" O_E="0.0" SE="1.410457106232719" STUDY_ID="STD-Memphis-1989" TOTAL_1="187" TOTAL_2="190" VAR="1.9893892485223754" WEIGHT="2.416543956283408"/>
<DICH_DATA CI_END="1.6596600463332982" CI_START="0.6684345448630188" EFFECT_SIZE="1.0532682980599648" ESTIMABLE="YES" EVENTS_1="37" EVENTS_2="36" LOG_CI_END="0.22001913917179342" LOG_CI_START="-0.17494111375214969" LOG_EFFECT_SIZE="0.022539012709821855" MODIFIED="2013-09-04 01:30:12 +0100" MODIFIED_BY="[Empty name]" ORDER="323" O_E="0.0" SE="0.23200160765230735" STUDY_ID="STD-South-Africa-2007" TOTAL_1="2016" TOTAL_2="2066" VAR="0.05382474595325515" WEIGHT="86.61926037953462"/>
<DICH_DATA CI_END="76.48660199368314" CI_START="0.12800729300037317" EFFECT_SIZE="3.129032258064516" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.883585367313023" LOG_CI_START="-0.8927652864490786" LOG_EFFECT_SIZE="0.4954100404319722" MODIFIED="2013-07-17 08:35:40 +0100" MODIFIED_BY="[Empty name]" ORDER="324" O_E="0.0" SE="1.6308421171772414" STUDY_ID="STD-Zurich-1988" TOTAL_1="278" TOTAL_2="290" VAR="2.659646011159147" WEIGHT="1.1923226520018657"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.645178559932971" CI_END="1.0052959252944593" CI_START="0.5515377922145567" CI_STUDY="95" CI_TOTAL="95" DF="8" EFFECT_MEASURE="RR" EFFECT_SIZE="0.7446198326389084" ESTIMABLE="YES" EVENTS_1="73" EVENTS_2="100" I2="0.0" I2_Q="0.0" ID="CMP-003.02" LOG_CI_END="0.002293922258785476" LOG_CI_START="-0.2584247236808935" LOG_EFFECT_SIZE="-0.128065400711054" METHOD="MH" MODIFIED="2014-01-14 04:30:41 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.9996509214331185" P_Q="0.9980491983379032" P_Z="0.05417000315889801" Q="0.0039054163910695987" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="8600" TOTAL_2="8776" WEIGHT="100.0" Z="1.9254746598939414">
<NAME>Stillbirth</NAME>
<GROUP_LABEL_1>Magnesium</GROUP_LABEL_1>
<GROUP_LABEL_2>No magnesium</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours magnesium</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours no magnesium</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.24202414782632384" CI_END="1.2528942582793392" CI_START="0.4484155179878271" DF="2" EFFECT_SIZE="0.7495446803295347" ESTIMABLE="YES" EVENTS_1="25" EVENTS_2="34" I2="0.0" ID="CMP-003.02.01" LOG_CI_END="0.09791441897209004" LOG_CI_START="-0.3483193665055438" LOG_EFFECT_SIZE="-0.12520247376672686" MODIFIED="2014-01-14 04:30:34 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.8860232656926265" P_Z="0.27140292047127734" STUDIES="4" TAU2="0.0" TOTAL_1="2954" TOTAL_2="3012" WEIGHT="34.00951772445635" Z="1.099837562032403">
<NAME>ICC: 0.0002</NAME>
<DICH_DATA CI_END="7.04666099030381" CI_START="0.14191118337834013" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.8479833784105825" LOG_CI_START="-0.8479833784105826" LOG_EFFECT_SIZE="0.0" MODIFIED="2014-01-14 04:30:34 +0000" MODIFIED_BY="[Empty name]" ORDER="307" O_E="0.0" SE="0.9962192681275941" STUDY_ID="STD-Austria-1997" TOTAL_1="265" TOTAL_2="265" VAR="0.9924528301886792" WEIGHT="2.0207645911480188"/>
<DICH_DATA CI_END="4.874442783174687" CI_START="0.2010177217576267" EFFECT_SIZE="0.9898734177215189" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="3" LOG_CI_END="0.6879249769527709" LOG_CI_START="-0.6967656534139578" LOG_EFFECT_SIZE="-0.004420338230593449" MODIFIED="2014-01-14 04:30:34 +0000" MODIFIED_BY="[Empty name]" ORDER="308" O_E="0.0" SE="0.8133741306065819" STUDY_ID="STD-Hungary-1988" TOTAL_1="395" TOTAL_2="391" VAR="0.6615774763400131" WEIGHT="3.0465725706239213"/>
<DICH_DATA CI_END="1.2452085142050775" CI_START="0.4011451010704584" EFFECT_SIZE="0.706759715380405" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="29" LOG_CI_END="0.0952420815411887" LOG_CI_START="-0.39669850719091027" LOG_EFFECT_SIZE="-0.1507282128248608" MODIFIED="2014-01-14 04:30:34 +0000" MODIFIED_BY="[Empty name]" ORDER="309" O_E="0.0" SE="0.28896833696642266" STUDY_ID="STD-South-Africa-2007" TOTAL_1="2016" TOTAL_2="2066" VAR="0.08350269976914" WEIGHT="28.942180562684413"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2014-01-14 04:30:34 +0000" MODIFIED_BY="[Empty name]" ORDER="310" O_E="0.0" SE="0.0" STUDY_ID="STD-Zurich-1988" TOTAL_1="278" TOTAL_2="290" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.24113507119398667" CI_END="1.252715814809887" CI_START="0.44836879768376287" DF="2" EFFECT_SIZE="0.7494522558013581" ESTIMABLE="YES" EVENTS_1="25" EVENTS_2="34" I2="0.0" ID="CMP-003.02.02" LOG_CI_END="0.09785256017364558" LOG_CI_START="-0.34836461789969" LOG_EFFECT_SIZE="-0.12525602886302223" MODIFIED="2014-01-14 04:30:37 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.8864172244554931" P_Z="0.27118012209236975" STUDIES="4" TAU2="0.0" TOTAL_1="2913" TOTAL_2="2971" WEIGHT="34.011314466047196" Z="1.1003489667432111">
<NAME>ICC: 0.002</NAME>
<DICH_DATA CI_END="7.04666099030381" CI_START="0.14191118337834013" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.8479833784105825" LOG_CI_START="-0.8479833784105826" LOG_EFFECT_SIZE="0.0" MODIFIED="2014-01-14 04:30:37 +0000" MODIFIED_BY="[Empty name]" ORDER="311" O_E="0.0" SE="0.9962192681275941" STUDY_ID="STD-Austria-1997" TOTAL_1="265" TOTAL_2="265" VAR="0.9924528301886792" WEIGHT="2.0207645911480188"/>
<DICH_DATA CI_END="4.865190359142931" CI_START="0.20092303384150945" EFFECT_SIZE="0.9887005649717514" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="3" LOG_CI_END="0.6870998374734336" LOG_CI_START="-0.696970272824458" LOG_EFFECT_SIZE="-0.00493521767551219" MODIFIED="2014-01-14 04:30:37 +0000" MODIFIED_BY="[Empty name]" ORDER="312" O_E="0.0" SE="0.8130096340465232" STUDY_ID="STD-Hungary-1988" TOTAL_1="354" TOTAL_2="350" VAR="0.6609846650524616" WEIGHT="3.048369312214767"/>
<DICH_DATA CI_END="1.2452085142050775" CI_START="0.4011451010704584" EFFECT_SIZE="0.706759715380405" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="29" LOG_CI_END="0.0952420815411887" LOG_CI_START="-0.39669850719091027" LOG_EFFECT_SIZE="-0.1507282128248608" MODIFIED="2014-01-14 04:30:37 +0000" MODIFIED_BY="[Empty name]" ORDER="313" O_E="0.0" SE="0.28896833696642266" STUDY_ID="STD-South-Africa-2007" TOTAL_1="2016" TOTAL_2="2066" VAR="0.08350269976914" WEIGHT="28.942180562684413"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2014-01-14 04:30:37 +0000" MODIFIED_BY="[Empty name]" ORDER="314" O_E="0.0" SE="0.0" STUDY_ID="STD-Zurich-1988" TOTAL_1="278" TOTAL_2="290" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.15805019065779827" CI_END="1.2510986048055455" CI_START="0.43091127454606654" DF="2" EFFECT_SIZE="0.734242803423747" ESTIMABLE="YES" EVENTS_1="23" EVENTS_2="32" I2="0.0" ID="CMP-003.02.03" LOG_CI_END="0.09729153977762005" LOG_CI_START="-0.36561214269723125" LOG_EFFECT_SIZE="-0.13416030145980556" MODIFIED="2014-01-14 04:30:41 +0000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.9240167596977805" P_Z="0.2559202987178877" STUDIES="4" TAU2="0.0" TOTAL_1="2733" TOTAL_2="2793" WEIGHT="31.979167809496467" Z="1.136086702142582">
<NAME>ICC: 0.02</NAME>
<DICH_DATA CI_END="7.04666099030381" CI_START="0.14191118337834013" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.8479833784105825" LOG_CI_START="-0.8479833784105826" LOG_EFFECT_SIZE="0.0" MODIFIED="2014-01-14 04:30:41 +0000" MODIFIED_BY="[Empty name]" ORDER="315" O_E="0.0" SE="0.9962192681275941" STUDY_ID="STD-Austria-1997" TOTAL_1="265" TOTAL_2="265" VAR="0.9924528301886792" WEIGHT="2.0207645911480188"/>
<DICH_DATA CI_END="15.677458916680134" CI_START="0.06232793319983488" EFFECT_SIZE="0.9885057471264368" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1952756713652637" LOG_CI_START="-1.2053172741153653" LOG_EFFECT_SIZE="-0.005020801375050797" MODIFIED="2014-01-14 04:30:41 +0000" MODIFIED_BY="[Empty name]" ORDER="316" O_E="0.0" SE="1.4101201793020501" STUDY_ID="STD-Hungary-1988" TOTAL_1="174" TOTAL_2="172" VAR="1.9884389200748462" WEIGHT="1.0162226556640326"/>
<DICH_DATA CI_END="1.2452085142050775" CI_START="0.4011451010704584" EFFECT_SIZE="0.706759715380405" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="29" LOG_CI_END="0.0952420815411887" LOG_CI_START="-0.39669850719091027" LOG_EFFECT_SIZE="-0.1507282128248608" MODIFIED="2014-01-14 04:30:41 +0000" MODIFIED_BY="[Empty name]" ORDER="317" O_E="0.0" SE="0.28896833696642266" STUDY_ID="STD-South-Africa-2007" TOTAL_1="2016" TOTAL_2="2066" VAR="0.08350269976914" WEIGHT="28.942180562684413"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" MODIFIED="2014-01-14 04:30:41 +0000" MODIFIED_BY="[Empty name]" ORDER="318" O_E="0.0" SE="0.0" STUDY_ID="STD-Zurich-1988" TOTAL_1="278" TOTAL_2="290" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="1.9619051077302367" CI_END="3.362576057879283" CI_START="1.4278325240310612" CI_STUDY="95" CI_TOTAL="95" DF="11" EFFECT_MEASURE="RR" EFFECT_SIZE="2.1911630381987077" ESTIMABLE="YES" EVENTS_1="64" EVENTS_2="29" I2="0.0" I2_Q="0.0" ID="CMP-003.03" LOG_CI_END="0.5266721163989272" LOG_CI_START="0.15467727035709286" LOG_EFFECT_SIZE="0.34067469337801" METHOD="MH" MODIFIED="2014-01-21 03:58:57 +0000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.9986253528321047" P_Q="0.9997768516186076" P_Z="3.308186230640413E-4" Q="4.463465690992476E-4" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="8366" TOTAL_2="8551" WEIGHT="100.0" Z="3.5898891426578285">
<NAME>Neonatal death prior to hospital discharge</NAME>
<GROUP_LABEL_1>Magnesium</GROUP_LABEL_1>
<GROUP_LABEL_2>No magnesium</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours magnesium</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours no magnesium</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.6078198460937141" CI_END="4.5339986365459755" CI_START="1.052566161167455" DF="3" EFFECT_SIZE="2.184567128656767" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="10" I2="0.0" ID="CMP-003.03.01" LOG_CI_END="0.6564813851904439" LOG_CI_START="0.02224940382065058" LOG_EFFECT_SIZE="0.33936539450554715" MODIFIED="2014-01-14 04:32:43 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.8946398953220027" P_Z="0.03595124449381546" STUDIES="4" TAU2="0.0" TOTAL_1="2876" TOTAL_2="2937" WEIGHT="34.44009496784483" Z="2.0974784317673283">
<NAME>ICC: 0.0002</NAME>
<DICH_DATA CI_END="8.83754700877319" CI_START="0.24946527693857526" EFFECT_SIZE="1.4848101265822784" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.9463317369148851" LOG_CI_START="-0.6029898952647096" LOG_EFFECT_SIZE="0.17167092082508778" MODIFIED="2014-01-14 04:32:16 +0000" MODIFIED_BY="[Empty name]" ORDER="319" O_E="0.0" SE="0.9100791960080615" STUDY_ID="STD-Hungary-1988" TOTAL_1="395" TOTAL_2="391" VAR="0.8282441430066797" WEIGHT="6.652992972705274"/>
<DICH_DATA CI_END="16.124834277434395" CI_START="0.06402192509700207" EFFECT_SIZE="1.0160427807486632" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.2074952598799804" LOG_CI_START="-1.1936712710473203" LOG_EFFECT_SIZE="0.006911994416330019" MODIFIED="2014-01-14 04:32:16 +0000" MODIFIED_BY="[Empty name]" ORDER="320" O_E="0.0" SE="1.410457106232719" STUDY_ID="STD-Memphis-1989" TOTAL_1="187" TOTAL_2="190" VAR="1.9893892485223754" WEIGHT="3.2833167011857993"/>
<DICH_DATA CI_END="5.988606051962803" CI_START="1.0343216057786768" EFFECT_SIZE="2.4888038548752833" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="7" LOG_CI_END="0.777325744861472" LOG_CI_START="0.014655596686790229" LOG_EFFECT_SIZE="0.3959906707741312" MODIFIED="2014-01-14 04:32:43 +0000" MODIFIED_BY="[Empty name]" ORDER="321" O_E="0.0" SE="0.44799622031592845" STUDY_ID="STD-South-Africa-2007" TOTAL_1="2016" TOTAL_2="2066" VAR="0.20070061341735793" WEIGHT="22.883797018408085"/>
<DICH_DATA CI_END="76.48660199368314" CI_START="0.12800729300037317" EFFECT_SIZE="3.129032258064516" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.883585367313023" LOG_CI_START="-0.8927652864490786" LOG_EFFECT_SIZE="0.4954100404319722" MODIFIED="2014-01-14 04:32:16 +0000" MODIFIED_BY="[Empty name]" ORDER="322" O_E="0.0" SE="1.6308421171772414" STUDY_ID="STD-Zurich-1988" TOTAL_1="278" TOTAL_2="290" VAR="2.659646011159147" WEIGHT="1.61998827554567"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.6090308142992921" CI_END="4.532887559706188" CI_START="1.0524196381178343" DF="3" EFFECT_SIZE="2.184147404644389" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="10" I2="0.0" ID="CMP-003.03.02" LOG_CI_END="0.6563749463243411" LOG_CI_START="0.02218894341084992" LOG_EFFECT_SIZE="0.33928194486759555" MODIFIED="2014-01-14 04:32:45 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.8943619058351332" P_Z="0.0359834235859902" STUDIES="4" TAU2="0.0" TOTAL_1="2835" TOTAL_2="2896" WEIGHT="34.444018625955884" Z="2.0971146934502776">
<NAME>ICC: 0.002</NAME>
<DICH_DATA CI_END="8.821441901724917" CI_START="0.24932883315988447" EFFECT_SIZE="1.4830508474576272" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.9455395781909428" LOG_CI_START="-0.6032274954306047" LOG_EFFECT_SIZE="0.17115604138016907" MODIFIED="2014-01-14 04:32:19 +0000" MODIFIED_BY="[Empty name]" ORDER="323" O_E="0.0" SE="0.9097534455659556" STUDY_ID="STD-Hungary-1988" TOTAL_1="354" TOTAL_2="350" VAR="0.8276513317191282" WEIGHT="6.656916630816334"/>
<DICH_DATA CI_END="16.124834277434395" CI_START="0.06402192509700207" EFFECT_SIZE="1.0160427807486632" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.2074952598799804" LOG_CI_START="-1.1936712710473203" LOG_EFFECT_SIZE="0.006911994416330019" MODIFIED="2014-01-14 04:32:19 +0000" MODIFIED_BY="[Empty name]" ORDER="324" O_E="0.0" SE="1.410457106232719" STUDY_ID="STD-Memphis-1989" TOTAL_1="187" TOTAL_2="190" VAR="1.9893892485223754" WEIGHT="3.2833167011857993"/>
<DICH_DATA CI_END="5.988606051962803" CI_START="1.0343216057786768" EFFECT_SIZE="2.4888038548752833" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="7" LOG_CI_END="0.777325744861472" LOG_CI_START="0.014655596686790229" LOG_EFFECT_SIZE="0.3959906707741312" MODIFIED="2014-01-14 04:32:45 +0000" MODIFIED_BY="[Empty name]" ORDER="325" O_E="0.0" SE="0.44799622031592845" STUDY_ID="STD-South-Africa-2007" TOTAL_1="2016" TOTAL_2="2066" VAR="0.20070061341735793" WEIGHT="22.883797018408085"/>
<DICH_DATA CI_END="76.48660199368314" CI_START="0.12800729300037317" EFFECT_SIZE="3.129032258064516" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.883585367313023" LOG_CI_START="-0.8927652864490786" LOG_EFFECT_SIZE="0.4954100404319722" MODIFIED="2014-01-14 04:32:19 +0000" MODIFIED_BY="[Empty name]" ORDER="326" O_E="0.0" SE="1.6308421171772414" STUDY_ID="STD-Zurich-1988" TOTAL_1="278" TOTAL_2="290" VAR="2.659646011159147" WEIGHT="1.61998827554567"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.7446364115718012" CI_END="4.7499049372418085" CI_START="1.024746651835197" DF="3" EFFECT_SIZE="2.2062296301550335" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="9" I2="0.0" ID="CMP-003.03.03" LOG_CI_END="0.676684917910246" LOG_CI_START="0.010616508016230127" LOG_EFFECT_SIZE="0.3436507129632381" MODIFIED="2014-01-14 04:32:46 +0000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.8626581447452887" P_Z="0.043130506133748955" STUDIES="4" TAU2="0.0" TOTAL_1="2655" TOTAL_2="2718" WEIGHT="31.115886406199277" Z="2.0224439732147994">
<NAME>ICC: 0.02</NAME>
<DICH_DATA CI_END="15.677458916680134" CI_START="0.06232793319983488" EFFECT_SIZE="0.9885057471264368" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.1952756713652637" LOG_CI_START="-1.2053172741153653" LOG_EFFECT_SIZE="-0.005020801375050797" MODIFIED="2014-01-14 04:32:36 +0000" MODIFIED_BY="[Empty name]" ORDER="327" O_E="0.0" SE="1.4101201793020501" STUDY_ID="STD-Hungary-1988" TOTAL_1="174" TOTAL_2="172" VAR="1.9884389200748462" WEIGHT="3.328784411059721"/>
<DICH_DATA CI_END="16.124834277434395" CI_START="0.06402192509700207" EFFECT_SIZE="1.0160427807486632" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.2074952598799804" LOG_CI_START="-1.1936712710473203" LOG_EFFECT_SIZE="0.006911994416330019" MODIFIED="2014-01-14 04:32:36 +0000" MODIFIED_BY="[Empty name]" ORDER="328" O_E="0.0" SE="1.410457106232719" STUDY_ID="STD-Memphis-1989" TOTAL_1="187" TOTAL_2="190" VAR="1.9893892485223754" WEIGHT="3.2833167011857993"/>
<DICH_DATA CI_END="5.988606051962803" CI_START="1.0343216057786768" EFFECT_SIZE="2.4888038548752833" ESTIMABLE="YES" EVENTS_1="17" EVENTS_2="7" LOG_CI_END="0.777325744861472" LOG_CI_START="0.014655596686790229" LOG_EFFECT_SIZE="0.3959906707741312" MODIFIED="2014-01-14 04:32:46 +0000" MODIFIED_BY="[Empty name]" ORDER="329" O_E="0.0" SE="0.44799622031592845" STUDY_ID="STD-South-Africa-2007" TOTAL_1="2016" TOTAL_2="2066" VAR="0.20070061341735793" WEIGHT="22.883797018408085"/>
<DICH_DATA CI_END="76.48660199368314" CI_START="0.12800729300037317" EFFECT_SIZE="3.129032258064516" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.883585367313023" LOG_CI_START="-0.8927652864490786" LOG_EFFECT_SIZE="0.4954100404319722" MODIFIED="2014-01-14 04:32:36 +0000" MODIFIED_BY="[Empty name]" ORDER="330" O_E="0.0" SE="1.6308421171772414" STUDY_ID="STD-Zurich-1988" TOTAL_1="278" TOTAL_2="290" VAR="2.659646011159147" WEIGHT="1.61998827554567"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
</COMPARISON>
<COMPARISON ID="CMP-004" MODIFIED="2014-01-21 03:58:57 +0000" MODIFIED_BY="[Empty name]" NO="4">
<NAME>Sensitivity analysis by quality rating</NAME>
<DICH_OUTCOME CHI2="6.3368231926857E-4" CI_END="1.64809955896406" CI_START="0.6718324682363351" CI_STUDY="95" CI_TOTAL="95" DF="1" EFFECT_MEASURE="RR" EFFECT_SIZE="1.0522579505986351" ESTIMABLE="YES" EVENTS_1="38" EVENTS_2="37" I2="0.0" I2_Q="0.0" ID="CMP-004.01" LOG_CI_END="0.2169834431637206" LOG_CI_START="-0.17273901145722784" LOG_EFFECT_SIZE="0.022122215853246373" METHOD="MH" MODIFIED="2014-01-21 03:58:57 +0000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.9799169356770613" P_Q="1.0" P_Z="0.8239161920643334" Q="0.0" RANDOM="NO" SCALE="100.0" SORT_BY="STUDY" STUDIES="2" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="2203" TOTAL_2="2256" WEIGHT="100.0" Z="0.22251089623642795">
<NAME>Perinatal mortality</NAME>
<GROUP_LABEL_1>Magnesium</GROUP_LABEL_1>
<GROUP_LABEL_2>No magnesium</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours magnesium</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours no magnesium</GRAPH_LABEL_2>
<DICH_DATA CI_END="16.124834277434395" CI_START="0.06402192509700207" EFFECT_SIZE="1.0160427807486632" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="1" LOG_CI_END="1.2074952598799804" LOG_CI_START="-1.1936712710473203" LOG_EFFECT_SIZE="0.006911994416330019" MODIFIED="2010-07-08 06:37:40 +0100" MODIFIED_BY="[Empty name]" ORDER="395" O_E="0.0" SE="1.410457106232719" STUDY_ID="STD-Memphis-1989" TOTAL_1="187" TOTAL_2="190" VAR="1.9893892485223754" WEIGHT="2.7141260466057937"/>
<DICH_DATA CI_END="1.6596600463332982" CI_START="0.6684345448630188" EFFECT_SIZE="1.0532682980599648" ESTIMABLE="YES" EVENTS_1="37" EVENTS_2="36" LOG_CI_END="0.22001913917179342" LOG_CI_START="-0.17494111375214969" LOG_EFFECT_SIZE="0.022539012709821855" MODIFIED="2013-09-04 01:30:30 +0100" MODIFIED_BY="[Empty name]" ORDER="397" O_E="0.0" SE="0.23200160765230735" STUDY_ID="STD-South-Africa-2007" TOTAL_1="2016" TOTAL_2="2066" VAR="0.05382474595325515" WEIGHT="97.2858739533942"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="1.7657653791687549" CI_START="0.32886186708370624" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.7620320855614974" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="12" I2="0.0" I2_Q="0.0" ID="CMP-004.02" LOG_CI_END="0.24693299748531183" LOG_CI_START="-0.48298648186925175" LOG_EFFECT_SIZE="-0.11802674219196993" METHOD="MH" MODIFIED="2014-01-14 03:37:03 +0000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="1.0" P_Q="1.0" P_Z="0.5261815250867082" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="187" TOTAL_2="190" WEIGHT="100.0" Z="0.6338457061411998">
<NAME>Small-for-gestational age (&lt; 10th percentile)</NAME>
<GROUP_LABEL_1>Magnesium</GROUP_LABEL_1>
<GROUP_LABEL_2>No magnesium</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours magnesium</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours no magnesium</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.7657653791687549" CI_START="0.32886186708370624" EFFECT_SIZE="0.7620320855614974" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="12" LOG_CI_END="0.24693299748531183" LOG_CI_START="-0.48298648186925175" LOG_EFFECT_SIZE="-0.11802674219196993" ORDER="594" O_E="0.0" SE="0.42875831533256575" STUDY_ID="STD-Memphis-1989" TOTAL_1="187" TOTAL_2="190" VAR="0.1838336929668199" WEIGHT="100.0"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.0" CI_END="1.4422273204057743" CI_START="0.6049372131220935" CI_STUDY="95" CI_TOTAL="95" DF="0" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9340540540540541" ESTIMABLE="YES" EVENTS_1="32" EVENTS_2="35" I2="0.0" I2_Q="0.0" ID="CMP-004.03" LOG_CI_END="0.15903371823162332" LOG_CI_START="-0.218289698751902" LOG_EFFECT_SIZE="-0.029627990260139316" METHOD="MH" MODIFIED="2014-01-21 03:58:57 +0000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Q="1.0" P_Z="0.7582356515365292" Q="0.0" RANDOM="NO" SCALE="10.0" SORT_BY="STUDY" STUDIES="1" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="185" TOTAL_2="189" WEIGHT="100.0" Z="0.30779851570522593">
<NAME>Pre-eclampsia</NAME>
<GROUP_LABEL_1>Magnesium</GROUP_LABEL_1>
<GROUP_LABEL_2>No magnesium</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours magnesium</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours no magnesium</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.4422273204057743" CI_START="0.6049372131220935" EFFECT_SIZE="0.9340540540540541" ESTIMABLE="YES" EVENTS_1="32" EVENTS_2="35" LOG_CI_END="0.15903371823162332" LOG_CI_START="-0.218289698751902" LOG_EFFECT_SIZE="-0.029627990260139316" ORDER="559" O_E="0.0" SE="0.22164164291716001" STUDY_ID="STD-Memphis-1989" TOTAL_1="185" TOTAL_2="189" VAR="0.04912501787501787" WEIGHT="100.0"/>
</DICH_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES MODIFIED="2014-03-20 10:01:38 +0000" MODIFIED_BY="Heather Maxwell">
<FIGURE FILENAME="Risk of bias graph.png" FILE_TYPE="PNG" ID="FIG-01" MODIFIED="2014-03-20 10:01:38 +0000" MODIFIED_BY="Heather Maxwell" NO="1" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_GRAPH_PLOT">
<CAPTION>
<P>'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAl4AAAEACAMAAABVk4iuAAADAFBMVEUAAADAAAAAwAAAAMDg4ADA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</FILE>
</FIGURE>
<FIGURE FILENAME="Risk of bias summary.png" FILE_TYPE="PNG" ID="FIG-02" MODIFIED="2014-03-20 10:01:38 +0000" MODIFIED_BY="Heather Maxwell" NO="2" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_TABLE_PLOT">
<CAPTION>
<P>'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study.</P>
</CAPTION>
<FILE>iVBORw0KGgoAAAANSUhEUgAAAUsAAAKBCAIAAABRTh6GAAAerklEQVR42u3dsW4dx/3FcQIB/kjB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</FILE>
</FIGURE>
</FIGURES>
<FEEDBACK MODIFIED="2013-08-27 12:29:57 +0100" MODIFIED_BY="[Empty name]">
<FEEDBACK_ITEM ID="FBK-01" MODIFIED="2013-08-27 12:29:57 +0100" MODIFIED_BY="[Empty name]" NO="1">
<TITLE>Gelband, April 2000</TITLE>
<DATE_SUBMITTED>
<DATE DAY="" MONTH="" YEAR=""/>
</DATE_SUBMITTED>
<FEEDBACK_SUMMARY>
<P>Methods of the review:<BR/>The largest trial in this review, Hungary 1998, was a cluster randomised trial with clinics as the unit of randomisation. The data appear to have been entered as though randomisation was by individual, without any adjustment for the cluster design. This is of particular concern as some results ware borderline for statistical significance, which might not be the case if the data were adjusted for cluster design.</P>
<P>[Summary of comments from Hellen Gelband, April 2000]</P>
</FEEDBACK_SUMMARY>
<FEEDBACK_REPLY MODIFIED="2013-08-27 12:29:57 +0100" MODIFIED_BY="[Empty name]">
<P>The review now includes two meta-analyses, one including the Hungrian trial and one excluding the Hungarian trial. We preferred this approach to the total exclusion of the Hungarian trial because it is the largest trial included in the review. When the Hungarian trial is excluded from the meta-analysis, three of six outcomes that were significantly different between treatment and placebo when all trials are included are no longer different. These outcomes are the frequency of preterm birth (&lt; 37 weeks' gestation), the frequency of low birthweight and the frequency of small for gestational age. These findings are discussed in the review.</P>
<P>[Summary of response from Maria Makrides, Caroline Crowther and Simon Gates, June 2001]</P>
</FEEDBACK_REPLY>
<FEEDBACK_CONTRIBUTORS>
<P>Hellen Gelband</P>
</FEEDBACK_CONTRIBUTORS>
</FEEDBACK_ITEM>
</FEEDBACK>
<APPENDICES MODIFIED="2014-03-20 09:30:02 +0000" MODIFIED_BY="Heather Maxwell">
<APPENDIX ID="APP-01" MODIFIED="2014-03-20 09:30:02 +0000" MODIFIED_BY="Heather Maxwell" NO="1">
<TITLE MODIFIED="2013-07-22 04:33:42 +0100" MODIFIED_BY="[Empty name]">Methods used in the previous version of this review</TITLE>
<APPENDIX_BODY MODIFIED="2014-03-20 09:30:02 +0000" MODIFIED_BY="Heather Maxwell">
<P>
<B>Search methods for identification of studies</B>
</P>
<P>
<B>Electronic searches</B>
</P>
<P>We searched the Cochrane Pregnancy and Childbirth Group&#8217;s Trials Register (June 2001). We updated this search on 1 October 2009 and added the results to Studies awaiting classification. The Cochrane Pregnancy and Childbirth Group&#8217;s Trials Register is maintained by the Trials Search Co-ordinator and contains trials identified from:</P>
<OL>
<LI>quarterly searches of the Cochrane Central Register of Controlled Trials (CENTRAL);</LI>
<LI>weekly searches of MEDLINE;</LI>
<LI>handsearches of 30 journals and the proceedings of major conferences</LI>
<LI>weekly current awareness alerts for a further 44 journals</LI>
<LI>plus monthly BioMed Central email alerts.</LI>
</OL>
<P>Details of the search strategies for CENTRAL and MEDLINE, the list of handsearched journals and conference proceedings, and the list of journals reviewed via the current awareness service can be found in the &#8216;Specialized Register&#8217; section within the editorial information about the Cochrane Pregnancy and Childbirth Group.</P>
<P>Trials identified through the searching activities described above are each assigned to a review topic (or topics). The Trials Search Co-ordinator searches the register for each review using the topic list rather than keywords.</P>
<P>In addition, we searched The Cochrane Controlled Trials Register using the terms: magnesium and pregnan* or pre-eclamp* or pre eclamp* or preeclamp* or hypertens* or preterm or premature. The Controlled Trials Register was last searched in June 2001. We did not apply any language restrictions.</P>
<P>
<B>Data collection and analysis</B>
</P>
<P>Included trial data were processed as described in Clarke 2000. Trials under consideration were evaluated for inclusion and methodological quality, without consideration of their results. This was separately assessed by each author. Discrepancies were resolved by discussion. There was no blinding of authorship.</P>
<P>Quality scores for concealment of allocation were assigned to each trial, using the criteria described in Section 6 of the Cochrane Handbook (Clarke 2000). A = adequate, B = unclear, C = inadequate, D = not used.</P>
<P>In addition, quality scores were assigned to each trial for use of placebo, blinding of outcome assessment and completeness of follow-up as follows:</P>
<P>Use of placebo:<BR/>(A) placebo - yes;<BR/>(B) placebo attempted;<BR/>(C) no placebo;<BR/>(D) unclear.</P>
<P>For blinding of assessment of outcome:<BR/>(A) Double-blind, neither investigator nor participant knew or were likely to guess the allocated treatment.<BR/>(B) Single-blind, either the investigator or the participant knew the allocation. Or, the trial is described as double-blind but side effects of one or other treatment mean that it is likely that for a significant proportion (&lt;/= 20%) of participants the allocation could be correctly identified.<BR/>(C) No blinding, both investigator and participant knew (or were likely to guess) the allocated treatment.<BR/>(D) Unclear.</P>
<P>Completeness of follow-up:<BR/>(A) &lt; 3% of participants excluded;<BR/>(B) 3% - 9.9% of participants excluded;<BR/>(C) 10% - 19.9% of participants excluded;<BR/>(D) 20% or more of participants excluded;<BR/>(E) unclear.</P>
<P>Data were independently extracted by the two reviewers and double entered. Discrepancies were resolved by discussion. Whenever possible, unpublished data were sought from investigators.</P>
<P>All eligible trials were included in the initial analysis. Sensitivity analysis was planned to evaluate the effect of trial quality by including trials given quality scores of A for allocation concealment, use of placebo, and blinding of primary outcome assessment and an A or B score for completeness of follow-up.</P>
<P>The meta-analysis was conducted using a fixed-effect model (Meta-View 4.1). Summary statistics for dichotomous variables are reported as relative risk (RR) with 95% confidence intervals, while summary statistics for continuous variables are reported as weighted mean difference with 95% confidence intervals.</P>
</APPENDIX_BODY>
</APPENDIX>
</APPENDICES>
<EXTENSIONS>



<EXTENSION ID="AFF_4805_1" NAME="PERSON" REVMAN_VERSION="5.1.0" TYPE="ADDRESS"><ALIAS ALIAS_ID="4805"><ADDRESS><DEPARTMENT>School of Paediatrics and Reproductive Health</DEPARTMENT><ORGANISATION>The University of Adelaide</ORGANISATION><CITY>Adelaide</CITY><REGION>South Australia</REGION><COUNTRY CODE="AU">Australia</COUNTRY></ADDRESS></ALIAS></EXTENSION><EXTENSION ID="AFF_5B46BAC782E26AA201D66C39740F85A3_1" NAME="PERSON" REVMAN_VERSION="5.1.0" TYPE="ADDRESS"><ALIAS ALIAS_ID="5B46BAC782E26AA201D66C39740F85A3"><ADDRESS><DEPARTMENT>Department of Obstetrics and Gynaecology</DEPARTMENT><ORGANISATION>Lyell McEwin Hospital</ORGANISATION><CITY>Adelaide</CITY><COUNTRY CODE="AU">Australia</COUNTRY></ADDRESS></ALIAS></EXTENSION><EXTENSION ID="AFF_15869_1" NAME="PERSON" REVMAN_VERSION="5.1.0" TYPE="ADDRESS"><ALIAS ALIAS_ID="15869"><ADDRESS><DEPARTMENT>ARCH: Australian Research Centre for Health of Women and Babies, The Robinson Institute, Discipline of Obstetrics and Gynaecology</DEPARTMENT><ORGANISATION>The University of Adelaide</ORGANISATION><ADDRESS_1>Women's and Children's Hospital</ADDRESS_1><ADDRESS_2>72 King William Road</ADDRESS_2><CITY>Adelaide</CITY><ZIP>5006</ZIP><REGION>South Australia</REGION><COUNTRY CODE="AU">Australia</COUNTRY><PHONE_1>+61 8 81617647</PHONE_1><PHONE_2>+61 8 81617000</PHONE_2><FAX_1>+61 8 81617652</FAX_1></ADDRESS></ALIAS></EXTENSION></EXTENSIONS>
</COCHRANE_REVIEW>